The Humoral Response of Sows and Young Pigs to Foot and Mouth Disease Vaccination. by Francis, Michael James.
THE HUMORAL RESPONSE OF SOWS AND YOUNG PIGS TO 
FOOT AND MOUTH DISEASE VACCINATION
By
Michael James Francis
Wellcome Biotechnology Ltd, P irbright, Woking, Surrey 
In collaboration with 
Department of Microbiology, University of Surrey
1 9  8 5
This thesis was submitted in fu lfi lm ent of the degree of Doctor of 
Philosophy.
ProQuest Number: 27558449
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com plete manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 27558449
Published by ProQuest LLO (2019). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLO.
ProQuest LLO.
789 East Eisenhower Parkway 
P.Q. Box 1346 
Ann Arbor, Ml 4 81 06 - 1346
SUMMARY
Groups o f pregnant sows were inoculated w ith  type On fo o t and mouth 
disease (FMD) o il emulsion vaccine at various times before farrowing and 
samples of the sow's serum, colostrum and milk, and piglets serum wære 
collected for analysis.
Pregnant sows responded well to  vaccination regardless o f th e i r  
s ta te  o f gestation. Single vaccination produced p ro te c t ive  leve ls  of 
antibody in  three out of four sows while  double vaccination produced 
protective leve ls  in a l l  s ix  sows tested. Although there was no 
evidence o f a f a l l  in the n e u tra l iz in g  antibody t i t r e s  over one year 
post vaccination the IgG antibody population did show signs o f a change 
in i t s  heterogeneity and a v id i ty .
No FMD n e u tra l iz in g  antibodies were detectab le in  the p ig le ts  serum 
at birth  but they were present l .B h r  after suckling and peak t i t r e s  were 
reached one to  three days la te r .  Samples o f co lostrum /m ilk  co llec ted  
from d i f fe re n t  tea ts  three days a f te r  farrowing showed s ig n i f ic a n t  
(P<0.005) fo re  to  hind v a r ia t io n .  A s ig n i f ic a n t  co rre la t io n  was also 
observed between the sow's serum t i t r e s  and colostrum t i t r e s  at 
farrowing (r=0 .90), and between sows colostrum t i t r e s  at fa rrow ing and 
th e ir  th ree day old p ig le ts  serum t i t r e s  (r=0 .99).
When sows were vaccinated 12 to  13 days before farrowing (dbf) the 
predominating n e u tra l iz in g  antibody at p a r tu r i t io n  was IgM and the 
observed h a lf- l iv e s  of the m aternally  derived antibodies in the p ig le ts  
were short (four to eight days). However, when sows were la s t
vaccinated 30 to  32dbf, the m aternally  derived n e u tra l iz in g  antibodies 
in the p ig le ts  were predominantly IgG and the observed h a l f - l i v e s  were 
seven to  21 days. I f  co rrec t ions  were made fo r  increase in blood volume 
the decay rates o f IgM antibodies in p ig le ts  were seven to  18 days while 
the decay rate for IgG was greater than 408 days.
The response of young pigs to FMD vaccination and the e f fe c t  of 
maternally  derived antibodies on th is  response was also stud ied. 
P ig le ts  born to  non-immunized sows were able to  respond to  vaccination 
when one week o ld , w ith  no de le te r ious  e f fe c t  on th e i r  growth ra te . 
However, to ta l  suppression o f the vaccination response was observed in 
one, two and fo u r  week old p ig le ts  born to  immunized sows and a p a r t ia l  
suppression occurred in e igh t week o ld p ig le ts .  This maternal antibody 
suppressive e f fe c t  could be mimicked by the passive tra n s fe r  of 
n e u tra l iz in g  IgG antibodies in to  older p ig le ts .
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CHAPTER 1 
INTRODUCTION AND LITERATURE REVIEW
1.1 INTRODUCTION
While o i l -  emulsion vaccines appear to  provide the best means of
prophylaxis against FMD in pigs there are s t i l l  mar^ questions relating  
to  the response of sows and young p ig le ts  th a t need to  be answered.
;
To date, l i t t l e  a tte n t io n  has been d irec ted  towards the sows
vaccination regimen and the class o f neutralizing antibody class present 
in  the ir  sera and co los tra  at time o f fa rrow ing . This is  important 
because the anti-FMD antibody class predominating at th is  time may
a f fe c t  both the uptake and persistence ( h a l f - l i f e )  o f m aternally  derived 
antibodies in  the young piglets. Furthermore, there is  a need to 
determine the e a r l ie s t  age at which p ig le ts  are competent to  respond to 
o i l  vaccination and whether passively acquired antibodies have any
suppressive e f fe c t  on th is  response, since reports  to  date are unclear 
on th is  matter.
This study has the re fo re  been designed to  in ve s t ig a te :
1. The e f fe c t  o f the sow's vaccination regimen on her serological 
response, and the re la t io n s h ip  between the sow's immune status at 
farrowing and th a t o f her l i t t e r  fo r  one week after  b i r t h .
2. The h a l f - l i v e s  of neutralizing antibodies in the p ig le ts  and the 
fa c to rs  a f fe c t in g  the ra te  o f decay, such as the antibody class and 
the p ig le t 's  growth rate.
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3. The response o f young piglets, born to  vaccinated and unvaccinated 
sows, to  o i l  vaccination.
4. The e f fe c t  of in jec ted  antibody on the pig's response to o i l  
vacc ina tion .
The results obtained w ill provide useful in formation on the 
relationship between passive protection and ac tive  immunization against 
FMD in  th is  species and, thus, should enable vaccine manufacturers to 
recommend vaccination regimens fo r  breeding stock on a more rational 
basis.
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1.2 PORCINE IMMUNOLOGY
a) The immune system of SŒüs and th e ir  young
Three n^nn immunoglobulins, analogous to human Ig^^ I< \^ and 1( 4^,
have been id e n t i f ie d  in pig serum and colostrum (Kim, Bradley and 
Watson, 1956(b); Karlsson, 1966) and o f these IgG was the f i r s t  to  be 
iso la ted  (Metzyer and Fougereau, 1967). These workers described two 
d is t in c t  subclasses, IgG-j and IgGL, with id e n t ic a l  sedimentation 
c o e f f ic ie n ts  o f 6 .7 -7 .OS but which could be separated by th e i r  
electrophoretic m obilities. More recen tly  th ree , poss ib ly  four, 
subclasses o f IgG have been id e n t i f ie d  by K a l tre id e r  and Johnson (1972). 
In 1969, Porter id e n t i f ie d  an IgM r ich  fraction from serum which was 
contaminated w ith  a similar molecular weight protein, az Macroglobulin. 
Porcine IgM has since been shown to  occur as a pentameric form in  serum 
w ith  a sedimentation c o e f f ic ie n t  o f 17.8-19.OS (Bourne, 1971; Porter and 
A llen , 1972). In the same year, Bourne (1969) successfu lly  iso la ted  
porcine IgA from milk and colostrum, and th is  has also been iso la ted  
from serum, sa l iva ,  u r ine , respiratory t r a c t  secretion and vaginal 
mucous (Porter and A l le n , 1972). Porcine IgA in external secretions 
occurs mainly as dimeric (9.3-9.5S or 10.8-11.6S) molecules but in  serum 
i t  occurs as monomeric (6 .4 -7 .OS) and dimeric (9.3-9.5S) molecules in 
equal p roportions. The 10.8-11.6S secretory IgA also has a secretory 
component w ith  a sedimentation value of 4.3S and a molecular weight o f 
80-90,000 dal tons. Two s t ru c tu ra l  forms of IgA have been id e n t i f ie d  in 
pigs, similar to  IgA-j and IgAg in man (Bourne, 1971).
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Immunoglobulin G is  q u a n t i ta t iv e ly  the major antibody class in 
porcine serum and colostrum, co n s t i tu t in g  80% o f the t o ta l .  C urt is  and 
Bourne (1971) found that the concentration IgG in colostrum vms 
approximately 3-fold higher than in sow serum (Table 1 .1 ), the mean 
value being between 50 and 60mg/ml. However, the actual concentration 
o f IgG in colostrum may vary between 11.74 and 101.39mg/ml (Inoue, 
Kitano and Inoue, 1980). A f i v e - fo ld  drop occurs in  th is  concentration 
in the f i r s t  24 hours o f la c ta t io n  fo llowed by a t h i r t y - f o l d  drop in  the 
f i r s t  week. Thus IgG accounts fo r  only 20-30% of m ilk  immunoglobulins. 
The IgA concentration i s  four times higher in  colostrum than in serum, 
although in absolute terms, i t  is  a minor component of both since the 
mean concentration of IgA in colostrum is  12.26mg with a range of 
5.63 -28 .14mg/ml (Inoue, 1981(a)). A three-fold drop in IgA con­
cen tra t ion  occurs in  the f i r s t  24 hours of la c ta t io n  but i t  s t i l l
accounts fo r  50-60% o f to ta l  m ilk  antibody. Immunoglobulin M is  present 
in  low concentration in serum (10-13%), colostrum (4%) and m ilk (18%) 
(Bourne, 1971) w ith  the mean concentration in colostrum reported as 
4.16mg/ml with a range o f 1.50-7.74mg/ml (Inoue, 1981(b)).
V i r t u a l l y  a l l  co lo s t ra l  IgG and a high proportion  o f IgM are derived 
from serum, as is  40% o f IgA. Thus, colostrum should be regarded as a 
serum transudate and not a true  secre tion , since 90% o f i t s
immunoglobulin content is  o f serum origin (Bourne and Curtis, 1973). 
Furthermore, there is  evidence to suggest th a t IgG, and IgG? are
p re fe re n t ia l ly  transferred from the serum to  the colostrum at d i f fe re n t
times post partum (Franek et aT^ , 1975). The source o f milk
immunoglobulin is  d iffe re n t, about one -th ird  to  one-ha lf o f IgG and IgM 
are derived from serum but only a minor amount o f IgA, (2-17%). Thus, 
the bulk o f m ilk  immunoglobulins, in  p a r t ic u la r  IgA, are formed lo c a l ly
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in  mammary lymphoid t issue . Colostrum is  therefore suited to i t s  
immunological role of providing the newborn pig let with circulating  
immunoglobulins, whereas milk is adapted to a role of providing 
intestinal trac t antibody during the post-natal and pre-weaning period 
(Bourne, 1976).
I t  has been reported that in p iglets, IgA production does not
con tr ibu te  sign ificantly  to  serum leve ls  during the f i r s t  7-12 days of 
l i f e ,  nor does IgG production during the f i r s t  14 days. However, IgM is  
produced in the f i r s t  week of l i f e  (C urt is  and Bourne, 1973), reaching a 
peak at 14 days a f te r  b i r th  in  colostrum-deprived p ig le ts  (Klobasa, 
Werhahn and B u t le r ,  1981). A study o f c e l ls  in  the in te s t in a l  t r a c t  has 
shown tha t there is  a s l ig h t  predominance o f IgM secre ting  c e l ls  over 
IgA secreting c e l ls  during the f i r s t  3 weeks of l i f e ,  a f te r  which time 
IgA secre ting  c e l ls  predominate. Immunoglobulin G secreting c e l ls  are 
present in considerable but smaller numbers at a l l  stages. At one month 
o ld the plasma c e l l  population is  s im ila r  to th a t seen in the adults 
(Brown and Bourne, 1976) and an interesting observation is  th a t the 
spleen and mesenteric lymph nodes o f either adu lt or young pigs contain
r e la t iv e ly  few mature plasma c e l ls  when compared to  the laminar propria
o f the gut (Bourne, 1976). Thus i t  appears t h a t , in  the p ig , the gut is  
an important s i te  fo r  the production o f a l l  antibody classes.
Immunological competence of the pig foetus has been demonstrated
after the 55th day of gesta tion  (Bourne et 1974) and the main
immunoglobulin involved was 19S IgM, w ith  smaller amounts o f 4S IgG, 75
IgG, 195 IgG and 75 IgA. The lack o f 95 and 115 IgA at th is  time
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suggested that the p ig let^  gut immune system had not developed fu l ly .  A 
study of young piglets has shown that by 16 weeks of age thi^/ possess a 
mature serum immunoglobulin p ro file  (Curtis and Bourne, 1971).
I t  IS generally accepted that foetal pigs develop within an 
impermeable epitheliochorial placenta and there is therefore normally no 
placental transmission of maternal immunoglobulins (Nelson, 1932; Young 
and Underdahl, 1949; 1950; Brambell, 1958; S terz l, Rejnek and Travicek,
1966). So the newborn piglets are v ir tu a l ly  devoid o f immunoglobulins
birth Kim et a^, 1966(a); Porter, 1969; Bourne j&b eUU 1974).
However, some workers have observed th a t in  concentrated globulin 
f ra c t io n s  of sera from colostrum-deprived p ig le ts  antibodies may be
detected (Myers and Segre, 1963). Porter (1969) i d e n t i f ie d  a component 
present at a concentration of <50yg/ml which showed antigen ic
determinants in common w ith  IgG and th is  appears to  be an actively  
synthesised immunoglobulin which is  made up o f ty p ic a l  IgG heavy and 
l ig h t  chains but which has a sedimentation c o e f f ic ie n t  o f only 45
( Prokesova et a l , 1969; Jonsson, 1973). Others have also found varying
amounts o f IgG, from trace leve ls  up to 225yg/ml, in  the serum of 
p ig le ts  p r io r  to t h e i r  f i r s t  colostrum intake (Yabiki, Kashimazaki and
Nomioka, 1974; V ior et a^, 1975; 5enft, Klobasa and Habe, 1976;
Movsesijan et a l , 1977; Chaniago et a l , 1978). Concentrations o f IgG as 
high as 1.3 to  3.8mg/ml have been reported (Payne and Marsh, 1962) 
although these may have been due to  placental damage at birth . While 
the func tion  o f these p reco los tra l immunoglobulins remains la rg e ly
obscure, i t  has been suggested th a t they may play a ro le  in  competence
o f the young pig to  respond to  an antigen ic  stimulus (Jonsson, 1973).
However, since they appear to  be a n t ig e n ic a l ly  distinc t from adult IgG 
and are present in  such low concentrations i t  is  reasonable to  assume
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that they do not provide the young pig with any s ignificant protection 
against infection and thus the transfer of maternal antibodies from the
colostrum intestinal absorption is major importance to the
survival of the neonatal pig.
Immediately a fter  birth the young pigs intestine has the capacity to
absorb antibodies and other macromolecules present in the sows colostrum
(McArthur, 1919; Nelson, 1932; 1934; Lecce, 1966). These antibodies are
subsequently concentrated in the piglets blood and lymphatic systems
(Earle, 1935; Foster et a^, 1951; Jakobsen and Moustgaard, 1950;
Nordbring cHid Olsson, 1957; Rutquist, 1958) ;md thus provide passive
pro tec tion  against in fe c t io n  (McArthur, 1919; Nelson, 1934). The
transmission of maternal antibodies to  the p ig le ts  has been extensively
reviewed by Brambell (1970) who has proposed a possible mechanism fo r
the absorption of immunoglobulins in the gut (Brambell, 1966). The
endoderm c e l ls  of the neonatal in te s t in e  would absorb pro te ins in
so lu t ion  by p inocytos is . The immunoglobulins transmitted would then
become attached to  s p e c if ic  receptors in the w a lls  o f the vacuoles which
would pro tec t them from degradation, fo l lo w ing  the junction of the
pinocytotic phagosomes w ith  lysosomes to  form phagolysosomes, before
they are passed out in to  the circulation. This hypothesis has been
supported by subsequent experimental data (Lecce, 1966; Perry and
Watson, 1967(a); Burton and Smith, 1977; Szeky et 1979; Smith,
Burton and Munn, 1979; Werhahn, Klobasa and B u t le r ,  1981). Although i t
appears th a t th is  absorption mechanism is  se le c t ive  fo r  immunoglobulins
from d i f fe re n t  species (W it ty ,  Brown and Smith, 1969; Burton and Smith,
1977) i t  has been shown th a t the major immunoglobulins (IgG, IgM and
IgA) from the same species are a l l  n o n -se le c t ive ly  absorbed (Brown, 
)
1976). The pigs capacity to  absorb immunoglobulin from colostrum
24
ra p id ly  dec lines, fo l lo w ing  the f i r s t  order reaction ra te  law, during 
the f i r s t  24hr after birth (Speer et a l , 1959) and generally ceases
altogether a f te r  24 to  48hr (Speer et a [,  1959; M ille r  et a l , 1962;
Yabiki, Kashiuazaki and Namioka, 1974; Vior  a^, 1975; Murata and
Namioka, 1977; Werhahn, Klobasa and B u t le r ,  1981). However, the 
duration of immunoglobulin absorption is related to the nutritional 
s ta te  o f the p ig le ts  (Lecce and Matrone, 1960). Thus p ig le ts  th a t  were 
allowed to  nurse immediately after b i r t h ,  or th a t were fed cows' milk, 
ceased to absorb immunoglobulins at 12 hours after b i r t h ,  while  p ig le ts  
tha t received only water or were starved re ta ined the a b i l i t y  to  absorb 
fo r  at lea s t 106 hours (Payne and Marsh, 1962). S im ila r  observations 
have been made using p o lyv in y lpy rro l ido ne  (PVR). In th is  example 
nursing pigs lo s t  t h e i r  capacity  to  absorb PVP 24-36 hours a f te r  b irth ,  
whereas starved pigs were s t i l l  able to  absorb PVP when 86 hours old 
(Lecce and Morgan, 1962). One explanation fo r  th is  phenomenon is  tha t 
once the e p i th e l ia l  c e l ls  o f the in te s t in a l  mucosa have been saturated 
w ith  gammaglobulins, or other solub le p ro te ins , fu r th e r  absorption 
ceases. The p ro tec t ion  o f maternal antibodies from p ro te o ly t ic  enzymes 
during protein absorbtion can be sa tis fac to r ily  explained by the 
presence o f a trypsin inhib itor in  the sows colostrum (Laskowski, 
Kassel 1 and Hagerty, 1957) which has been shown to have a p o s it ive  
in f luence  on IgG and IgA absorption (Jensen and Pedersen, 1982). Indeed 
i t  has been suggested th a t the ea r ly  cessation o f protein absorption is  
due not so much to gut c losure as to  the s ta r t  o f p ro te in  d igestion  as 
the level o f i n h ib i t o r  f a l l s  (Ba in tner, 1973). Varia t ions observed in 
c o lo s t ra l  immunoglobulin leve ls  may be p a r t ly  due to  d if fe rences in  the 
output by the sow which in tu rn  may be influenced by the d i s t r i c t ,  
number of p a r tu r i t io n s ,  kind o f feed, type o f farming and the number o f 
sows raised on the farm (Inoue, Kitano and Inoue, 1980). Furthermore,
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v a r ia t io n  in c o lo s t ra l  IgG concentration has been shown to increase 
rapidly up to 12 hours ^]st partum, thereafter decreasing rapidly,
(Frenyo eM: a^  ^ 1980/81) and i t  is interesting to note that antibody
t i t re s  m^ y also vary in colostrum samples collected from d ifferent
tea ts  o f the same sow (Perry and Watson, 1967(b); Wu, Wang and Chang, 
1980).
Bourne (1971) showed tha t 24 hours a f te r  b i r th  the peak 
concentration of maternally derived IgG in piglets was 18.7 to 39mg/ml 
and th is  f e l l  to  a minimum value o f 6.3mg/ml w ith in  the fo l lo w in g  36-40 
days. The IgA and IgM peak concentrations were 2.1 to  8.6mg/ml and 1.1 
to 2.0mg/ml respectively at 24 hours and these both f e l l  very ra p id ly  to  
reach minimum values o f 0.15mg/ml and 0.6mg/ml w ith in  17-22 and 8-14 
days resp ec t ive ly .  I t  has been ca lcu la ted  tha t the h a l f - l i v e s  o f 
passively acquired maternal IgA, IgM and IgG were 2-3.5, 1.3-4.5 and 
6.4-22.5 days re spec t ive ly  (Porter and H i l l ,  1970; C urt is  and Bourne, 
1971; Curtis and Bourne, 1973; Prochazka, Franek and Krejci, 1979; 
Frenyo et a l , 1980/81; Klobasa, Werhahn and Butler, 1981). The marked 
differences in the reported decay rates may be partly  due to  d if fe rences 
in  growth rates between ind iv idua l pigs (C urt is  and Bourne, 1971; Curtis 
and Bourne, 1973) and values may be exaggerated by the young p ig le ts ’ 
ra p id ly  expanding blood volume (Frenyo et a l , 1980/81). However, few 
authors have corrected the ir  data fo r  body weight or blood volume 
increase. One report on porcine parvovirus (PPV) has shown th a t a 
h a l f - l i f e  of 18.5 days, ca lcu la ted  in  16-24 week o ld p ig le ts ,  becomes 29 
days when corrected fo r  weight gain. Furthermore, the PPV antibody 
h a l f - l i v e s  were found to  be shorter (14 days) in  0 to  6 week o ld p ig le ts  
than in 8 to  14 week old p ig le ts  (21.7 days) (Paul, Mengeling and 
P ir t le ,  1982), suggesting th a t the rapid growth ra te  in  the younger
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p ig le ts  has a marked e f fe c t  on the observed h a l f - l i f e  o f passive 
antibody. I t  is  in te re s t in g  to  speculate th a t the short h a l f - l i f e  of 
c o lo s t ra l  IgA in p ig le t  serum may be the result of i t s  redistribution to  
mucosal s i te s  since i t  has been demonstrated th a t serum-derived IgA is  
s e le c t iv e ly  transported from serum in to  re sp ira to ry  t r a c t  secretions 
(Bradley, Bourne and Brown, 1976). This would confer add it iona l surface 
immunity to  th a t provided by m ilk IgA which coats the in te s t in a l  
ep ithe lium  o f the young pig (Porter and A l le n , 1972).
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b) The response o f sows and young pigs fo l lo w in g  exposure to  antigens,
other than FMD v irus
The immune response of sews and piglets to both non-environmental
antigens ( fo r  example, he te rospec if ic  red blood c e l ls ,  f e r r i t i n ,  bovine 
serum and egg white) and environmental antigens ( fo r  example, nematodes, 
bacteria and viruses) has been examined.
( i ) Non-environmental antigens
Parenterally administered sheep red blood c e l ls  (SRBC), bovine 
serum or egg white do not produce a measurable sero log ica l response in 
piglets under 8 weeks old which have been deprived of colostrum. 
However, i f  the animals receive 'normal' colostrum they respond at 3 
weeks o ld which suggests th a t colostrum in take is  important fo r  the
development o f ac tive  immunity and i t  has been suggested th a t maternally  
derived immunoglobulins may be required fo r  the recogn it ion  o f fo re ign  
antigens (Hoerle in , 1957). The f i r s t  antibodies formed in germ-free 
p ig le ts  a f te r  immunization w ith SRBC are o f macroglobulinémie (IgM) 
nature w ith  a sedimentation c o e f f ic ie n t  o f 193. They are fo llowed by 
the formation o f more slow ly sedimenting 75 antibodies of the IgG type 
(Proskesova e t a l , 1969). However, using keyhole limpet haemocyanin as
an antigen, Kim, Bradley and Watson (1968) showed tha t in  the true
primary response o f germ-free p ig le ts  the f i r s t  antibody synthesised was 
195 IgG which was a n t ig e n ic a l ly  id e n t ic a l  to  la te  immune 75 IgG and 
d is t in c t  from 195 IgM. In add it ion  there was a sequential synthesis o f 
75 IgG before the appearance o f IgM or IgA. Furthermore th is  response 
was not dependent on the p ig le ts  having p re -e x is t in g  'natural' 
antibodies or maternally derived antibodies (Kim, Bradley and Watson,
1967).
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The passive transfer of SRBC specific antibodies via colostrum 
can in terfere  with active antibody production during the f i r s t  3 to 6 
weeks of l i f e  and can also sensitise the piglets to anaphylactic shock 
when the^ are challenged with the antigen intravenously (Hoerlein, 1957) 
which suggests that Ig E -lik e  antibodies may also be passively passed 
from sows to piglets.
More recent studies using a hapten-carrier conjugate of t r i n i -  
trophenylated sheep erythrocytes (TNP-SRBC) have sh(^ light on the
regu la t ion  by maternal antibodies of the immune response in neonatal 
piglets. I t  was found in th is  system tha t passive ly acquired maternal 
antibody would completely in h ib i t  the in  v i t r o  primary response to  SRBC 
while leaving the response to  TNP in tact. I t  was suggested th a t the
maternal antibody was regulating the in v i t r o  response at the B-ce ll
leve l since T-cell helper func tion  to  SRBC could not have been in h ib ite d
in  order fo r  an anti-TNP response to have remained in tact. In these 
experiments, the regu la tion  o f immune responses in the p ig le ts  by
maternal antibody disappeared before they were 3 months o f age 
(Muscoplat, Setcavage and Kim, 1977).
Using a f e r r i t in  antigen the influence of the route of
vaccination on the systemic and local immune response in the la c ta t in g  
sow was examined and i t  was found th a t intramammary vaccination was
superior to  intramuscular vaccination fo r  the production of not only
loca l but also systemic responses. Although a l l  three major 
immunoglobulin classes (IgG, IgM and IgA) were involved there was a 
s l ig h t l y  higher percentage involvement o f IgA fo l lo w in g  the intramammary 
stimulation than a fter  stimulation 1^ / other routes. Furthermore,
vaccination o f one mammary gland gave r is e  to  significant antibody
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a c t i v i t y  in other glands (Bourne, Newby and Chidlow, 1975). Thus the 
route of vaccination of the d<m could be important in providing not only
local in te s t in a l  tract immunity but also systemic protection to the
young suckling p ig .
( i i )  Environmental antigens
Nematodes - In fe c t io n  o f pregnant sows w ith  nematode parasites 
(Hyostrongylus rub idus) e l i c i t s  a strong a g g lu t in in  response in the
serum and colostrum of predominantly the IgG antibody c lass. Such 
antibodies are passed to  the young pigs w ith in  4 days o f b i r th  and the ir  
presence appears to  aid the production o f a gg lu t in ins  in the p ig le ts  i f  
they subsequently become in fe c ted , while  also reducing the ir  paras ite  
burden (Smith and Herbert, 1976).
Bacterial antigens - Toxigenic s tra in s  o f Escherichia c o l i  when 
present in  the pig gut can re s u l t  in neonatal d iarrhoea which is  an 
important cause of death. Studies on the serum o f weaned p ig le ts  and 
sows in fec ted  w ith E. c o l i  have shown th a t the sp e c if ic  antibody is  
largely confined to  the IgM class (Porter and Kenworthy, 1969; Porte r,
1969) and when passively acquired by p ig le ts  has a h a l f - l i f e  o f between
I . 3  days (Porter and H i l l ,  1970) and 4.3 days (Curtis and Bourne, 1971). 
Colostrum has also been shown to  have a high proportion o f IgA directed
against E. c o l i  although a f te r  passive aquisition i t  did not appear to 
co n tr ibu te  greatly to  the piglets' serum antibody t i t r e s .  On the basis 
o f th is  observation i t  was concluded th a t  these 11.6S secretory IgA 
antibodies could not be absorbed by the young pig (Porte r, 1969). 
Subsequently, however. Bourne (1971) has shown th a t  p ig le ts  can absorb
I I .6 3  IgA and i t  was concluded th a t previous re s u lts  (P o rte r, 1969) may 
be explained by the short h a l f - l i f e  of th is  form of IgA compared with
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9.5S serum IgA. Further work (Porte r, Noakes and A llen , 1970) has 
confirmed the predominance of 11.65 IgA directed against E. coli in pig 
secretions. In addition a low molecular weight component active against 
E. c o l i , and antigenically similar to IgG, has been identified  in
p re -co lo s tra l p ig le t  serum but i t s  func tion  remains unclear.
Colostrum-deprived piglets f a i l  to produce antibody to
d ip th e r ia  toxo id inoculated in t ra p e r i to n e a l ly  at 3 weeks of age and 
respond only s l ig h t l y  to  tetanus toxo id  administered in  the same manner.
However, th is  immunological de fic iency  can be overcome by the suckling 
of colostrum, or by adminstration o f immune swine or horse serum (Segre 
and Kaeberle, 1962). Furthermore, colostrum-deprived p ig le ts  fed on 
a r t i f i c i a l  bovine m ilk su b s t i tu te  responded to  E. c o l i  antigen at an 
e a r l ie r  age than immune colostrum fed l itterm ates, suggesting th a t  the 
immune response may be suppressed by the presence o f passively acquired 
antibody (Porter and H i l l ,  1970). Passively acquired antibodies also 
suppress the number o f immunoglobulin secreting c e l ls  in  the in te s t in e  
o f 19 day old p ig le ts  which have been fed h eat-k il led  E. c o l i  (Watson, 
Bennell and Chianiago, 1979). The suppressive e f fe c t  o f passively 
acquired antibodies has been observed w ith  other b a c te r ia l  antigens, fo r  
example Bordete lla  bronchiseptica (Pedersen and Jensen, 1980), 
Salmonella typh im irium  (Senft and Heckelmann, 1980) and Brucella abortus 
(Hoerle in , 1957).
As noted e a r l ie r  the route o f ino cu la t io n  in f luences the class 
of antibody which is  formed. For instance, oral immunisation provoked 
secretion o f IgA antibodies in  10-day-old p ig le ts  (Porter et a l , 1974), 
whereas intramammary and intramuscular inocu la t ions  in the la c ta t in g  sow 
provoked predominantly IgG antibodies in  both the serum and
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colostrum. Other antibody classes tha^ were provoked twere IgM by 
intramuscular in jection, and IgM and Ic^^ equally, intramammary 
in jection (Chidlow and Porter, 1977).
Viral antigens - Transmissible gastroenteritis (TGE) is an 
enteric v ira l disease which causes diahorrea and high mortality in pigs 
under 2 weeks o ld . In the sow infection with TGE e l i c i t s  the production
of IgA class antibodies in m ilk while intramuscular or intramammary 
in je c t io n  of v irus  results in predominantly IgG antibodies in  th is  
secre tion . I t  is  important to note tha t immunity in p ig le ts  is  best 
a f te r  ingestion  of IgA immunoglobulin (Bohl et a l , 1974; Bohl and S a if ,  
1975; S a if  and Bohl, 1977; 1979). A reason fo r  th is  is  th a t there is  
se le c t ive  binding o f IgA to  intestinal e p i th e l ia l  c e l ls  which may act as 
an immunological barrier to  the attachment o f the v irus  (S a if  and Bohl, 
1979).
Rotaviruses have frequently been associated w ith  m ild diarrhoea 
in piglets both at and before weaning but co lostrum-deprived p ig le ts  
experimenta lly  in fec ted  develop severe diarrhoea and q u ick ly  d ie . 
However, piglets can be protected for 37 days by feeding bovine 
colostrum conta in ing rotavirus-neutralizing a c t i v i t y  and piglets trea ted  
in  th is  way are s t i l l  capable of developing t h e i r  own natural immunity 
(Bridger and Brown, 1981). The anti-rotavirus antibodies in  colostrum 
are predominantly IgG and IgM while  those in m ilk  and faeces are 
predominantly IgA (C orth ie r and Franz, 1981) and i t  is  the IgA 
antibodies th a t provide high long-lasting antibody a c t i v i t y  in  lac tea l 
secretions (Hess and Bachmann, 1981). Thus p ro tec tion  from ro ta v iru s  
appears to  invo lve a s im i la r  mechanism to  immunity to  TGE.
32
Aujeszky's disease, also known as pseudorabies, is an acute
infectious disease that is characterized by signs and symptoms of
central nervous system disturbance. Sows which hzn/e been infected with 
Aujeszky's disease virus (ADV) are v ir tu a l ly  immune for l i f e  (Akkermans,
1970) and w il l  secrete antibodies in the colostrum after every farrow 
(Kojnok and Surjan, 1963; Akkermans, 1970). The colostral antibody can
have a t i t r e  11 to  1 6 - fo ld  greater than the circulating antibody but
th is  w ill  decline ra p id ly  within 24 hours (McFerran and Dow, 1973). 
Unlike TGE, natural exposure to ADV e l i c i t s  a major IgG antibody 
response, with minor q u a n t it ie s  of IgM, in  colostrum (S a if and Bohl, 
1977). The h a l f - l i f e  o f maternally derived ADV antibody in  p ig le ts  over 
the f i r s t  4 weeks of l i f e  is  8.5 days (McFerran and Dow, 1973). Such 
antibodies can p ro tec t 1-week-old p ig le ts  against contact challenge w ith 
ADV and w i l l  not in terfe re  with  an ac tive  antibody response in 2 - week 
old p ig le ts  vaccinated w ith  a DEAE dextran vaccine (Wittmann and 
Jakubik, 1979). However, maternal antibodies tra n s fe rred  from sows 
vaccinated w ith  an o i l  vaccine, while  providing at leas t 3 weeks passive 
p ro tec tion  against ADV, w i l l  prevent the ac tive  formation o f 
n e u tra l iz in g  antibodies in  1, 2 or 3 week old p ig le ts  when vaccinated 
with an o i l  vaccine (Wittmann, 1981). Assuming th a t these observations 
are accurate, i t  is  possib le th a t DEAE dextran adjuvant may be able to  
overcome the suppressive e f fe c t  o f passive ADV antibody.
Swine in f luenza  is  a v i r a l  re sp ira to ry  disease which produces 
bouts of dyspnoea and coughing fo llow ed, generally, by a rapid recovery. 
P ig le ts  develop high antibody t i t r e s  in th e i r  serum w ith in  30hr of 
suckling from immune sows (Young and Underdahl, 1950). In fe c t io n  of 
p ig le ts  possessing such m aternally  derived antibodies may re s u lt  in 
c l in i c a l  disease but the frequency and ease o f v i r a l  isolation is
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related to the concentration of anti-influenza antibody present at the 
time of exposure (Renshaw, 1975; Mensik et a l , 1976). The concentration 
of maternal antibody present at the time infection also influences 
the active immune response o f the host. Thus, i f  the concentration is  
high the passively protected host is  not immunologically stimulated 
(primed) while  i f  the concentration is  low the host becomes in fec ted  and 
is immunologically primed, although active antibody production is not 
always seen. I t  has been suggested (Uhr and Mol 1er, 1968) tha t high 
concentrations of passive antibody exert suppression through a 
peripheral effec t, by masking an tigen ic  determinants and preventing them 
from reacting  w ith  receptors on immunocompetent ce lls , whereas lower 
concentrations o f passive antibody have a centra l e ffec t, by combining 
w ith  antigen at a c e l lu la r  leve l and thus reducing the immunocompetence 
of the lymphoid system (Feldmann and Diener, 1970; Renshaw, 1975). 
Other studies on swine in f luenza have shown th a t p ig le ts  in fec ted  or 
immunized when one day old produce antibodies w ith in  5 days and a 
s im ila r  response has been shown in both colostrum-fed and colostrum 
deprived p ig le ts  (Mensik e t a l , 1976).
Hog cholera virus (HCV), also known as c lass ica l swine fever 
virus, causes a h igh ly  in fe c t io u s  septicaemia characterized by 
generalized haemorrages, 95 to  100 percent morbidity, and almost as high 
m ortality . As long ago as the ea r ly  1900s i t  was recognised th a t sows 
immunized against HCV transm it immunity to  t h e i r  offspring and th a t th is  
immunity was associated w ith  the p ig le ts  suckling (McArthur, 1919). 
Nursing p ig le ts  acquired s im ila r  leve ls  o f HCV antibodies to  those in 
the ir  mother's serum w ith in  24 hours of suckling and these antibodies 
have a h a l f - l i f e  o f 13 days (Coggins, 1964). The immune status o f the 
p ig le ts  depends on the in te rv a l  between vacc ination of the sow and
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farrowing and can be a t t r ib u te d  to the q u a l i ty  o f the antibodies
transmitted in the colostrum (Corthier and Charley, 1978; Precausta, 
Kato and Brun, 1983). When present at a high level, transferred 
maternal HCV antibody w il l  suppress the immune response to hog cholera 
vaccine (Coggins, 1964; Corthier, 1976; Mierzejewska et a l , 1977; 
Launais, Aynaud and Corthier, 1978; Corthier and Charley, 1978).
However, this suppressive effect can b^  overcome increasing the
vaccine v irus  dose (Coggins, 1964), and animals which have suppressive 
leve ls  o f maternal antibody are s t i l l  primed fo r  a secondary vaccination 
or v irus  challenge (Corthier, 1976; C orth ie r and Charley, 1978).
Vaccination against the CL Chinese s t ra in  can be ca rr ied  out in 7 - day 
old p ig le ts  born to  non-immune sows (Precausta, Kato and Brun, 1983) and 
w i l l  be f u l l y  e f fe c t iv e  in p ig le ts  having passive immunity when they are
1 to  2 months old (Mierzejewska et ajl ,^ 1977; Launais, Aynaud and
C orth ie r ,  1978; Precausta, Kato and Brun, 1983), at a time when p ig le ts  
are s t i l l  passive ly protected by maternal antibody (Launais, Aynaud and 
Corthier, 1978; Precausta, Kato and Brun, 1983).
In fe c t io n  w ith  porcine parvovirus (PPV) generally re su lts  in 
e i th e r  s u b c lin ica l or mild c l in ic a l  s igns, although natural exposure o f 
susceptib le  swine during gesta tion  o ften re s u lts  in  embryonic and fo e ta l 
death (C artw right and Huck, 1967). Passively acquired antibodies have 
been shown to in terfere  with  the ac tive  immunity to  l iv e  PPV (Paul,
Mengeling and Brown, 1980). The b io lo g ica l h a lf- l ive s  o f antibodies to  
PPV, unadjusted and adjusted fo r  body weight gain, are approximately
19.7 and 29.0 days, re sp e c t ive ly .  However, these values w ill vary with 
the age o f the p ig le t  and period over which observations are made (Paul, 
Mengeling and P i r t l e ,  1982).
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1.3 FOOT AND MOUTH DISEASE
Foot and mouth disease virus (FMDV) is a member the family 
P icornavir idae (very small, RNA-contain i ng v iruse s ) . I t  has recently
been placed in its  own genus Apthovirus (Cooper 6^ : a^, 1978), aptha
being Greek for 'vesicles in the mouth'. The Apthovirus genus is 
distinguished from the three other Picornaviridae genera (Enterovirus, 
Cardiovirus and Rhinovirus) by being unstable below pH 5.6; having a 
buoyant density in caesium chloride 1.43-1.45; æid its  c lin ica l  
manifestations (Cooper et a l , 1978).
The c l in ic a l  signs of FMD in fe c t io n  were probably f i r s t  described by 
F rac tas to r ius  in 1514 (see Bachrach, 1968). He noted tha t animals 
refused the ir  feed, and the in te r io r s  of t h e i r  mouths became permeated 
with a redness and small ves ic les , which then descended to the fe e t .  
Evidence th a t FMD was a v i r a l  in fe c t io n  was produced by Loeffler and 
Frosch (1897) who showed th a t the in fe c t io u s  agent o f the disease was 
f i l te ra b le .  This was the f i r s t  animal virus to  be described.
a) Antigenic c h a ra c te r is t ic s
Vi rus
Not only was fo o t and mouth disease^ the f i r s t  animal v irus  to  be 
discovered but i t  was also the f i r s t  v irus  in  which antigenic 
d if fe rences between s tra in s  were recognised. The existence o f more than 
one an tigen ic  type was discovered by Vallee and Carre (1922), when they 
observed th a t recovered c a t t le  in  France became re in fec ted  when brought 
in to  contact w ith  s ick animals from Germany. In a series o f carefully  
co n tro l le d  experiments they fa i le d  to  obtain cross-immunity between two 
groups o f s tra in s  and the viruses were named 0 (Oise) and A (Allemagne), 
a f te r  t h e i r  areas of o r ig in  (Vallee and Carre, 1922; Waldmann and 
Trautwein, 1926). Four years la te r ,  a t h i r d  type was described by 
Waldmann and Trautwein (1926) and ca lled  type C.
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In the 1930's there was evidence that strains of virus isolated from 
outbreaks of typical foot and mouth disease in parts of Africa did not 
f i t  into the framework of the c lassification 0, A emd C <md, in 1948, 
Galloway and his colleagues Pirbright in England, confirmed the 
presence of three additional, immunologically d is tinct serotypes by 
cross-immunity test in ca ttle  and pigs. These new strains of virus were 
isolated from regions of South Africa where types 0, A C did not 
seem to occur and were called SAT (South African te r r i to r ie s )  1, 2 and 3 
(Research In s t itu te , P irb r ig h t  report 1937-1953). In 1954 a fu r th e r  new 
type was id e n t i f ie d  at the Animal Virus Research In s t itu te , Pirbright, 
in materia l received from Pakistan and subsequently, in samples from 
India, Thailand and Hong Kong. This strain , the seventh immunologically 
d is t in c t  serotype of FMD was named ASIA 1 (Brooksby and Rogers, 1957).
In add it ion  to the seven major serotypes, immunological subtypes or 
va r ian t s tra in s  are frequently encountered in natural outbreaks o f the 
disease and give r is e  to d i f f i c u l t i e s  in  c la s s i f ic a t io n  and 
immunization. Subtypes of FMDV (Waldmann and Trautwein, 1926; Bedson, 
Maitland and Burbury, 1927) were o r ig ina lly  defined as s tra in s  w ith in  a 
type which, because o f antigen ic  differences, did not cross-immunize 
completely. The c r i t e r i a  c u r re n t ly  adopted, by the World Reference 
Laboratory at Pirbright, fo r  subtype d i f fe r e n t ia t io n  are based on 
sero log ica l relationships established by a v a r ie ty  o f techniques, the 
most commonly used being complement f i x a t io n  (Pereira, 1978).
b) Structure
The in fe c t io u s  v irus  p a r t ic le  is  an icosahedron w ith  a diameter of 
23-25nm (Elford and Galloway, 1937; Bachrach and Breese, 1958; Bradish, 
Henderson and Kirkhom, 1960), a sedimentation c o e f f ic ie n t  of 140-146S 
(Breese, Trautman and Bachrach, 1960; Strohmaier, 1971) and an 
isodens ity  in  caesium chloride of between 1.42 and 1.46g/ml (Trautman 
and Breese, 1962; Terry, Clark and Rweyemamu, 1982). I t  is  composed o f
*commonly misquoted as South but should be Southern g ly
one molecule of s ing le-stranded RNA (MW 2.6 x 10^) (Bachrach, Trautman 
and Breese, 1964) and sixty copies of each of four structural proteins
(VPl-3 MW 24 X 10^ and VP4 MW 14 x 10^) (Wild, Burroughs and Brown, 
1969, Laporte, 1969). Virus harvests also contain non-infectious 
RNA-free empty capsids (Plantrose and Ryan, 1965; Graves, Cowan and 
Trautman, 1968) which have a sedimentation c o e f f ic ie n t  of 75S and an 
isodens ity  in caesium ch lo r ide  of 1.31g/ml. These 75$ p a r t ic le s  are 
composed o f 60 copies o f VPl, VP3 and VPO (a precursor o f VP2 and VP4) 
(Vande Woude, Swaney and Bachrach, 1972; Rowlands, Sangar and Brown, 
1975) and in a stab le form are capable o f evoking a s t r a in - s p e c i f i c  
n e u tra l iz in g  antibody response (Rweyemamu, Terry and Pay, 1979). 
Heating the v irus  to  56°C for 30min or lowering pH to  6.5 d is rup ts  the 
virus capsid to  produce 12S p a r t ic le s  (composed of VPl, 2 and 3), 
aggregated VP4 and free-RNA (Burroughs et a l , 1971; Talbot et a l , 1973).
This p a r t ic le  w ill  e l i c i t  complement-fixing antibodies but has a very 
low immunizing a c t i v i t y  (Brown and Newman, 1963). A fu r th e r  antigen
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with a sedimentation c o e f f ic ie n t  o f 43 and molecular weight o f 56 x 10 
was discovered in in fec ted  c e l l  ex trac ts  by Cowan and Graves (1966). 
This was re fe rre d  to  as v i ru s - in fe c t io n -a sso c ia te d  antigen (VIA antigen) 
and has subsequently been recognised as the RNA polymerase (Newman et 
aj^ 1979).
Of the fou r s t ru c tu ra l  p ro te ins VPl appears to  play a key ro le  in 
the immunizing a c t i v i t y  o f the virion since cleavage o f th is  protein by 
trypsin re su lts  in  loss o f immunizing a c t i v i t y  (Wild, Burrows and Brown, 
1969). Furthermore, VPl is  the only s tru c tu ra l  p ro te in  which, in  i t s  
iso la ted  form, w i l l  evoke n e u tra l iz in g  antibodies (Laporte et a l , 1973; 
Bachrach e t a l , 1975). A more de ta ile d  study o f enzymic and chemical 
cleavage fragments of 0-j Kaufbeuren VPl has id e n t i f ie d  two areas 
(between amino acids 138-154 and 200-213) which are found on the surface 
o f the v i r io n  and peptides conta in ing these regions are able to  induce
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neutralizing antibodies against the homologous virus (Strohmaier, Franze 
and Adam, 1982). Application of recombinant DNA technology has allowed 
nucleotide sequences of the virus genome to be determined, frrm which 
the primary amino (Xyid sequence VPl can be deduced. Independent 
groups of workers have used the published sequence of CL Kaufbeuren VPl 
(Kurz et a l , 1981) in order to chemically synthesize peptides 
corresponding to several regions VPl and have identified  specific
sites on the molecule (141-160 and 200-213; B it t le  jet 1982 and
144-159; P fa f f  et a l , 1982) which e l i c i t  neutraliz ing, and protective,
antibodies to  the whole virus. Although such peptides perform with an
efficiency of 1-10% of tha t of the ina c t iva ted  virus partic le , on an
equal weight basis, the t i t r e  of the antibodies produced is  several 
orders of magnitude greater than the best results obtained with the 
whole VPl protein (Arnon, Shapira and Jacob, 1983) and the antibodies
w ill mimic the subtype s p e c i f ic i t y  of the in ta c t  v i r io n  (Rowlands et a l , 
1983; Clarke et a l , 1983). Such encouraging re s u lts  have* prompted 
active  research in to  the p o s s ib i l i t y  of t o t a l l y  syn the tic  vaccines fo r  
FMD.
c) Clinical signs and transmission
C a t t le ,  swine, sheep and goats, in  th a t order, are the species most 
f re qu en t ly  a ffec ted  by FMD v irus  although a l l  ruminants and 
c loven-footed animals are susceptib le  (Bachrach, 1968). The condit ion  
is  characterized by the formation o f ves ic les on the mucous membranes o f 
the mouth, on the nose, and on the skin between and adjacent to the 
claws o f the fe e t (Shahan, 1962). In c a t t le ,  vesicles are most often
seen on the tongue and fe e t ;  in  nursing or m ilk ing  cows they may also 
appear on the udder and te a ts ,  re s u lt in g  in  v i r tu a l  cessation o f milk 
yields. Rumen and heart lesions are frequently found at necropsy.
There is  usua lly  a profuse droo ling  o f ropey saliva, and the raised
e p i th e l ia l  covering of the tongue ves ic les in v a r ia b ly  ruptures and
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sloughs o f f ,  leaving large areas raw tissue underneath. Mouth 
soreness prevents the animals eating, and ihaot lesions, which are 
usually invaded by bacteria, cause lameness (Bachrach, 1968). In pigs, 
vesicles formi on the heels and may encircle the coronet, leading to
'thimbling' as the horn detaches and the old hoof is carried downwards
1^ / new growth. Lesions may also develop on the snout and tongue but 
these are more rare in the pig. Inflammation of the foot is often so 
severe that lameness occurs and th is  is  significant in  the diagnosis o f 
the disease (Sard, 1978). Although mortality in  adult stock is  low, 
below 5%, i t  can approach 50% in young stock, with the animals dying 
without showing any signs o f in fe c t io n .  Furthermore, in breeding
stock abortion and a reduction in breeding a b i l i t y  are both common
results o f in fe c t io n .
Transmission of FMD is  p r im a r i ly  from the in fec ted  animal i t s e l f ,  
espec ia lly  during the e a r ly  f e b r i le  stage when virus is  present in  the 
blood and a l l  organs, tissues, secretions (saliva, lachryma, milk and 
semen), and excretions (sweat, urine and faeces) (Hyslop, 1970). The 
spread of FMD among animals in  close proximity probably occurs c h ie f ly  
through the dissemination of virus from saliva and foot lesions, which 
remain infectious for 9 to 11 days a fter  infection. However, the mode 
o f  transmission has not been f u l l y  e luc idated because in fe c t io n  often 
goes from one area to another or from one country to another without 
i l ln e s s  being evident in  the in te rven ing  premises. Suspected means of 
transmission include wind-borne droplet infection (Sellers amd Parker, 
1969), migratory birds (Stockman, and Garnett, 1923) and carr ie r  animals 
(van Bekkum et a l , 1959). FMD is  considered to  be the most contagious 
disease known and morbidity in fu l ly  susceptible contact stock is often 
close to 100%.
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d) Vaccines
The f i r s t  effective  vaccine against foot and mouth disease (FMD) was 
developed in the late 1930's (Waldmann, IO]be and ^ / l ,  1937). This 
vaccine, prepared frcm virus extracted frcm infected tongue epithelium 
and associated vesicular f lu id ,  used a process crF formaldehyde 
inactivation (Vallee, Carre and Rinjard, 1926) followed by aluminium 
hydroxide adsorption (Schmidt, 1936). I t  was referred to as the 
Vallee-Schmidt-Waldmann vaccine. However, as l i v e  animals were the 
source of virus the quan tity  o f vaccine th a t could be produced was 
s t r i c t l y  lim ited. In 1947, Frenkel developed a technique in which the 
epithelium and superficial t issue  o f tongues from f re s h ly  slaughtered 
c a t t le  was used to  c u ltu re  the v irus  on a large scale (Frenkel, 1950). 
The v irus  was ina c t iva ted  with formalin and adsorbed onto aluminium 
hydroxide.
Frenkel and primary t issu e  c u ltu re  vaccines, although s t i l l  in  use 
today, required a constant supply o f t issue  from recen t ly  slaughtered 
animals and suffered from the p o s s ib i l i t y  o f contamination w ith  unwanted 
pathogens. In 1962, i t  was shown th a t c e l ls  derived from baby hamster 
kidneys (BHK 21 c e l ls ;  MacPherson and Stoker, 1962) would provide a 
su ita b le  continuous c e l l  l in e  fo r  the production o f FMD (Mowat and 
Chapman, 1962). These monolayer c e l ls  were subsequently adapted to
suspension culture in 250ml vessels (Capstick et aj_, 1962; Capstick
1963). This advance enabled vaccine manufacturers to  increase th e i r  
production capacity  dramatically and there are now commercial vaccine 
production p lants operating c u ltu re  vessels w ith  capac it ies  o f 4000 
l i t r e s  (Mowat, Garland and Spier, 1978).
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e) Vaccination o f sows and young pigs
The systematic vaccination of ca ttle  during the 1950's with
aluminium hydroxide adjuvanted vaccines led to optimism about the
possib ility  of rapid eradication of FMD from the European continent. 
However, the appearance of major pig epizootics in the 1960's dashed
such optimism, particu larly  since the trad itiona l aqueous ca ttle  
vaccines appeared to be fa r  less effective  at controlling the disease in 
pigs (reviewed by de Leeuw, 1980). This led to a period cf intensive 
research in to  FMD vaccines fo r  pigs which included several studies on 
maternal antibodies and the ir  effect on protection and subsequent
vacc ination o f young pigs.
In the ea r ly  1960's studies on the immune response o f sows and the ir  
young to  the then curren t FMD aqueous c a t t le  vaccines demonstrated th a t
p ig le ts  from sows vaccinated repeatedly s t i l l  had neutralizing
antibodies at 3 to 4 months a f te r  b i r th  (van Bekkum, Frenkel and 
Nathans, 1963; Nathans, 1965). However, at 2 months o f age the antibody 
leve ls  were only s u f f i c ie n t  to  p ro tec t 50% of the p ig le ts  from l iv e  
virus challenge and attempts to boost the immune response of 6-10 week 
old p ig le ts ,  already possessing maternally derived antibodies, by 
vaccination f a i le d  (van Bekkum, Frenkel and Nathans, 1963). Even at 16
weeks the maternal antibody t i t r e  was s u f f ic ie n t  to  i n h ib i t  a
sero log ica l response to  vaccination w ith  both standard and experimental 
aqueous vaccines, the la t t e r  containing extra  antigen and a saponin 
adjuvant. In th is  study i t  was apparent th a t the level of maternal 
antibody was c r i t ic a l  thus where t i t r e s  were above 1.35 log^gSNgg there 
was no se ro log ica l response but below th is  a response to  vaccination 
could occur (Nathans, 1965). However, the p ig le ts  which showed no 
response to  primary vacc ination appeared to  have been primed because
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they produced an in te n s i f ie d  immune response to  subsequent vacc inations.
In 1966, van Bekkum showed th a t p ig le ts  from the same l i t t e r  did not 
necessarily acquire the same level of maternal antibodies. Absorption 
of maternal antibody ended 2-3 days after birth and thereafter the 
leve ls  declined w ith  a h a l f - l i f e  of 13-14days. Ind iv idua l va r ia t io n s  in 
the h a lf- l ive s  which increased with age may have been due to  d if fe rences  
in growth rates of the p ig lets . The influence of other factors such as 
the frequency of the sows*vaccination and the interval between the f in a l  
vaccination and parturition were also inves t iga ted  and both appeared to 
be responsible fo r  wide va r ia t io n s  in  passive antibody leve ls  in  the 
young. Revaccination of sows during pregnancy sometimes resu lted in 
p ro trac ted  persistence of maternal antibodies in  piglets fo r  up to  160 
days but values between th is  maximum and zero were recorded.
In the ea r ly  1970's studies ca rr ied  out using a commercial 
monovalent ' type  C  aqueous vaccine, conta in ing aluminium hydroxide and 
saponin as adjuvants, showed th a t sows and sucX/ing p ig le ts  had s im i la r  
se ro log ica l responses. In both, antibody which was detected 7 days 
after vaccination persisted f o r  approximately 90 days. The t i t r e s  in 
the p ig le ts  being equiva lent to  (D u jin , 1971) or lower than (Dujin et 
a l , 1975) those in  the sows. However, in  both reports  the leve ls  of 
antibody appeared to  be unaffected by revacc ina tion . The passively 
acquired antibodies in p ig le ts  born to  sows revaccinated during 
pregnancy pers is ted fo r  up to  35 days but t i t r e s  were generally low and 
only l i k e l y  to protect the p ig le ts  fo r  1-2 weeks (D u jin , 1971). 
Furthermore, the h a l f - l i f e  o f these maternal antibod ies appeared to  be 
6.6 days, a lower value than th a t genera lly  associated w ith  IgG which 
has a mean h a l f - l i f e  o f 13.8-14.2 days (Curtis and Bourne, 1971; Curtis 
and Bourne, 1973). I t  seems possib le th a t these low values re f le c te d
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the presence of IgM and IgA, both of which have shorter h a lf- l ives  of 
2 .8-4.5 and 2.6-3.5 days respectively. This would be consis ten t w ith  
the generally accepted theory that the fa i lu re  aluminium hydroxide 
absorbed aqueous vaccines to e l ic i t  long- term immunity in pigs is 
associated with the poor a b i l i ty  of such vaccines to provoke a switch 
frc^ an IgM to an IgG response (Anderson, Masters and Mowat, 1971 a;b; 
Ouldridge, Francis and Black, 1982).
Popovic e t al (1975 and 1976) monitored the response of pigs to  IFFA 
t r i v a le n t  'type  0, A and C and Wellcome monovalent 'type C aqueous 
vaccines and observed th a t responses were generally low so th a t 
revaccination was often required to  produce reasonable leve ls  of 
antibody. Attempts to improve the response to  the IFFA vaccine by using 
2 to  100 times the normal recommended dose did not a f fe c t  the antibody 
t i t r e s  nor, incidentally , did i t  a f fe c t  the health o f the sows or th e i r  
l i t t e r s .  However, the immune response to  the higher doses pers is ted fo r  
35-40 days longer than a f te r  the normal dose (D u jin , Popovic and 
Panjevic, 1975). Another interesting observation was th a t lower t i t r e s  
occurred in immunized p ig le ts  su ffe r in g  from severe re s p ira to ry  syndrome 
at the time o f vaccination (Popovic e t a l , 1976) and th is  may account 
fo r  some of the v a r ia t io n s  often observed in vaccination responses 
e spec ia lly  in view of the frequent incidence o f swine in f luenza 
(Easterday, 1975).
Sidorov (1974) also studied the e f fe c t  o f pre-existing passive 
antibodies on subsequent immunization o f p ig le ts  w ith  aluminium 
hydroxide adsorbed saponin vaccines. He inoculated piglets with 
convalescent c a tt le  serum, convalescent pig serum or Immunolactone, and 
subsequent to  vacc ination detected antibody t i t r e s  ranging from 0.5-2.8
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log^gSNgg the highest leve ls  being obtained from the animals i n i t i a l l y  
injected with convalescent ca ttle  serum. However, although these 
antibodies persisted at detectable levels for only 3-5 dæ/s, inhib ition  
of both a post-vaccination and a post-infection immune response occurred 
for up to 10 days. A similar suppression the immune response in 
calves, due to naturally acquired passive antibodies, has also been 
noted a fter  use of aluminium hydroxide adsorbed FMD vaccines in the dams 
(Graves, 1963; van Bekkum, 1966; Srubar, 1966; Wisniewski and Jankowska, 
1972; Mayr and Thein, 1972; N icho lls  et a l , 1984).
In 1961, Michel sen recognised th a t acceptable leve ls  o f immunity to 
FMD in pigs were u n l ik e ly  to be a tta ined by use o f the aluminium 
hydroxide absorbed vaccines developed fo r  c a t t le .  He suggested tha t 
alternative adjuvants were necessary and ca rr ied  out experiments using a 
w ater-in -o il emulsion f i r s t  described by Armbruster e t al (1960). These 
experiments provided the f i r s t  evidence th a t oi1-emulsion vaccines would 
p ro tec t a higher percentage o f pigs than the e x is t in g  aluminium 
hydroxide adsorbed aqueous vaccines. Further progress was not made 
u n t i l  McKercher and Giordano (1967a) demonstrated th a t such s ing le  o i l  
emulsion vaccines were capable o f provoking leve ls  o f antibody which 
protected adult swine from FMD fo r  at leas t 90 days, and th e i r  f in d in g s  
were subsequently confirmed by others (Graves et a l , 1968; Giraud et a l , 
1969; Wittmann, Bauer and Mussgay, 1969; Anderson, 1969; Basarab, 1978).
Oil emulsion vaccines were also capable o f inducing immunity in 
p ig le ts  at one month o f age whether they were derived from vaccinated or 
unvaccinated mothers (Giraud et a l , 1969). I t  was observed tha t the 
l i t t e r  sizes appeared to be unaffected by vaccination o f the sows as 
la te  as one month p r io r  to  fa rrow ing and p ig le ts  born to  such sows were
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immune fo r  up to  one month. P ig le t  immunity was extended to 2 months 
when sows were given repeated vaccinations every 6 months, the last one 
being given in the f i r s t  3 months of pregnancy (Giraud et a l , 1974). 
Under such a regimen, when s(%vs were revaccinated f ive  times at 
approximately 30 dæ/ intervals, the last being given 15 days before 
farrowing, they produced colostrum with high antibody t i t r e s  and these 
antibodies were demonstrable fo r  at least 6 weeks in the ir  p ig le ts  
(Ercegan, Panjevic and Ercegovac, 1976). In the same year, a study was 
ca rr ied  out on p ig le ts  from sows which had a mean t i t r e  o f 2.0 logUgSNcQ 
at the time o f farrowing. The antibody t i t r e  o f the 3 - day-old p ig le ts  
was 2.72 log^gSNrQ ( th a t is  5 times higher than th a t  circulating in  the 
sows). This passive antibody declined to  a mean t i t r e  o f 0.8 log^gSNgg 
w ith in  3 months, with  a h a l f - l i f e  of 12.71 days, and experimental 
exposure to  l iv e  v irus  showed th a t 75% o f the p ig le ts  were protected at 
1 month, 73% at 2 months and 33.3% at 3 months. Vaccination of 10-week 
old piglets w ith  no pre-existing antibody produced an antibody peak o f 
1.76 log^gSNgQ at 42 days which declined to  1.16 log^gSNgg a f te r  a
further 84 days at which time 80% were protected. A similar group o f 10 
week old p ig le ts  vaccinated and revaccinated a f te r  21 days produced an 
antibody peak o f 2.12 log^gSNgg at 42 days which declined to  1.52
log-|gSNgg 84 days la te r  at which time 100% of p ig le ts  were s t i l l  
protected. In these experiments, the vaccination o f sows did not a f fe c t  
the s ize or q u a l i ty  o f l i t t e r s  but Chappuis e t al (1977) noted th a t the
vaccination o f 14-day-o ld  p ig le ts  appeared to  re ta rd  th e i r  growth and
recommended regimens fo r  use of oil-emulsion vaccines in p igs. For 
fa t te n in g  pigs from unvaccinated sows vaccination at 8-10 weeks old was 
recommended, while  vaccination o f p ig le ts  from vaccinated sows should be 
delayed u n t i l  the p ig le ts  were 10-12 weeks o ld . I t  was also recommended 
th a t breeder pigs should be vaccinated at 8-12 weeks and the vaccination
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repeated at 6-8 month in tervals. However this was modified following 
the observations that vaccination of piglets at 1 and 2.5 months old did 
not retard the ir  growth rc :^e (Mougeot et a l , 1980) and revaccination 
after 21 days extended the period of protection from 42 days to 126
days. The modified regimen was, therefore, th a t p ig le ts  from 
unvaccinated scwvs should be vaccinated c# 5 weeks old and again 2-3 
weeks la te r ,  while piglets frxm vaccinated scMS should be vaccinated 
when 10 weeks o ld , which could be reduced to  5 weeks w ith  revaccination 
21 days la te r  in high risk areas. Breeder pigs could be treated the 
same as the fattening pigs and then given a further vaccination 6-8 
months old followed by boosters every 6 months.
In 1978 Morgan and McKercher demonstrated th a t oi1-emulsion vaccines 
e l i c i te d  immunity in  sows regardless o f the ir  gesta tion  sta tus. 
Furthermore, when the sows were vaccinated 21 to  72 days before
farrowing, the immunity which was passed onto th e i r  p ig le ts  lasted fo r
1-4 weeks. The h a l f - l i v e s  o f these an tibod ies, as ca lcu la ted by the 
present reviewer from the ava ilab le  data, were 6 .9-9 .6  days. However, 
i f  sows were revaccinated at 6 days prior to fa rrow ing , the antibody
passed to  the p ig le ts  decayed more rapidly, with a h a l f -  l i f e  o f 3.6 
days and th is  was probably due to  high leve ls  o f IgM antibodies which 
would have been present in  the sow at the time o f fa rrow ing . I f  th is  
were the explanation i t  is  the f i r s t  suggestion th a t the class of 
antibody at fa rrow ing was important to  the duration of the FMD
neutralizing antibodies in  the ir  progeny.
The in je c t io n  o f o i l -e m u ls io n  vaccines in to  p ig le ts  from immunized 
sows at fou r weeks a f te r  b i r th  produced immunity which lasted fo r  at 
lea s t 4 months. I t  was claimed th a t such piglets also responded to  o i l
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emulsion vaccination at 7, 14 and 21 days old regardless o f the presence 
o f maternal antibody (Morgan and McKercher, 1978).
In a la te r  report Morgan and McKercher (1980) restated the ir  1978 
conclusions cited above and added that the t i t re s  of antibodies in 
colostrum were d irec tly  re la ted  to  the sow serum t i t r e  at the time of 
fa rrow ing . They observed tha t p ig le ts  vaccinated w ith  the o i l  vaccine 
produced 'a meaningful response' regardless of the F14D immune status 
the ir  mothers and th a t any f a i lu r e  in response o f p ig le ts  would be due 
to 'something other than colostral ly acquired antibodies'. I t  n^y be
re levant tha t the ir  observations on the p ig le t  responses (Morgan and
McKercher, 1978) were based on sero log ica l data o f only 2 or 4 sample 
po ints and the re su lts  were not compared to  matching groups o f p ig le ts  
from unvaccinated mothers. The only comparison between p ig le ts  from
vaccinated and unvaccinated sows involved unmatched l i t t e r s  vaccinated 
at 7 or 28 days re sp ec t ive ly  and challenged 3-4 months la te r .  Although 
almost a l l  the p ig le ts  were protected the l i t t e r  from the unvaccinated 
sow had a 10-fold higher n e u tra l iz in g  antibody t i t r e  at challenge.
In more recent studies i t  has been shown th a t p ig le ts ,  from
vaccinated or unvaccinated sows, vaccinated at 1, 3 or 5 weeks of age 
were protected from challenge at 2 months old while  unvaccinated p ig le ts  
were not (Black e t a l , 1982). However, when the sero log ica l responses 
o f p ig le ts  from vaccinated and unvaccinated mothers were compared there 
was an in d ic a t io n  th a t p ig le ts ,  from vaccinated mothers, vaccinated at 1 
or 3 weeks old ( i . e .  in  the presence of maternally derived antibody) had 
lower t i t r e s  in the ea r ly  stages post vaccination (Black e t a l ,  1982).
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One problem associated with the use of oil_emulsion FMD vaccines in 
pigs has been the occurrence local inflammatory reactions at the 
in jection sites (Mussgay and Wittmann, 1968; Wittmann and Bauer, 1969) 
with subsequent damage being recognisable in the carcase. This effect  
has been minimised ky using modified oil formulations (Giraud et a l , 
1969) reduced doses (McKercher and Morgan, 1969; Anderson, Masters and 
Mowat, 1971(a); McKercher and Bachrach, 1976) and by inoculating the
pigs intramuscularly behind the ear (McKercher and Bachrach, 1976; 
Basarab, 1978; de Leeuw, 1980) but the search for better adjuvants
continues. Nk)st a lternative adjuvants have been found to be hsss 
effective  than the oil emulsion e.g. adjuvant 65 (Giraud et a l , 1969;
Wittmann, Bauer and Mussgay, 1969) and calcium phosphate (Turubatovic et 
a l , 1972). Of these, DEAE-Oextran seems most promising since i t
appears to  produce reasonable immunity in  11-15 week old p ig le ts  with 
minimal local reactions. Antibody t i t r e s  were detected in these animals 
4 days a fter vaccination and reached a peak at 14 days. I t  is 
in te re s t in g  to  note th a t the n e u tra l iz in g  antibodies detected in these 
experiments showed l i t t l e  correlation with results challenge tests
against l iv e  FMD virus (Wittmann, Bauer and Mussgay, 1970; 1972). Tests 
in  younger, 6-8 week o ld , p ig le ts  produced s lig h tly  lower t i t r e s  which 
nevertheless protected 75% of the animals 6-14 weeks la ter (Wittmann, 
Bauer and Mussgay, 1971). However, immunity to  DEAE-Dextran vaccines
has genera lly  been short (1-3 months) despite the development of IgG
antibodies (Anderson, Masters and Mowat, 1971(b)). There have also been 
some reports  o f t issue  reactions caused by th is  adjuvant although these 
were not expected to  be economically important (Wittmann, Bauer and
Mussgay, 1970; 1972; Bauer et a l , 1974). Thus on balance these
adjuvants do not appear to provide an acceptable a lte rn a t iv e  to o i l
emulsion vaccines in  pigs.
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CHAPTER 2
MATERIALS AND METHODS
2.1 ANIMALS
Large White pigs which had not been previously vaccinated or exposed 
to  FMD were housed in  quarantine condit ions at the Animal Virus Research 
In s t i tu e ,  P i rb r ig h t ,  England, for the duration  of the experiments. The 
sows and weaned pigs were fed with Sow and Weaner P e lle ts  ( B i l le r s  Ltd,
UK) twice a day and water was f re e ly  ava ilab le  at a l l  times. Sows were
housed 3 to  a loose box u n t i l  about 1 week before farrowing when they 
were placed in ind iv idu a l loose boxes. When farrow ing was imminent they
were placed in farrowing crates and kept there until the p ig le ts  were
weaned at 8 weeks old. Newborn piglets were injected intramuscularly 
with 1ml FerrofaxlO Iron Supplement (C-Vet Ltd, UK) and then weekly 
u n t i l  weaned to avoid any p o s s ib i l i t y  o f n u t r i t io n a l  anaemia. The 
piglets* ta i ls  were docked at b i r th  and male p ig le ts  were castrated when 
4 weeks old.
Sows were id e n t i f ie d  using metal ear tags while p ig le ts  were tatooed 
in the ear at birth . Each p ig le t  w ith in  any one l i t t e r  was given a 
number prefixed by i t s  mothers tag number e.g. p ig le ts  96/01 to  96/10 
were the ten p ig le ts  born to  sow number 96.
2.2 VIRUSES
a) Virus s tra in
The FMD virus strain used throughout these experiments was O-jEFS 
1860/67 which was iso la te d  from the Wrexham area in  1967 during the la s t  
major FMD outbreak in B rita in .
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Virus fo r  vaccine production, m ic ron eu tra liza t ion  and enzyme 
labelled immunosorbent assay (ELISA) was prepared frcm a master s(%2d 
bank stock O^ BFS 1860/67 stored at -70°C at the Wellcome Lab­
oratories, P irbright. This stock was o r ig ina lly  obtained from the World 
Reference Laboratory in 1978, with a history of 10 passages in monolayer 
BHK 21 clone 13 c e l ls  (Stoker and McPherson, 1964) followed by one 
passage in BHK suspension (Susp) cells  (Capstick et a l , 1962), and was 
given a fu r th e r  two passages in BHK monolayer c e l ls  to produce the 
Wellcome stock.
Virus used fo r  challenge o f immunity was O-jBFS 1860/bin the form o f a 
1 in  50 g lycerina ted  f i l t r a t e  of bovine tongue ep ithe lium  (Burrows, 
1966), stored at -20°C.
b) Preparation o f stock v irus  fo r  m ic ron eu tra l iza t ion  tes ts
Virus suspension from the master seed bank stock was thawed rapidly  
at 37°C and 1ml plus 4m 1 o f v irus  maintenance medium (VMM, see Appendix 
1) was used to  inoculate a Roux f la s k  containing a monolayer of 
Institu to  Biologico - Renal Swine (IBRS) cells  (de Castro, 1964). After 
adsorbtion fo r  30min at 37°C the culture was drained, 100ml o f VMM 
conta in ing 1% normal bovine serum was added and the f la s k  was incubated 
at 37°C fo r  16hr. Virus was harvested once cy topa th ic  e f fe c ts  (CPE) 
were advanced. To do th is  the medium was decanted in to  universal 
b o tt le s  and c e l l  debris was sedimented by centrifugation (600 x g fo r  
lOmin at room tem perature). The supernatant was reta ined and used to 
in fe c t  a second f la s k  in  a similar manner to  th a t described above. The 
v irus  suspension obtained from th is  f la s k  was again cen tr ifuged as 
described above to  remove c e l l  debris and dispensed in 2m 1 volumes, 
labelled O^ BFS 1860/67 BHK 10 Susp 1 BHK 2 IBRS 2 and frozen at -70°C.
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c) Preparation o f p u r i f ie d  in ta c t  FMD v ir io n s
Two ml o f the master seed bank stock v irus  was thawed ra p id ly  at 
37°C and diluted with 98ml of VMM. Ten confluent BHK monolayers, 
prepared in Thompson bottles, være each inoculated with ICh  ^ of the 
diluted seed virus. The virus was allowed to adsorb for 30min at 37°C, 
cu ltu res  were drained and 200ml of serum-free VMM was added. The 
bottles were incubated at 37°C for 16hr and when CPE was advanced the 
medium was decanted in to  1 l i t r e  cen tr i fuge  pots. The c e l l  debris was 
removed by c e n tr i fu g a t io n  (2,200 x g fo r  30min at room temperature) and 
the resulting supernatants were pooled.
The v irus  harvest (approximately 2 l i t r e s )  was inac t iva ted  fo r  24hr 
at room temperature with 0.05% v/v acetyl e thy lene im ine (AEI; Aeroject, 
USA). This has been shown to  render the virus non- in fec tious  w ithout 
a l te r in g  i t s  immunogenicity (Brown and Crick, 1959). The residual AEI 
was inac t iva te d  by add it ion  o f 0.5% sodium th iosu lphate  (Brown et a l , 
1963).
Inactiva ted  v irus  was concentrated by a method based on tha t 
described by Fayet (1969) and Wagner, Card and Cowan (1970). Poly­
ethylene glyco l (PEG; molecular weight 6,000 daltons) was added to  the 
v irus  harvest to  give a f in a l  concentration o f 6% w/v. This m ixture was 
s t i r r e d  overnight at 4°C and the p re c ip i ta te  was sedimented (2,200 x g 
for 30min). After discard ing the supernatant the sediment was 
resuspended in 0.2M T r is  b u ffe r  (pH 7.6) conta in ing 1.5M NaCl to  give a 
f in a l  volume one tenth  o f the o r ig in a l  harvest. Using th is  concentrate 
as s ta r t in g  m a te r ia l ,  the PEG precipitation procedure was repeated to 
produce 20ml of a lOOx virus concentrate.
52
P u r i f ic a t io n  was achieved by the method o f Brown and Cartwright 
(1963). The concentrate was c la r i f i e d  by centrifugation at 10,000 x g 
fo r  30min and the v ir io n s  in  the supernatant were sedimented by 
ultracentrifugation (100,000 to 120,000 x g for Ih r ) .  The pe lle t was 
resuspended in 2ml of 0.04M phosphate b u ffe r  and allowed to  e lu te  
overnight at +4°C. Sodium dodecyl sulphate (SOS) was added to  give a 
f in a l  concentration o f 1% before layering  the v irus  concentrate onto an 
lEk^ linear sucrose gradient (15% to 45% v^ Sv) containing 0/%M NcKH 
prepared in 23ml polycarbonate centrifuge tubes. The gradient was 
cen tr ifuged at 95,000 x g fo r  2 |h r and 20 x 1ml f ra c t io n s  were collected  
a f te r  a hole was pierced in the base o f the polycarbonate cen tr i fuge  
tube using a red-hot 18 gauge needle.
Fractions conta in ing the in ta c t  purified FMD v ir io n s  known as the 
1465 p a r t ic le s  (Bachrach, 1952; Breese, Trautman and Bachrach, 1960) 
were id e n t i f ie d  by measuring the op t ica l density  at 259nm. The mass of 
v irus  in  these f ra c t io n s  was ca lcu la ted  using the formula o f Bachrach, 
Trautman and Breese (1964) which showed th a t an o p t ica l density of 1.0 
at 259nm is  equiva lent to  131.5pg of v irus  per m i l l i l i t r e .
The iso la ted  v i r io n s  were fu r th e r  analysed fo r  purity and in teg rity  
o f v i r a l  p ro te ins by a m od if ica tion  o f the polyacrylamide gel 
electrophoresis (PAGE) method (Maizel, 1969; Laemmli, 1970). A gel 
p la te  (15cm x 17.5cm x 1mm) was prepared between two pieces o f glass 
using a stock so lu t ion  o f 30% acrylamide and 0.8% N, N‘ , -methylene- 
b is-acry lam ide . A reso lv ing  ge l, which contained 12.5% stock acrylamide 
made up in  0.375M T r is  b u f fe r  (pH 8.8) conta in ing 0.1% SDS, was poured 
in to  a well formed by the two pieces o f glass to  a height o f 13.5cm. 
This was polymerised chemically by adding 4% v/v N, N, N ', N '- te t ra -  
methylethylenediami ne (TEMED) and 5% w/v ammonium persulphate to  the gel
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immediately prior to pouring. Once the resolving gel had fu l ly
polymerised a stacking gel, which contained acrylamide rmade up in 
0.125M Tris buffer (pH 6.8) conta in ing 0.1% SDS, was added to  give a
f in a l  gel height o f 15cm. This gel was polymerised in a s im ila r  manner 
to  the resolving ge l. Before polymerisation of the stacking gel was 
complete a template, which formed twelve 15 x 11mm sample w e l ls ,  was 
inserted into the gel. The p u r i f ie d  v ir io n s  were dialysed fo r  24hr 
against 0.0625M Tris buffer (pH 6.8) containing 2% SDS, 10% glycerol, 1%
2-mercaptoethanol and 0.001% bromophenol blue, heated to 100°C for 4mnn 
to  d issoc ia te  the v i r a l  proteins and lOOyL samples o f th is  materia l were 
added to  each sample channel on the ge l. The space at the top of the 
gel and the e lec trophores is  apperatus rese rvo irs  were f i l l e d  w ith  
e lectrode b u ffe r  (0.025M T r is  buffer conta in ing 0.192M g lyc ine  and 0.1% 
SDS, pH 8.3) and 8 m illiamps o f constant curren t was applied to  the gel 
using a power pack ('Vokam' Shandon Southern, UK). When the bromophenol 
blue marker reached the bottom o f the gel (a f te r  approximately 16hr) the 
curren t was switched o f f  and the gel was removed and stained w ith  0.1% 
coomassie b r i l l ia n t  blue in 50% methanol and 7% ace tic  acid fo r  2hr at
37°C. F in a l ly  the gel was destained by repeated washing in  7% acetic
acid.
d) Preparation o f challenge virus
Steers were inoculated in t rade rm o lingua lly  w ith  2.0ml o f a 1:10 
d i lu t io n  o f O^BFS 1860 co lle c ted  from c a t t le  and stored at -20°C as a 
g lycerina ted  f i l t r a t e .  Twenty s i te s  were inoculated per tongue, 
approximately 0.1ml per s i te ,  under Rompun (Bayer UK Lim ited) sedation. 
Epithelium (approximately 20gm) was harvested from each steer at 28hr 
post inoculation and stored at -20°C in 50:50 glycerol:0.04M phosphate 
buffer with 0.01% phenol red. Virus was harvested from e igh t grams of 
t is su e  which was minced w ith  scissors and ground in a mortar using a
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pestle, s te r i le  sand and 0.04M phosphate buffer to produce a 1^25 
suspension. The suspension was c la r if ie d  by centrifugation (1,800 x g 
room temperature) and then f i l te re d  through a 0.22y membrane. The 
f i l t r a t e  was mixed with an equal volume of s te r i le  glycerol to a f ina l  
concentration equivalent to one part (yF the harvested infected bovine 
tongue epithelium in  50 parts glycerol/0.04M phosphate buffer, stored at 
-20°C and labelled C2.
The in fe c t iv i ty  t i t r e  was then estimated in  pigs using a method 
described by Burrows (1966). Ten-fold d i lu t io n s  o f the C2 v irus  were 
prepared in 0.04M phosphate bu ffe r  and 0.1ml volumes were inoculated 
in tra de rm a lly  in to  the heel bulbs o f four Large White cross-bred pigs 
(25-30Kg bodyweight). Each of four dilutions were tested using a 
separate foot, i . e .  r ig h t  fo re  10 l e f t  fo re  10~^, r ig h t  hind 10’ ^, 
l e f t  hind 10 . A f te r  3 days the inoculation s ite s  were examined fo r
FMD lesions and s i te s  showing signs o f ve s ic le  formation (blanching) 
were recorded as p o s it iv e .  The percentage of p o s it iv e  s i te s  at each 
d i lu t io n  on the four pigs was tabulated and the log-jg IDrg t i t r e  was 
calculated using the following proportiona l d istance formula:-
% positive sites at d ilu tion  
log dilu tion  next + next above 50% - 50
above 50% % p o s it iv e  s i te s  at d i lu t io n  - % p o s it iv e  s i te s
p o s it ive s  next above 50% at d i lu t io n  next
below 50%
= log^Q Pig foot IDgg per 0.1ml.
(1 log^Q can be added to  th is  value to  give the pig fo o t IDrg per ml)
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2.3 VACCINES
Standard batches Wellcome and mouth disease o i l -  emulsion
vaccines, prepared by the production department at Wellcome Laboratory, 
Pirbright, were used. Baby hamster kidney 21 clone 13 suspension cells  
(Capstick et a l , 1962; Capstick, 1963) være grown in stainless steel 
vessels equipped with automatic pH and temperature control (Telling and 
Stone, 1964; T e l l in g  and Elsworth, 1965). Cultures were in fec ted  with 
OnBFS 1860/67 virus and the 24hr f i l te re d  virus harvest w^  ^ inactivated 
w ith acetyl e thy lene im ine as described by Pay et al (1971) and made up as 
a water -  i n - o i l -  emulsioii with Marcol 52 (ESSO) and Arlacel A (ICI 
America) using Tween 80 (D ifco) as emulsifier (Basarab, 1978). The 
batches used,coded 0-115 and 0-121 ,contained 5.23 and 13.4yg o f v irus  
antigen per 2ml dose respectively. Each batch was potency- tested 1-2 
months prior to  i t s  use or had produced 100% p ro tec t ion  in  8 to  10 week 
old pigs 21 days after vaccination with mean serum antibody t i t re s  fo r  
batches 115 and 121 o f 2.7 and 2.8 log-jg SNgg re sp e c t ive ly .
2.4 VACCINATION AND CHALLENGE
Sows and p ig le ts  were inoculated w ith 2m 1 o f the vaccine in t r a -  
muscularly behind the ear using a an 18 ggpge hypodermic needle.
Immunity was challenged by ino cu la t ion  o f 100 pig fo o t  I D r g  of O-jBFS 
1860 C2 challenge v irus  in to  each o f two heel bulbs on the l e f t  fo re  
fo o t  o f each p ig . Inspections fo r  the development o f loca l les ions were 
made 1, 3, 7 and 10 days la te r  and pigs were c la s s i f ie d  as protected i f  
lesions were found at the in je c t io n  s i te  and only one add it iona l s i te  on 
the body. Animals with more extensive les ions were regarded as 
unprotected. Two unvaccinated pigs in each te s t  group were also 
challenged, as c o n tro ls ,  to  demonstrate the e f f ic a c y  o f the challenge 
v iru s .
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2.5 SERUM, COLOSTRUM AND MILK SAMPLING
Blood was taken from the anterior vena cava of piglets (Carle and
Dewhirst, 1942) using a 20 gauge 4cm hypodermic needle. New- born
p ig le ts  were hand held during the procedure but la rge r animals, up to  
approximately 30Kg, were placed on t h e i r  backs in  a V-shaped trough w ith  
th e i r  heads extended downwards. One ass is tan t held the forelimbs and 
head, while another held the hind limbs. Larger pigs, over 30Kg, were 
allowed to stand during bleeding and a 17 gauge 10cm hypodermic needle 
was used. A slip-noose over the upper jaw behind the canine teeth 
restrained the animal and pu lled  i t s  head upwards to  expose the required 
area. A f in g e r  was run down the side of trachea to a po in t ju s t  in 
f ro n t  o f the sternum to  locate the hollow formed by the angle of the 
r ib s  with the trachea and at th is  s i te  the needle was inserted in to  the
a n te r io r  vena cava. Five ml o f blood was co llec te d  from the p ig le ts  fo r
the f i r s t  month, 10ml during the second and th ird  month, and th e re a f te r  
20ml volumes were obtained.
The blood was allowed to c lo t  at room temperature and the c lo t  was 
separated from the sides o f the c o l le c t io n  b o t t le  w ith  a glass rod. 
After leaving overnight at room temperature the serum was decanted and 
c la r if ie d  by c e n tr i fu g a t io n  at 600 x g fo r  lOmin. The c lea r supernatant 
was stored at -20°C. When required fo r  te s t in g  the sera were thawed and 
inactivated at 56°C for 30min.
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Samples colostrum cmd milk were collected separately fnxn twK) 
fore (one le f t  and one r ig h t) ,  two central and two hind teats of ecwzh 
sew at various times after farrowing. Collection was fa c i l i ta te d  by 
injecting the sows with 1ml of Oxytocin (Leo Laboratories, UK) 
intravenously immediately before sampling. Some samples from individual 
teats were kept separately, while others w^re pooled, prior to 
centrifugation at 50,000 x g for 30min at +4°C. The wh( /^ was collected 
by c a re fu l ly  in s e r t in g  a needle through the s u p e r f ic ia l  fa t  layer,
formed a f te r  centrifugation, and stored at -20°C. Before te s t in g  the
thawed samples were inactivated at 56°C for 30min.
2.6 BODY WEIGHT AND BLOOD VOLUME DETERMINATION
Before blood samples were taken a l l  the p ig le ts  were weighed. To do 
th is  p ig le ts  up to  1 month old were placed in a p la s t ic  bag and weighed 
using a spring balance (S a lte r ,  UK). P ig le ts  1 to  3 months old were
placed in  a sp e c ia l ly  constructed box and weighed on a bathroom scale 
(S a lte r ,  UK). P ig le ts  older than 3 months were weighed on a commercial 
pig balance (Avery, UK). The body weight o f each p ig le t  was converted 
to  blood volume using the formula o f von Engelhardt (1966):
For p ig le ts  up to  25Kg body weight 
BV = 9.5 X
and fo r  p ig le ts  above 25Kg body weight 
BV = 17.9 %
where
BV = blood volume in ml/lOOg o f body weight, and
W = body weight (Kg).
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2.7 CALCULATION OF OBSERVED ANTIBODY HALF-LIVES
The observed ha lf - l iv e s  maternally derived antibodies fc^ ei%:h 
l i t t e r  were calculated from the decrease in the rmaan log^g neutralizing  
antibody t i t r e s  for that l i t t e r  over time using a linear regression and 
the following two conditions. F irs t ly ,  only piglets with antibody 
t i t r e s  >1.0 log^Q at 3 days old were taken into account and secondly, in 
any l i t t e r  where the antibody levels of individual piglets had fa llen  to 
the ir  least detectable value (as indicated by subsequent bleedings) the 
mean h a l f - l i f e  of the l i t t e r  was determined up to that point.
2.8 CALCULATION OF ANTIBODY CATABOLISM AND/OR EXCRETION RATE
The antibody t i t r e s  observed were corrected fo r  increases in  blood 
volume according to  the fo l lo w in g  formula:
Blood volume at sample po in t (a ) FMD neutralizing  
Blood volume at s ta r t  o f the X antibody t i t r e  at = corrected 
experiment (3 days a f te r  sample po in t (c) t i t r e
birth) (b)
In practice, the log^g values fo r  the blood volumes were subtracted 
from each other (log^^a - log-jgb) and the re s u lt  was added to  the log-jg 
observed antibody t i t r e s  (log^gc) to give the corrected log^g t i t r e .  
These corrected t i t r e s  were used to  ca lcu la te  the h a l f - l i v e s  of 
n e u tra l iz in g  antibodies due to  the catabo lism /excre tion  using a l in e a r  
regression.
59
2.9 NEUTRALIZING ANTIBODY ASSAY
Test samples were assayed by a modification of the method described 
by Golding et al (1976). F i f ty  m icro litre  amounts of microtest medium
(see Appendix 1) were dispensed in to  each well o f 96 well f la t-bo ttom ed 
polystyrene microplates (M29ART; S te r i l in  laboratories, UK). equal
volume of test sample was then placed in the f i r s t  well at the end 
each pair of rows and doubling d i lu t io n s  were prepared using a motorised 
hand d i lu te r  (Flow laboratories, UK). F i f ty  yl was discarded from the 
f in a l  dilu tion . F i f t y  m ic ro l i t re s  o f stock v irus  d i lu te d  to  contain 100 
tissue culture in fective  doses (TCIDrg), was then added to each vw^ ll and 
the p la tes were allowed to stand fo r  1 hr at room temperature. Following 
th is , 50yL of IBRS c e l l  suspension (1 x 10^ c e l ls  per ml) was added to 
each well, the p lates were sealed with p la s t ic  p la te  sealers and 
incubated at 37°C fo r  48hr. A f te r  incubation the p la te  sealers were 
removed and the wells flooded with 10% c i t r ic  acid in 0.85% saline, in 
order to  f i x  the c e l ls  and in a c t iv a te  in fe c t io u s  v iru s .  F ixa t ive  was 
discarded after 30min and the c e l ls  were stained by f lood ing  w ith  0.4% 
naphthalene black in  0.85% sa line . Stain was washed o f f  w ith  tap water 
a f te r  30min and the p la tes were b lo t te d  dry. Virus in fe c t io n  o f the 
c e l ls  resu lted  in CPE which rendered them non-adherent to  the p la s t ic  
and they were easily washed away on s ta in in g . Therefore, b lue-s ta ined  
c e l l  sheets were taken as an in d ic a t io n  th a t either no v irus  was present 
or th a t in fe c t io u s  v irus  had been neutralized by the te s t  sample, while  
clear unstained m icroplate wells ind ica ted  tha t in fe c t io u s  v irus  was 
present.
Control plates were included in  each te s t  as fo l low s :
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a) Medium Control
This consisted of 4 rows of 8 wells containing ISOyL of test medium.
b) Cell Control
F if ty  yL of IBRS cell suspension at the test concentration (1 x 10 
cells  per ml) were placed in 2 rows of 8 wells, 50yL of suspension at 
half th a t concentration (5 x 10^ c e l ls  per ml) were placed in a fu r th e r  
2 rows of 8 wells and 50yL of cell suspension at double the test 
concentration (2 x 10  ^ cells  per ml) were placed in a th ird  series of 2 
X 8  w e lls .  Each well also contained lOOyL o f te s t  medium.
(c) Negative Serum Control
Two rows o f a d i lu t io n  series (1:2 to  1:256) of normal pig serum 
were prepared using the method described fo r  te s t  samples.
(d) P os it ive  Serum Control
Convalescent serum from an OUBFS 1860/67 in fec ted  steer was d i lu te d  
from 1:2 to  1:4096 in  50yL of te s t  medium using 6 w ells  per d i lu t io n .  
The m icrop la te  was then d iv ided in to  pa irs  o f rows and 50yL of three 
d i f fe re n t  virus doses (10,100 and lOOOTCIDrg) were added to  each p a ir .  
After 1 hr incubation at room temperature 50yL o f c e l l  suspension (1 x 
10  ^ cells /m l) were added to  each well and the te s t  was carried out as 
described.
(e) T i t r a t io n  o f Stock v irus
Stock v irus  was d i lu te d  in  h a l f  log,g steps, using m icro test medium 
as d i lu e n t .  A l l  v irus  d i lu t io n s  were expressed as log,g of the 
reciprocal of the d i lu t io n .  The lowest d ilu tion used was the expected 
log-|o v irus  t i t r e  minus 2 log^g, and the highest d i lu t io n  was 3.5 log,g 
from th is .  The assay consisted o f 24 wells  each conta in ing 50yL of te s t
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medium, 50yL of one of the virus dilutions and 50yL of cell suspension 
(1 X lo f ce lls /m l).
All control plates were sealed, incubated and stained as described
prev ious ly .
Tests were discarded i f  any of the control plates gave 
unsatisfactory results. Acceptable control parameters were:
(a) Medium Controls
Appeared c lea r red before the p lates were stained in d ic a t in g  tha t 
the te s t  medium was not contaminated.
(b) Cell Controls
At te s t  d i lu t io n  c e l l  sheets were confluent, at h a l f  te s t  
concentration cell sheets were sparse and at double cell concentration 
the c e l l  sheets were overgrown.
(c) Negative Serum Controls
Maximum CPE and the absence o f c e l l  sheets were taken to  ind ica te  
th a t no non-spec if ic  n e u t ra l iz a t io n  was occurring .
(d) P os it ive  Serum Controls
Titres ( i . e .  50% end po in ts) o f the rows conta in ing lOOTCIDgg f e l l  
within a predetermined range.
(e) Virus Dose Used Within the Test
The te s t  v irus  t i t r e  (TCID^g per 50yL was ca lcu la ted  from the number 
o f wells on t i t r a t io n  plates conta in ing in tact,b lue-sta ined c e l l  sheets 
using an adaptation of a formula described by Spearman (1908) and 
Karber (1931):
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log^g highest d i lu t io n  + log -jg dilution stepj
No. of wells with intact cell sheets X log ,g d ilution step/
No. of w e lls  per d i lu t io n  /
The v irus  dose used fo r  any p a r t ic u la r  te s t  was an estimated 
lOOTCIDgg based on the mean of a ll t i t ra t io n s  carried out previously on 
that particular virus (expected t i t r e ) .  However, as a v irus  t i t r a t i o n  
was also included w ith in  each te s t, to  give the observed t i t r e ,  i t  was 
possible to calculate the exact virus dose used applying the 
fo l lo w ing  formula:
Virus t i t r e  ( lo g ,^ )  observed) - /  Expected v irus  - 2 log-,J
by t i t r a t io n  /  I t i t r e  ( lo g ,g) J
'determined prev ious ly
I f  the v iru s  dose used was above 2.5 log^g or below 1.5 log^g the 
te s t  was discarded.
The neutralization te s t  re su lts  were expressed as the log,g 
rec ip roca l o f the sample d i lu t io n ,  in  the to ta l  volume of the reaction  
mixture ( i . e .  after the virus had been added), which demonstrated 50% 
CPE in  the w e l ls .  This t i t r e  was subsequently standardised to  a 2 log ,g 
virus dose using a dose-correction fa c to r  ca lcu la ted  from the p o s it ive  
serum contro l and v irus  t i t r a t i o n  p la te  re s u l ts .  A worked example, w ith  
photographs of ty p ic a l  te s t  and contro l p la te  results, is  shown in 
Appendix 2.
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2.10 ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA)
The indirect ELISA method f i r s t  described ix)r virus antigen cmd 
antibody detection by Voiler, Bidwell and B artle tt  (1976) and Voiler and 
Bidwell (1976), and subsequently adapted for measuring FT1D antigen and 
antibody by Abu Elzein and Crowther (1978), was used fo r  th is  study. 
The optimum test conditions were established using methods described by 
Voiler, Bidwell and B art le tt  (1979).
Purified 11^ 3 virus (146S antigen) was diluted in 0.05M 
carbonate-bicarbonate b u ffe r ,  pH 9.6, to  give a f in a l  concentration of
3yg/ml, and lOOyL was added to each well o f f l a t  bottomed f le x ib le  
polyvinyl chloride m icrotitration plates (M29, Dynatech Laboratories, 
UK). The v irus  was allowed to adsorb onto the microplates overnight at 
room temperature. The p lates were then washed three times w ith  
phosphate buffered saline, pH 7.3, (PBS) containing 0.05% Tween 20 (BIM 
Chemicals Ltd, UK). The te s t  samples were d i lu te d  in PBS conta in ing 
0.05% Tween 20 and 1% ovalbumin (Grade I I I ,  Sigma London Chemical 
Company Ltd, UK) and added in lOOyL volumes. After incubation at 37°C 
fo r  1 hr in  a hum id ified conta iner, the p lates were washed three times as 
before and lOOyl of anti-pig immunoglobulin conjugated to horseradish 
peroxidase was added at a pre-determined d i lu t io n  (1 in  2,000 fo r  
anti-p ig IgG whole molecule. Miles Laboratories, UK; 1 in 1,000 fo r  
a n t i -p ig  IgG and IgM heavy chain s p e c i f ic ,  and 1 in  8,000 fo r  a n t i -p ig  
IgA heavy chain s p e c i f ic ,  Bristol University, UK) in  PBS containing 
0.05% Tween 20 and 1% ovalbumin. The p lates were then incubated fo r  a 
further 1 hr at 37°C in  a hum id ified conta iner, washed as before and 
lOOyL of substrate (0.04% 0-phenylenediami ne w ith  0.004% hydrogen 
peroxide in O.OIM phospha te /c itra te  buffer) was added to each w e l l .  
After leaving the te s t  p la tes in the dark at room temperature until
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su ita b le  colour development had occurred in  +ve contro l samples, usually  
about 2 to 8min depending on conjugate used, the reactions were stopped 
by adding lOOyL of 12.5% sulphuric acid to each well. The intensity of 
the colour which developed was recorded by reading the plates at 492nm 
in a 'Multiskan' spectrophotometer (Flow Laboratories, UK). The 
apparatus was zeroed against 8 blank wells at the end of each 
microplate, containing only substrate and 12.5% sulphuric acid. All 
samples were assayed twice and results were e ither expressed as a fixed  
dilution OD or as a t i t ra t io n  end po in t (for d e ta i ls  of methods and 
analyses, see Appendix 2).
The ELISA technique described above was also modified, by using a 
f ixe d  serum d i lu t io n  o f 1:10 and va r ia b le  antigen concentrations ranging 
from 0 to  8yg/m l, in  order to  provide data fo r  l o g is t i c  model analysis 
(Hingley and Ouldridge, 1985). This model provided estimates o f changes 
in the avidity and heterogeneity o f the to ta l  antibody population ( fo r  
d e ta i ls  o f the methods of analysis see Appendix 2).
2.11 METHODS FOR THE ISOLATION AND CHARACTERISATION OF IMMUNOGLOBULINS
a) Gel f i l t r a t i o n
Bio-Gel A-5M (Bio-Rad Laboratories, UK) with a fractionation range 
fo r  p ro te ins  o f 10,000 to  5,000,000 daltons was used (Burgin-Wolff, 
Hernandez and Just, 1971). To prepare the column 500ml o f Bio-Gel A-5M 
s lu r ry  was mixed w ith  1L o f column b u ffe r  (O.IM Tris buffer conta in ing 
0.3M NaCl and 0.005% Thiomersal, pH 7.2) and the gel was allowed to 
settle  in a 2L glass measuring c y l in d e r .  The supernatant was aspirated 
and discarded, and the process was repeated to ensure th a t any f in e  
p a r t ic le s  were removed from the ge l. The gel was trans fe rred  to  a 
Buchner f la s k  and degassed by evacuating the f la s k  fo r  5min. A 26mm x
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950mm glass column (LKB Instruments Ltd, UK) was mounted v e rt ic a l ly ,
b u ffe r  was added to  the bottom 10cm and an extension reservoir was f ixe d  
to the top. The top of the outlet tube was then positioned above the 
extension reservoir and the degassed gel slurry was gently poured down a 
glass r(^ into the column. Care was taken to avoid trapping a ir  
bubbles. The gel was allowed to  s e t t le  fo r  30min before the t i p  o f the 
o u t le t  tube was lowered to  give a hydrostatic pressure o f 100cm H^ O in 
order to pack the gel. After packing the extension reservoir was 
removed and an upper f low  adaptor and b u ffe r  re se rvo ir  were f i t t e d .  The 
gel was then washed w ith  1L o f gel buffer at a hyd ros ta t ic  pressure of 
95cm HgO.
A 2.5ml sample of serum was added to  the top o f the column v ia  a 3 
way valve system connected to  a syringe and e luted f ra c t io n s  o f 38 drops 
(approx. 2.5ml) were co lle c te d  as they emerged from the bottom of the 
column using an LKB U ltro rac  f ra c t io n  collector. A to ta l  o f 180 
f ra c t io n s  were co llec ted  from each run. The p ro te in  separation was 
monitored by continuous scanning o f the e luate at 280nm using a 
flow-through c e l l  in  an LKB Uvicord 'S' U.V. monitor and recording the 
OD p r o f i le  on an LKB 2210 pen recorder.
b) Sucrose density  f ra c t io n a t io n
Following the method described by Ouldridge, Francis and Black 
(1982) pig serum samples were diluted to 50% in  iso to n ic  sa line  and 
layered in 1ml volumes onto a 20ml sucrose density  gradients in  23ml 
polycarbonate ultracentrifuge tubes. The gradients, which were 5 to  25% 
sucrose in isotonic saline, were formed using an LKB gradient mixer. The 
tubes were spun at 95,000 x g fo r  17hr at 18°C in  an MSE 'P repspin ' 
u l t ra c e n tr i fu g e  a f te r  which 1ml sample f ra c t io n s  were co llec ted  in
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bijoux bottles frcm a hole punctured in the bottom the tubes.
Generally, 20 x 1ml f ra c t io n s  were co llec ted  from each gradient. Each 
fraction was examined for optical density at 280nm and for RID 
neutralizing a c t iv ity .  Resultant peaks være also characterised using 
Immunoelectrophoresis, immunodiffusion and sedimentation c o e f f ic ie n t  
analysis.
c) Production o f anti serum to  normal pig serum
A method similar to  th a t described by Dresser and Greaves (1973) was 
used. Each rabbit was in jec ted  intramuscularly (i/m) in  one th igh  w ith  
1ml o f a w ater-in -o il emulsion, containing 0.5ml Complete Freunds 
adjuvant (Difco Laboratories, UK) and 0.5ml normal pig serum (NPS) 
d i lu te d  1:5. One week la te r  a similar i/m inoculation was given in  the 
other th ig h . After 4 weeks the rabbit was in jec ted  w ith  1ml o f a 
w a te r - in -o i l  emulsion, containing 0.5ml incomplete Freunds adjuvant and 
0.5ml NPS d ilu te d  1:5, d iv ided among several subcutaneous s i te s .  A fte r  
a fu r th e r  14 days ra b b its  were te s t  bled and the q u a l i ty  o f the serum 
was assessed in Immunoelectrophoresis and immunodiffusion te s ts .  I f  the 
re su lts  were considered acceptable the ra b b it  was bled out and the serum 
was stored at -20°C.
d) Immunoelectrophoresi s
The method o f Graber and Williams (1953) was used. Microscope 
s l ides  were covered w ith  2.5ml o f molten 1% Noble agar (D ifco 
Laboratories, UK) in  0.05M barbitone b u f fe r ;  pH 8 .6 . After allow ing the 
agar to  set at +4°C w ells  were cut in to  the middle o f each s l id e .  The 
s l ides  were then placed in an e lectrophores is  tank (Shandon Southern, 
UK) and 2yL of sample was added to each well using 'Microcap' pipettes 
(Drummond S c ien tif ic  Co, UK). Some samples were mixed with 1%
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bromophenol blue which acted as an e lec trophores is  marker. Paper wicks
soaked in electrode buffer (O.IM barbitone buffer; pH 8.6) were
connected across the ends the slides to the buffer reservoirs and a 
constant current of 8ma/slide was applied to the gels using a 'Vokam' 
power pack (Shandon Southern, UK). When the bromophenol blue marker
neared the ends of the slides (about 1 to l.Shr la te r )  the current was
switched o f f  and the s l ides  were removed from the tank. Troughs were 
cut in the gel and f i l l e d  w ith  rabbit anti-NPS. After keeping the
slides in a humid container at temperature for 24 to jW3hr
precipitation l ine s  developed, which could be observed by viewing 
against a dark background. The s l ides  were preserved by drying the gel 
under absorbant paper. They were then soaked tw ice in  0.85% saline fo r  
15min, washed in  d is t i l le d  water and stained w ith  0.5% Coomassie 
B r i l l i a n t  Blue in  d i s t i l l e d  water. A f te r  15min the s l ides  were 
destained w ith  a 4:5:1 mixture of 96% ethanol, g la c ia l  ace tic  acid and 
water.
e) Double gel d i f fu s io n
The method o f Oudin (1946) modified by Ouchterlony (1948) was used. 
P la s t ic  immunodiffusion p lates (Miles Laboratories, UK) were f i l l e d  w ith 
10ml of molten 1% Noble agar. After allowing the gel to set at +4°C 
w e l ls ,  5mm in  diameter, were cut to  form a pa tte rn  o f one centra l well 
surrounded by s ix  others. F i f t y  m icrolitres o f ra b b it  antiserum to  pig 
IgG, IgM or IgA (Nordic Laboratories, UK) was placed in the cen tra l well
and 50yL o f various te s t  samples were added to the outer w e lls .  The
pla tes were covered, incubated in a moist chamber at room temperature 
fo r  48hr and then examined fo r  precipitation l in e s .
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f ) Sedimentation coeffic ient determination
Samples vwsre dialysed ii]r 72hr against frequently changed 0.85% 
saline and diluted in 0.85% saline to give a protein concentration 
l-2mg/ml. The sedimentation coefficients (S values) were determined in 
an analytical ultracentrifuge, at 115,000 x g and 20°C, f i t te d  with a 
Schlieren optical system with wavelength 550nm, knife-edge angle 75° and 
transmission scale 100-0%. Isotonic saline vwas used in the reference 
c e l l  and scans were performed at 10-minute in tervals . The S values were 
ca lcu la ted using the following equations
dr X 1 . ' .  S.dt = dr . 1
^  T r '  —  v r
where W = 2 tt x ro to r  speed in rpm
r = Distance o f a moving peak from the centre of ro ta t io n ,
t  = Time at which the scan was taken,
dr = The ra te  o f movement o f the peak.
Tft
In te g ra t in g  and s u b s t i tu t in g  fo r  W,
S = 2.303 X log r x 3600
t(sec) (2 7T rpm)
Thus, i f  log r  was p lo t ted  against t  a linear slope could be 
ca lcu la ted  and used in the fo l lo w in g  equation:-
S = 2.303 X 3600 x slope o f graph
-T ^ '^ - 'rp m r------
This c a lc u la t io n  was performed in  a Wang 2200 desk-top computer by 
'feeding in '  speed in RPM, R1 to  R2 distance o f f  graph in  millimetres, 
balance c e l l  d istance in  millimetres, scan in te rv a l  in  minutes, number 
o f scans, number of peaks and the R1 to  peak d istance in  m i l l im e tre s  fo r  
successive scans and peaks.
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In order to  standardize re s u lts  the observed sedimentation
coefficients \wyre corrected for water at 20°C using the following
equa tion :-
Sgnw = S, X Viscosity  saline 20°C x 1-VP water
Viscosity water 20°C 1-VP saline
where
= S value observed 
V = Partial specific volume (Albert and Johnson, 1961
P = Density
Thus
S?nW = X 1.07 X 1-(0.725 x 0.9982)
l - i m  T:-(D-.775 "x ' l.'OOT)
S2qW =  Sobs T-0936
Worked examples and traces o f analytical runs on p u r i f ie d
preparations of pig IgG and IgM are given in  Appendix 2.
g) Prote in assay
The protein assay method used was based on the binding of cm acidic
so lu t ion  o f Coomassie B r i l l i a n t  Blue G-250 to proteins. When th is  
occurs there is  a s h i f t  in  the wavelength o f the maximum adsorption from 
465nm to  595nm which allows the concentration of p ro te ins to  be 
determined (Bradford, 1976).
One hundred m ic ro l i t re s  o f bovine serum albumin pro te in  standards 
w ith concentrations ranging from 0 to  1.4mg/ml p ro te in  and o f
appropriately d ilu te d  te s t  samples were dispensed in to  clean, dry te s t
tubes. Five m i l l i l i t r e s  of diluted, and f i l te r e d ,  dye reagent (Bio Rad
Laboratories, UK) was then added and the so lu t ions  were mixed in a
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vortex mixer, tak ing care to avoid foaming. A f te r  5min the op tica l 
density was measured at 595nm against a reagent blank. The optical 
dens it ies  o f the p ro te in  standards at 595nm were p lo t ted  against th e i r  
protein concentrations and the protein concentration test samples kære 
then read from the standard slope.
2.12 PREPARATION OF FMD NEUTRALIZING IgG ANTIBODY CONCENTRATE FOR 
PASSIVE TRANSFER EXPERIMENT
Five Large White pigs were inoculated i/m at 0 and 28 days with 2ml 
o f 0-jBFS 1860/67 o i l-e m u ls io n  vaccine. A f te r  a fu r th e r  30 days and at 
weekly intervals thereafter fo r  2 months, 400 to 500ml o f blood was 
co llec ted  from each animal. A f te r  a break of 60 days ( i . e .  6 months 
after the in t ia l  vacc ina tion) each pig was given a fu r th e r  vaccination 
and 400 to  500ml o f blood was again co llec ted  weekly from 30 days a f te r  
th is  vaccination fo r  2 months. Serum from the blood samples was 
t i t r a t e d  fo r  FMD neutralizing a c t i v i t y  and fo r  the class of antibody 
responsib le using the sucrose density  gradient separation technique, 
described previously. I f  the FMD n e u tra l iz in g  t i t re s  proved to  be 
satisfactory (>2.0 log^gSNgg), and a c t i v i t y  was re s t r ic te d  to the IgG 
f ra c t io n ,  the samples were pooled. This stock o f antiserum was p u r i f ie d  
and concentrated using a m od if ica tion  o f the methods described by 
Warrington and Morgan (1971); In g lo t ,  Gadzinska and Chudzio (1975); 
C ur l ing , Lindquist and Erikson (1977).
The optimal cond it ions fo r  concentrating FMD n e u tra l iz in g  pig IgG 
antibodies were inves t iga ted  by p re c ip i ta t in g  pig an ti serum w ith  a range 
o f PEG 6,000 concentrations varying from 0 to 25% f in a l  concentration 
and the fo l lo w in g  technique was estab lished.
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A 50% w/v so lu t ion  o f PEG 6000 was added slowly w h i ls t  s t i r r i n g  to  
pig antiserum pools to give a f in a l  concentration o f 10% PEG and the 
mixture was s t i r r e d  overnight at +4°C. The p re c ip i ta te  was sedimented 
at 2,200 X g fo r  30min in  an MSE 6L cen tr i fuge  and redissolved by adding 
0.2M Tris buffer (pH 7.6) conta in ing 1.5M NaCl to  give one tenth  of the 
o r ig in a l  volume. After s t ir r in g  fo r  4hr at +4°C the concentrates were 
treated w ith  a n t ib io t ic s  (100 i .u ./m l p e n ic i l l in ,  100 i .u ./m l neomycin 
and 100 i .u . /m l  polymyxin). In order to monitor the concentration 
process samples of the original serum pool, PEG supernatant, redissolved 
precipitate and f in a l  concentrate were assayed fo r  an ti 0,BFS 1860 FMD 
n e u tra l iz in g  a c t i v i t y .
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CHAPTER 3
VALIDATION OF TESTS
3.1 CORRELATION OF MICRO NEUTRALIZATION TEST WITH CHALLENGE RESULTS
In troduction
In order to evaluate the virus neutralizing antibody t i t r e s ,  
reported in subsequent chapters, i t  is important to determine the ir  
correlation with protection from infection.
This study compares the neutralizing antibody t i t r e s  (log^gSNgg) 
determined, just p r io r  to  l iv e  v irus  challenge, with the re s u lts  o f th a t 
challenge. In th is  way, predicted log^gSNgg values (PA values) can be 
equated w ith  percentage protection from in fe c t io n .
Experimental design
Sera co llec ted  from 156 pigs prior to  0,BFS FMD virus challenge were 
tested on three separate occasions fo r  in  v i t r o  FMD v irus  n e u tra l iz in g  
a c t i v i t y  using the micro te s t  method described in Chapter 2. The data 
produced were used in a p ro b it  ana lys is .
Results
Figure 3.1(a) shows the log^gSNgg t i t r e s  (mean of repeated in  v i t r o  
te s ts )  o f the ind iv idu a l pigs and whether or not they were protected 
from Q-|BFS challenge, wh ile  Figure 3.1(b) is  the p ro b i t  regression slope 
showing the percent protected against the serum t i t r e s  (the confidence 
l im i t s  are also shown). Table 3.1 summarises the predicted log^gSN^g 
t i t r e s  (PA values) o f the probit analysis at selected in te rv a ls  between 
1% and 99% p ro te c t io n , the ir  standard errors  and the 95% f id u c ia l  
confidence l im i t s .  The PA value fo r  62.5% p ro tec tion  is  o f special
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Table 3.1: Probit analysis of the OuBFS neutralizing antibody
t i t ra t io n  and protection results for 156 O. BFS 
challenged pigs
Percentage Predicted log^Q antibody t i t r e  (PA value)
protection Estimate Standarde rro r
95% fiducial 
confidence lim its
1 -0.38 0.29 -1.21 0.05
10 0.37 0.18 -0.11 0.64
20 0.70 0.13 0.33 0.90
30 0.92 0.10 0.65 1.09
40 1.11 0.09 0.91 1.27
50 1.30 0.08 1.13 1.46
60 1.48 0.08 1.32 1.67
70 1.67 0.10 1.51 1.92
80 1.90 0.12 1.71 2.23
90 2.22 0.17 1.96 2.68
99 2.97 0.28
........ ...........
2.55 3.76
N.B. PA value fo r  62.5% p ro tec tion  is  1.53
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in te re s t  since i t  corresponds to  5 out of 8 pigs protected which is  the 
accepted passmark for oi1-emulsion vaccines in pig potency tests.
Pi scussion
The probit analysis demonstrated that neutralizing antibody t i t re s  
were correlated w ith  protection from infection (p<0.01) and th a t the 
observed values were not sign ificantly  d i f fe re n t  from expected values in  
a chi-square test. Therefore, the results of th is  analysis can be used 
to p red ic t the levels of protection tha t would be afforded by the 
log-jpSNgQ t i t r e s  measured in  the subsequent chapters o f th is  thesis.
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3.2 ANALYSIS OF GEL-FILTRATION FRACTIONS
Introduction
In order to study the immunoglobulin c lass-specific  neutralizing
a c tiv ity  of test samples a fter  separation on a g e l - f i l t r a t io n  column i t  
was necessary to characterize a sample of normal pig serum (NFS) and to 
identify  the immunoglobulin-rich column fractions.
Experimental design
A Bio-Gel A-5M column was calibrated using seven d i f fe re n t  molecular 
weight markers. This column was then used to f ra c t io n a te  2.5ml samples
of NFS into either 54 x 90 drop fractions or IfW x 38 drop fractions.
The 90-drop f ra c t io n s  were then tested fo r  the presence of the three 
major serum immunoglobulin classes in an ELISA using anti-p ig IgG, IgM 
or IgA conjugated to  peroxidase. The 38 -drop f ra c t io n s  were combined 
in to  8 pools, using the 280nm e lu t io n  p r o f i le  (Figure 3.2) as a
guideline, and tested fo r  the ir  sedimentation c o e f f ic ie n t ,  p re c ip i ta t io n  
in double gel d i f fu s io n ,  and, immunoelectrophoretic (lEP)
character i sties.
Results
The 280nm elution p ro file  fo r  NFS and the e lu t io n  s i te s  fo r  the
molecular weight c a l ib ra t io n  markers are shown in Figure 3.2. This 
figure also gives the sedimentation c o e f f ic ie n t ,  gel d i f fu s io n  and lEP 
re s u lts  o f the 8 pooled f ra c t io n s .  The op tica l density  values obtained
by te s t in g  30 o f the 90 -drop fractions in an ELISA are given in  Table
3.2 and are presented g ra p h ica l ly  in  Figure 3.3. From th is  figure the 
IgM, IgA and IgG-rich areas o f the column could be id e n t i f ie d  and these 
corresponded with pooled fractions 2 to 3, 3 to 4 and 4 U) 5 (Figure 
3.2) respectively.
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Figure 3.2; Separation of normal pig serum on a Bio-Gel A 5M gel filtration column
FRACTION NUMBER (38 DROPS/FRACTION) 
50 100 150
1.5
?§
>
</iz
<u
o
0.5
ALDOLASE OVALBUMIN 
(158,000) (43,000)
BS A 
(67,000)
BLUE
DEXTRAN
( 2 ,000 ,000)
FERRITIN
(440,000)
PORCINE
IgM
(1,000,000)
RIBONUCLEASE A 
(13,700)
1
POOLS j ® @ ® ® ® ® @
r........
®
SEDIMENTATION
COEFFICIENT (Sgo J 30.8 19.1 18.2 11.6 6.9 4.2 N.T. N.T.
IgM + + + — — — - —
GEL
DIFFUSION IgA — — + + + — - -
IgG - - — + + + — —
I.E.P.
(MAIN COMPONENT)
- IgM a2-
Macro
IgA IgG Albumin N.T. N.T.
N T. = NOT TESTED
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Discussion
The gel diffusion and IEP results identif ied  pools 2, 4 and 5 as
being r ich  in IgM, IgA and IgG re sp ec t ive ly . The sedimentation 
coefficients (S2 Q,w) for these pools (19.1, 11.6 and 6.9) agree fa i r ly  
closely with published S^Q.w values for pig IgM, IgA and IgG (18.1, 9.5 
and 6.6; Setcavage and Kim, 1976), despite the fact that these fractions  
contained scwæ admixture of serum proteins. The calibration of the 
column w ith  molecular weight markers could also be used to  predict th a t 
IgM (MW 1,100,000), IgA (MW 330,000) and IgG (MW 170,000) would occur in 
pools 2, 4 and 5 re sp e c t ive ly .  Finally  a l l  these re su lts  were confirmed 
by ELISA analysis which id e n t i f ie d  three areas r ic h  in  IgM, IgA and IgG 
co inc id ing  with pools 2, 4 and 5. There was some evidence of minor IgG 
a c t i v i t y  in  pool 2 (see ELISA p ro fi le . Figure 3 .3 ) ,  which agrees with 
p rev ious ly  published f in d ing s  where an IBS IgG component was id e n t i f ie d  
(Franek, Riha and Sterz l, 1961). However, a c t i v i t y  was low in 
comparison to  the main IgG peak in  pool 5.
These results served to  id e n t i f y  the IgM, IgA and IgG-rich areas of 
the gel f i l t r a t i o n  e luates, thus enabling neutralization re su lts  of 
column fractions to  be broadly ascribed to  the a c t i v i t y  o f ind iv idu a l 
immunoglobulin classes. They also confirmed th a t  the conjugated 
antisera used in the ELISA were immunoglobulin class s p e c if ic .
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CHAPTER 4
RESPONSE OF PREGNANT SOWS TO VACCINATION
INTRODUCTION
The effectiveness of FMD oil-emulsion vaccines has been widely 
studied in fattening pigs from 1 to 2 up to 10 months old (McKercher and 
Giordano, 1967a; Anderson, 1969; Basarab and P^y, 1982; Ouldridge, 
Francis and Black, 1982). However, l i t t l e  information is available on 
the immune response of pregnant sows to FMD vaccination. Such 
information is  essentia l fo r  the design o f rational vacc ination regimens 
for breeding stock. This chapter w i l l  provide data on the level and 
persistence o f FMD v irus  n e u tra l iz in g  antibody in the pregnant sow, the 
antibody classes involved and whether the nature of the antibodies 
changes with time a f te r  vacc ina tion .
EXPERIMENTAL DESIGN
Ten pregnant Large White sows, never previously vaccinated against 
nor exposed to FMD, were d iv ided into three groups o f two and one group
of fou r and vaccinated with FMD oil-emulsion vaccine according to  the
following schedule:
Group A: Sows NU02 and NÜ05 vaccinated once at 12 to  13 days before
farrowing (d b f) .
Group B: Sows NUOl and NÜ04 vaccinated once at 30 to  32dbf.
Group C: Sows NUOO and NU03 vaccinated tw ice at 51 to  52 and 31 to
32dbf.
Group D: Sows 0E91, 0E92, 0E93, 0E94 vaccinated tw ice at 87 to  89
and 30 to 32dbf.
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Serum samples were co llec ted  from each sow at the time of 
vaccination or revaccination and at frequent intervals (generally 
weekly) thereafter for nx)re than 300 dc^ /s post in i t ia l  vaccination 
(dpiv) and tested for neutralizing a c t iv ity .  Sera collected up to 
80dpiV fr(M SCMS NUOO to 05 and up to 90dpiv from 0E91 to 94 were also 
tested by ELISA, at a single d ilution cf 1 in 50, for immunoglobulin 
class a c t iv ity  using IgG, IgM or IgA specific conjugates.
Samples co llec ted  from one s ing ly  vaccinated sow (NU02) and one 
doubly vaccinated sow (NUOO) were fu r th e r  analysed by ELISA fo r  IgG 
antibodies using (a) a t i t r a t io n  method and (b) a log is tic  analysis (see 
appendix 2).
RESULTS
a) N eu tra l iz ing  antibody response
The mean data o f the repeated v irus  n e u t ra l iz a t io n  te s ts  are shown 
in  Table 4.1 . These data are also presented g ra p h ica lly  in  Figures 4.1,
4.2 and 4 .3 . From Figures 4.1 and 4.3 i t  can be seen th a t n e u tra l iz in g  
a c t i v i t y  reached peak leve ls  2 to  4 weeks a f te r  primary vaccination and 
th a t th is  a c t i v i t y  began to  subside w ith in  4 to  8 weeks. In those sows 
th a t did not receive a booster vaccination (Figure 4.1) the n e u tra l iz in g  
a c t i v i t y  returned to  i t s  o r ig in a l  peak leve l about 14 to  35 weeks after  
vacc ina tion . The level o f n e u tra l iz in g  a c t i v i t y  was then sustained or 
increased steadily (sows NUOl and NU05) until the end the experiment 
(10 to  12 months a fter  the original vacc ina t ion ) .
In 3 out o f the 4 s ing ly  vaccinated sows v irus  neutralizing antibody 
levels remained above the 50% protection value (1.30 loQigSNrQ) and
close to  the 62.5% p ro te c t ive  level (1.53 log^gSNgg) from 1 to  2 weeks
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Table 4. Neutra l iz in g  antibody t i t r e s  ( lo q ^oSN^g l o f  sows following FMD vaccination
C Z l Farrow
Group A Group B
DPV
Tag no.
DPV
Tag no.
NU02 NU05 NUOl NU04
► 0 <0.46 <0.46 ► 0 <0.47 <0.47
7 1.31 1.37 6 0.91 0.71
11 1.62 1.67 13 1.22 1.06
12-13 | l  67 1 | 1 . 6 7 1 20 1.68 1.14
13-14 1.97 1.92 27 2.13 1.29
15-16 1.82 1.74 30 - 11 .44  1
18 2.03 1.87 31 - 1.38
25 1.60 1.70 32 1 2 .071 -
32 1.82 1.41 33 2.05 1.29
39 1.67 1.78 35 1.90 -
46 1.89 1.63 37-38 1.88 1.30
53 1.82 1.55 44-45 1.56 1.24
60 1.66 1.56 51-52 1.76 1.01
67 1.67 1.41 58-59 2.08 1.16
74 1.60 1.48 65-66 2.16 1.01
80 1.62 1.45 72-73 1 .94 1.01
88 1.74 1.48 79-80 1.93 1.16
95 1.52 1.70 86-87 1.94 1.08
102 1.67 1.71 93-94 2.01 1.16
112 1.59 1.40 100-101 2.09 1.08
116 1.54 1.48 107-110 2.20 0 .99
123 1.67 1.48 114-115 2.24 0 .94
132 1.52 1.48 121-122 2.01 1.09
137 1.46 1.41 129 2.16 0 .94
144 1.52 1.37 139 2 .09 0 .94
150 1.72 1.42 143 2 .09 1.01
164 1.65 1.49 150 2.31 0 .93
178 1.72 1.57 157 2 .39 1.28
199 1.96 1.74 164 2 .09 1.28
213 1.90 1.69 171 2.22 1.32
241 1.90 1.74 177 2.22 1.11
255 1.90 1.69 191 2.22 1.18
269 1.83 1.87 205 2.30 1.35
283 1.93 1.86 226 2.47 1.29
297 1.92 1.96 240 2 .43 1.26
311 1.81 2.05 268 2 .38 1.33
318 1.95 1.85 282 2 .38 1.25
296 2.41 1.35
310 2.44 1.32
324 2.47 1.26
338 2.51 1.15
345 2.61 1.29
Vacc inat ion DPV = Days post vacc inat ion
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Table 4.1 contd; N eutra l iz ing  antibody t i t r e s  ( lo g ^gSNgp) of sows f o l l owing FMD vaccination
Group C Group D
DPV
Tag no.
DPV
Tag n o .
NUOO NU03 0E91 0E92 0E93 0E94
► 0 <0.58 <0 58 ► 0 <0 72 <0.72 <0.72 <0.72
8 0 . 8 8 0 .82 3 <0 72 <0.72 <0.72 <0.72
12-14 1.05 1 64 10 1 04 1.26 0 .98 1.42
20 1.13 1 .71 17 1 62 1.76 1.42 1.87
27 2.32 2 91 24 1 72 2.07 1.72 2.17
34 2.39 2 62 31 1 67 2.02 1.77 2.03
41 2.17 2 69 38 1 62 1.72 1.46 1.87
48 1.94 2 39 45 1 51 1.72 1.62 1.92
51-52 | 1 . 8 6  1 1 2 391 *► 57 1 42 1.51 1.66 1.87
52-53 1.85 1 80 60 1 51 1.61 1.67 1.77
54-55 1.88 1 95 66 2 93 2.79 2.73 2 .78
58-59 1.91 1 95 78 2 68 2.42 2 .43 2.42
65-66 1.83 1 81 87 2 47 2.31 2 .28 1 2.27 1
72-73 1.58 1 63 88 1 2 37 ] - -
79-80 1.63 1 80 89 1 2 52 1 - 12 ia| -
86-87 1.73 1 96 90-92 2 48 2.07 2 .08 2.37
93-94 1.53 1 65 94-96 2 52 2.28 2.17 2.23
100-101 1.68 2 11 101-103 2 37 2.27 2.12 2.17
106-107 1.63 1 88 108-110 2 12 2.28 1.97 2.07
114-115 1.58 2 19 115-117 2 22 2.17 1.92 2.22
120-121 1.54 2 22 122-124 2 22 2.12 2 .22 2.07
128-129 1.68 1 93 129-131 2 17 2.02 2.18 2.22
135-136 1.63 2 03 136-138 2 23 2.12 1.97 2.12
143 1.68 1 96 143-145 2 22 2 .02 1.92 2.12
153 1.58 2 11 156-158 2 32 2.12 1.77 2 .08
157 1.68 2 11 170-172 2 17 2.17 2 .00 1.82
164 1.54 2 34 184-186 2 37 2.17 1.74 2.05
171 1 .83 2 34 198-200 2 12 2.17 1.97 2.02
178 1.58 2 38 212-214 2 52 2.43 2 .09 1.98
185 1.74 2 44 226-228 2 22 2 .28 1.78 2 .09
191 1.70 2 24 240-242 2 47 2 .32 1.82 2.02
205 1.59 2 30 254-256 2 33 2.52 1.67 2.07
219 1.79 2 32 268-270 2 38 2.23 1.72 2.07
240 1.93 2 47 281-284 2 48 2.02 1.93 2.02
254 1.87 2 50 295 2 58 2.17 1.83 2.27
282 1.93 2 59 312 2 34 2 .22 1.92 2.22
296 1.78 2 56
310 1.93 2 47
324 1.99 2 44
338 1.84 2 56
352 2.11 2 41
359 1.80 2 41
r _ n Farrow V a c c in a t io n DPV = Days post va cc i na t i on
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after vaccination for rære than 45 weeks. The exception vwis sow NUCW 
the neutralizing antibody t i t r e s  of which remained at or just below the 
50% protective level. Figures 4.2 and 4.3 shmv that revaccinating the 
smvs at either 20 or 57dpiv boosted antibody levels from approximately 
1.5 log^gSNgQ to more than 2.2 log^QSNgg within 7 days. The peak 
this a c t iv ity  subsided during the next 7 to 10 weeks but, as in the case
the singly vaccinated sows, some i f^ the sows' t i t re s  gradually 
increased or else remained constant over the following months. Although 
the neutralizing a c tiv ity  never reached the revacc ination peak leve ls  i t  
did persist at between 70% to 90% protection levels for the duration of 
the experiment (312 to  359dpiv).
I t  is  in te re s t in g  to  note th a t at the time o f revacc ination (20dpiv) 
the serum antibody t i t r e  of sow NUOO (1.13 log^gSNgg) was almost 
identical with th a t o f sow NU04 (1.14 log^gSNgg) and th a t revaccination 
boosted the antibody t i t r e s  o f NUOO to  a 70 to  80% p ro tec tion  leve l fo r  
more than 10 months while those o f NU04 remained at only a 40 to  50% 
p ro tec t ion  le v e l .
There was some in d ic a t io n  of a l im ite d  f a l l  in  the SNgg t i t r e s  
immediately a f te r  fa rrow ing (see Figures 4.1 to  4.3) but th is  was not 
severe and was only o f short duration.
b) Comparative immunoglobulin-class a c t i v i t y
The mean op tica l density  (00) values from two immunoglobulin 
class-specific ELISA te s ts  are summarised in  Tables A3.1 and A3.2 (see 
appendix 3), and immunoglobulin class response curves fo r  each animal 
are given in Figures 4.4 to 4 .6 . I t  is not possible to make direct  
comparisons between the magnitude o f each immunoglobulin class response
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as the a c t iv ity  of the specific conjugates used in the ELISA test could 
not be equated. However, i t  is possible to make comparisons between the 
profiles of response for the d iffe rent antibody classes and to examine 
the effect of vaccination and revaccination on them.
Following a single vaccination (Figure 4.4) the IgM a c tiv ity  reached 
a peak within 1 to 2 weeks and then subsided to undetectable levels 
a f te r  5 to  9 weeks. In contrast, the IgG response in  the same sows did 
not reach a peak u n t i l  3 to 8 weeks after the primary vaccination and 
persisted for least 11 weeks. The IgA response vwas generally 
variable. For example, in sow NU05 the IgA response was especially pro­
nounced and a peak of a c t i v i t y  was observed 2 to 3 weeks after primary 
vaccinat ion which persisted fo r  more than 11 weeks. In sows NU02 and 
NU04 however, IgA a c t i v i t y  was only present at very low leve ls .  The 
remaining s ing ly  vaccinated sow (NUOl) had a biphasic IgA response curve 
with peaks of a c t iv ity  at 27 and 73dpiv.
Revaccination of the sows (Figures 4.5 and 4.6) resulted in further  
IgM a c tiv ity  similar to that observed in the primary response. The 1(^ 3 
response, however, was sign ificantly  increased in magnitude to reach 
peak a c t iv ity  1 to 2 weeks a fter revaccination. This e ffect vms most 
apparent in sows revaccinated c# 57dpiv (0E91 94) as the primary
response had either levelled o ff  or was declining by then. 
Revaccinat ion did appear to increase the IgA responses although the 
magnitude of these revaccinat ion responses also varied from one animal 
to another.
Farrowing did not appear to have any marked e f fe c t  except f o r  a 
inor  and short-lived drop in the immunoglobulin t i t r e s  (see Figurem
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4 .5 ) .  However, i t  is worth noting that the re la tive  distribution of 
class a c tiv ity  ad: the time farrowing was greatly affected ky the 
sow's vaccination regimens.
c) The nature of the IgG antibodies involved in long-term immunity
The OD values obtained f o r  IgG a c tiv ity  in an ELISA t i t ra t io n  are 
presented in Table 4.2 and the calculated (see appendix 2b) IgG t i t re s
are shown in Table 4.3 and Figures 4.7 and 4.8. For comparison, 
neutralizing antibody t i t r e s  fo r  each sample are also given, showing 
tha t  the ELISA IgG response p ro f i le s  (Figures 4.7 and 4.8) f o r  both sows 
were similar to the neutralizing antibody profiles , other than those 
from the 18dpv value f o r  sow NU02 and the 20 and 51dpiv values f o r  sow 
NUOO. The ELISA te s t  results in those cases may have been inf luenced by 
competition due to the presence of anti-FMD IgM a c t iv ity  in the sera.
The ELISA OD values used to  produce computer f i t t e d  sigmoid curves 
fo r  l o g i s t i c  analysis are provided in Table 4.4. From the curves 
estimates of K, average i n t r i n s i c  associat ion, and a, heterogeneity 
index, for IgG were established.
Although i t  is  d i f f i c u l t  to  carry  out re liab le  inves t iga t ions  in to  
the functional a f f in i ty  ( a v id i t y )  of FMD v i rus /an t ibody  in te rac t io n s ,  
due to  the heterogeneity of the antigens and ant ibodies involved, the K 
value obtained log is tic  analysis gives the association constant 
between the FMD antigen f ixe d  to the ELISA p la tes and the IgG ant ibodies 
in the serum o f  the sows and thus an increase in  K may be taken as an 
increase in the avid ity  of the antibody population being studied. The 
heterogeneity index (_a) is  a measure of the number of d i f f e r e n t  
molecular species of IgG which can range from a value of 0 to 1; low
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Figure 4.7: Nature of response to single vaccination (sow NU 02)
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Figure 4.8: Nature of response to double vaccination (sow NU 00)
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Table 4.4: ELISA data fo r  l o g i s t i c  analysis o f sera
Uï) f r c ^  a s ing ly  vaccinated sow (NU02)
140S antigen 
dose (ug/ml)
Days post i n i t i a l  vaccinat ion
0
À
18 53 102 199 318
0 0.23* 0.19 0.20 0.14 0.18 0.14
0.25 0.39 0.48 0.45 0.39 0.49 0.43
0.50 0.57 0.65 0.64 0.53 0.68 0.61
1.00 0.67 0.82 0.92 0.76 0.99 0.96
2.00 0.90 1.22 1.13 1.19 1.44 1.46
4.00 1.08 1.60 1.65 1.55 1.72 1.71
8.00 1.26 1.67 1.67 1.66 1.79 1.75
(b) from a doubly vaccinated sow (NUOO)
1405 antigen 
dose (ug/ml)
Days post i n i t i a l  vaccinat ion
A
20
A
51 100 205 324
0 0.16* 0.14 0.17 0.18 0.12 0.14
0.25 0.35 0.43 0.49 0.58 0.52 0.51
0.50 0.40 0.58 0.71 0.86 0.78 0.75
1.00 0.54 0.78 1.03 1.16 1.11 1.09
2.00 0.65 1.20 1.43 1.58 1.50 1.53
4.00 0.78 1.41 1.67 1.76 1.73 1.69
8.00 0.95 1.48 1.67 1.74 1.76 1.76
A = FMD vaccinat ion
*Optica l  density at 492nm
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values represent a large degree of heterogeneity, whereas monoclonal 
antibodies would have an index of 1. Table 4.3 and Figures 4.7 and 4.8  
show that there were differences between the K and ^ curves of the tvm 
sows studied. Thus, in the serum samples from the singly vaccinated sow 
(NU02) the K and values increased steadily for at least days 
indicating that the IgG antibody population became nw)re avid and less 
heterogeneous with time after vaccination, while in the doubly 
vaccinated sow (NUOO) both K and ^ increased for 30 to 80 days after  
revaccinat ion and then remained f a i r l y  constant f o r  the next 200 to  250 
days suggesting that frc^ di /^s a fter  revaccination the avid ity  and 
heterogeneity of the ant ibodies remained more or less unchanged.
DISCUSSION
A s ing le  vaccinat ion of pregnant sows with FMD oi1-emulsion vaccine 
resulted in n e u t ra l i z in g  antibody leve ls  tha t  would be regarded as 
p ro tec t ive  (>1.53 log^gSNrg) in three out of the four  sows tested. 
Furthermore, the antibody leve ls  were sustained f o r  nearly a year with 
no dec l ine. This persistence was also observed in the sow with a low 
neutralizing antibody t i t r e  (NU04) in d ica t ing  tha t  the durat ion of the 
response was not a ffec ted by the animals poor i n i t i a l  response. These 
observat ions compare favourably with anti-FMD responses seen previously 
in young fa t te n in g  pigs (McKercher and Giordano 1967(a); Graves et a l , 
1968; Wittman, Bauer and Mussgay, 1969; Anderson, 1969; Basarab, 1978; 
Ouldridge, Francis and Black, 1982).
Repeating the vaccinat ion during pregnancy, with an in te rva l  of 
e i th e r  20 or 57 days between doses, provoked neutralizing antibodies 
which were maintained f o r  nearly 1 year at leve ls  th a t  would be expected 
to afford 70 to 90% pro tec t ion  from FMD in a l l  s ix  sows, inc lud ing one
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that h(W shown a primary response. Thus i t  is possible that
revaccination during pregnancy may overcome any problem of a fX)or 
primary response and would assure that the sow would have king lasting  
high t i t r e  antibodies against FMD virus. In these experiments farrowing 
h(W l i t t l e  effect on the neutralizing antibody response which is in 
agreement with the findings of Morgan and McKercher (1978).
This study is  the f i r s t  in which anti-FMD immunoglobulin class 
a c tiv ity  in the pig has been studied using the ELISA technique. 
Previous investigations in to  the v i rus  n e u t ra l iz in g  a c tiv ity  of 
vaccinated pig sera have employed sucrose density gradient or gel 
f i l t r a t io n  techniques (McKercher and Giordano, 1967(b); Anderson, 
Masters and Mowat, 1971(a); Ouldridge, Francis and Black, 1982) in order 
to examine the IgM and IgG a c t iv ity .  Following vaccinat ion with an 
aqueous vaccine, conta in ing saponin and aluminium hydroxide as 
adjuvants, only IgM ant ibodies were detectab le and i t  was necessary to 
use oi1-emulsion vaccines in order to  evoke a switch to  IgG production, 
which would provide long-lasting immunity. The ELISA data obtained from 
pregnant sows supports these observations by demonstrating tha t  IgM 
a c tiv ity  is transient, lasting for only 40 to 60 days a fter  vaccination, 
and tha t  i t  is  the IgG ant ibodies tha t  provide sustained leve ls  of 
immunity. Although a c lear  IgA response was also present a f te r  both 
primary and secondary vaccinations no clearcut conclusions about the 
magnitude and durat ion o f  the response were possible because of marked 
animal»to-animal v a r ia t io n .  However, i f  they were present in the local 
secretions, such antibodies would provide the animals with  t h e i r  f i r s t  
l i n e  of defence against airborn in fe c t io n .
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The result that IgG antibody population becomes gradually less 
heterogeneous and more avid with tiine has been observed previously with 
antibodies against polio (Svehag, 1965), bacteriophage (Finkelstein and 
Uhr, 1966) and influenza (Webster, 1968), in various animal species. 
This observation may account for the apparent gradual increase in the 
FMD virus neutralizing antibody t i t r e  since neutralization i s  a func t ion  
not only of antibody concentration but also of a f f in i ty ,  valence imd 
possibly molecular conf igura t ion  of the antibody (Blank, Les l ie  and 
Clem, 1972). In the present study revacc inat ion of the sows also 
increased the a v id i t y  and decreased the heterogeneity of the antibody 
population. However, the change was more rapid and leve l led  o f f  a f te r  
30 to 80 days suggesting tha t  a populat ion of memory c e l l s ,  produced as 
part of the animals immune response to the primary vaccination, were 
being st imulated.
In conclusion i t  is apparent from these results tha t  o i l—emulsion 
vaccinat ion provides pregnant sows with  long las t in g  immunity to FMD 
virus infection equivalent to  tha t  prev ious ly  observed in young 
fattening pigs.
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CHAPTER 5
THE PASSIVE TRANSFER OF MATERNAL ANTIBODIES
INTRODUCTION
In order to  design an optimal vaccinat ion regimen for breeding sows 
i t  is essential to understand the factors affecting the transfer 
immunity to the young. I t  is known that most, or a l l ,  absorption of 
colostral antibodies through the i n te s t in a l  wal l o f  the newborn p ig le t  
occurs during the f i r s t  24 to 48 hours a fter b irth  (Lecce and Morgan, 
1962; Bourne, 1971; Dujin, 1971; Xabiki, Kashiwazaki and Namioka, 1974) 
and th is  raises the quest ion as to what e f fe c t  vaccinat ion of the sow 
has on the passive transfer of maternally derived ant ibodies to  the 
p ig le ts .  The proportion of the various antibody classes in the serum 
during the c r i t i c a l  few days around farrowing and the predominant
antibody class passed onto the p ig le ts  is  o f special  importance since
IgG, IgM and IgA vary in the ir  decay rates (Porter and H i l l ,  1970;
Cur t is  and Bourne, 1971). Hence inappropria te  vacc inat ion schedules fo r  
breeding sows may r e s u l t  in p ig le ts  which are e i t h e r  d e f i c ie n t  in t h e i r  
i n i t i a l  ant ibody leve ls  or conversely p ig le ts  which have satisfactory  
antibody t i t r e s  i n i t i a l l y  but become suscept ib le  to  FMD at an early age 
due to  the rapid decay ra te  o f the ir  maternal ly  derived ant ibodies.
This chapter provides information about the class and t i t r e  of
neutralizing antibodies t rans fe r red  to p ig le ts  v ia  the colostrum and the 
e f fe c t  tha t  the sows vacc inat ion regimen has on t h i s  t ra n s fe r .
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EXPERIMENTAL DESIGN
The ten Large White pregnant sows, grouped and vaccinated as 
described in Chapter 4 were used to study the sow-to-piglet transfer of 
antibodies.
Blood was collected from groups A, B and C sows (NUOO to 05) at the 
t ime of farrowing and at 1, 3 and 5 to 7 days l a t e r .  The p ig le ts  were 
bled just before suckling (groups B and C), or 1.5 to 2.5 hours after  
(group A) and again, 1, 3 and 5 to 7 days la te r .  Blood samples were 
also co l lec ted from group D sows (0E91 to 94) at the time of farrowing 
and from t h e i r  p ig le ts  at 3 days a f te r  farrowing.
Colostrum/milk samples were co l lec ted  from group A, B and C sows at 
the time o f  farrowing and at 1, 3 and 5 to  7 days la te r .  Samples taken
on each occasion from two fo re  (one l e f t  and one r i g h t ) ,  two central  and
two hind tea ts were pooled. Colostrum/milk was also co l lec ted from
group D sows at the time of farrowing and at 3 and 7 days la te r but in 
th is  case the tea t  samples were analysed separate ly.
A l l  the serum and colost rum/milk  samples were examined fo r
neutralizing antibody and fo r  immunoglobulin class a c t iv ity .
RESULTS
a) Analysis of immunoglobulin class by ELISA
Table 5.1 summarises the resu l ts  of the immunoglobulin class 
a c t i v i t y  in  sow serum and colostrum at farrowing, and in the pooled sera 
of 3-day-old p ig le t  l i t t e r s .
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The IgM concentration in group A sows at farrowing (where 
vaccination was close to farrowing) was higher than that in groups B, C 
or D sows (where the last vacination had been carried out at least one 
month before farrowing) whereas the IgG a c t iv ity  in groups B, C and D 
predominated over thc^ in group A. The IgA a c t iv ity ,  however, was 
variable and was not predominant in any single group.
The r e la t i v e  concentrat ions of each immunoglobulin class in the sows 
serum at farrowing was also reflected in the colostrum and in the sera 
of th e ir  3 'day -o ld p ig le ts .  However, the leve ls  of IgM a c tiv ity  in 
group A, and IgG a c tiv ity  in groups B, C and C, \vere re la t iv e ly  greater 
in the colostrum, and in the 3-day-old p ig le t  sera, than those observed 
in the sows serum at farrowing.
b) Neutra l iz ing  antibody a c t i v i t y
Tables 5.2 to  5.4 summarise the neu t ra l iz in g  antibody t i t r e s  present 
in  the sow serum, colostrum/milk and p ig le t  serum of groups A, B and C 
at farrowing and fo r  144 to  168 hours a fte r . Figure 5.1 shows the mean 
n e u t ra l i z in g  a c tiv ity  w ith in  groups A, B and C in the form of a bar 
char t .  At far rowing the mean serum t i t r e  o f the sows vaccinated once at
12 to 13dbf (group A) was 1.67 log,g while that of the animals
vaccinated 30 to  32dbf (group B) was 1.78 log,Q. The sows vaccinated 
twice (group C) had a mean t i t r e  of 2.13 log,Q at farrowing. The serum 
t i t re s  of a l l  four groups were corre la ted with co los t ra l  t i t r e s
(r=0.897) as i l l u s t r a t e d  in  Figure 5.2a. The in te r re la t io n s h ip  between 
the serum and colostrum t i t re s  was reflected by the slope of the 
regression l in e  (m=1.568) which was in turn inf luenced by colostral 
t i t r e s  which were lower than the serum t i t r e s  at farrowing in group A, 
but higher than those in groups B, C and D.
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Table 5.2; N eutra l iz ing  antibody t i t r e s  1n Group A sows (vaccinated 12 to 13dbf) and t h e i r  p ig le ts
Sow number
NU02 NU05
Time a f t e r  fa r r ow (hrs) Time a f t e r fa r row (hrs )
1.5
..................
21 72 144 2.5 30 72 168
Sow serum 1.67 1.37 1.82 2.03 1.67 1.92 1.74 1.87
1 1.01 1.87 1.49 1.33 1.11 1.32 1.13 1.07
2 1.11 1.52 1.48 1.34 0.91 1.41 1.38 1.18
3 1.36 1.67 1.58 1.46 1.72 1.52 1.44 1.34
4 1.06 1.41 1.39 1.24 1.21 1.36 1.23 1.05
5 <0.46 1.17 0.97 0.80 1.41 1.26 1.22 1.16
6 1.26 1.62 1.45 1.21 1.06 1.10 0 .90 0 .95
1 7 <0.52 Crushed - 1.21 1.47 1.38 1.35
% 8 1.06 1.62 1.45 1.12 1.46 1.51 Died on -
bleeding
QJ 9 1.06 1.72 1.39 1.23 1.27 1.42 1.38 1.26
cn
-  10 0.71 1.67 1.43 1.27
1 1 1.21 1.67 1.39 1.30
12 <0.46 Died weak - -
at  b i r t h
X 0 . 9 4 1.59 1.40 1.23 1.26 1.37 1.26 1.17
tO.31 ±0.18 ±0.15 ±0.17 ±0.23 ±0.13 ±0.18 ±0.13
Sow
Colost rum/mi lk 1.64 1.77 1.51 0 .97 1.56 1.62 1.56 1.35
d b f Days b e fo re  f a r r o w i n g
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Table 5.3: N eutra l iz ing  antibody t i t r e s  in  Group B sows (vaccinated 30 to 32dbf) and their p ig le ts
NUOl NU04
Sow number Time a f t e r  farrow (hrs) Time a f t e r fa r r o w  ( h r s )
0 18 72 144 0 24 72 168
Sow serum 2.11 2.05 1.90 1.88 1.44 1.38 1.29 1.30
1 <0.60 2.35 2.13 1.84 <0.47 1.36 1.29 0 .96
2 <0.60 2.05 2.13 2.14 <0.47 0 .99 0 .99 0 .95
3 <0.60 2 .20 1.98 1.95 <0.47 0.84 0.62 0.61
4 <0.60 1.45 1.29 1.31 <0.47 1.29 1.21 0 .94
5 <0.60 2.05 2.05 1.95 <0.47 1.21 1.14 1.00
6 <0.60 1.90 1.75 1.65 <0.47 1.29 0 .99 0.89
#  7 <0.60 1.83 1.83 1.69 <0.47 1.07 0 .84 0 .74
% 8 <0.60 2.28 1.98 1.84 <0.47 <0.56 <0.47 <0.48
9
'5, 10
<0.60 2.35 2 .28 1.99 <0.47 1.29 1.14 0.96
<0.60 1 .60 1.60 1.62 <0.47 0.99 0.92 0.86
Q . <0.47 1.07 0 .99 0.89
12 <0.47 1.29 Died on 
b le e d in g
-
13 <0.47 1.14 1.07 1.07
X <0.60 2.01
±0.29
1.90
±0.28
1.80
±0.23
<0.47 1.11
±0.22
0.97
±0.22
0.86
±0.17
Sow
C o lo s t r u m /m i l k 2.41 2.13 1.52 1.11 1.42 0.91 <0.47 <0.48
d b f  = Days b e fo re  f a r r o w in g
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Table 5 .4 :  N e u t r a l i z i n g  a n t ib o d y  t i t r e s  in  Group C sows (v a c c in a te d  51 t o  52 and 31
and t h e i r  p i g l e t s
to 32dbf)
Sow number
NUOO NU03
Time a f t e r  f a r r o w  ( h r s ) Time a f t e r f a r r o w  ( h r s )
0 24 72 168 0 24 72 168
Sow serum 1.86 1.85 1.88 1.91 2.39 1.80 1.95 1.95
1 <0.58 2.11 2.03 1.95 <0.58 1.55 1.94 1.73
2 <0.58 2.11 2.15 2.18 <0.58 1.76 2.02 1.99
3 <0.58 2.18 2.14 2.03 <0.58 2.03 1.87 2.02
4 <0.58 1.91 2.15 2.00 <0.58 1.87 1.87 1.88
5 <0.58 1.91 2.02 1.94 <0.58 1.83 2.02 1.80
2 6 <0.58 1.78 1.54 1.67 <0.58 1.90 1.91 1.91
7 <0.58 S t i 11 born - - <0.58 Crushed - -
8 <0.58 2.15 2.21 2.05 <0.58 2.04 1.95 2.05
cn  g <0.58 1.72 2 .00 1.76 <0.58 2.01 1.98 2.01
10 <0.58 S t i l l  born - - <0.58 1.73 1.91 1.64
11 <0.58 1.96 2.00 2.00
X <0.58 1.98 2.02 1.95 <0.58 1.86 1.94 1.89
±0.16 ±0.19 ±0.14 ±0.15 ±0.05 ±0.13
Sow
Colostrum/mi  1k 2 .37 2 .34 1.42 1.02 2.39 1.87 1.60 0 .76
d b f Days b e fo re  f a r r o w in g
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Figure 5.1 : The mean neutralizing antibody titres of sow serum, colostrum/milk 
and piglet serum during the first week after farrowing
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Figure 5.2: Regression analysis of relationship between sow serum, 
colostrum and 3 day old piglet serum titres
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The serum t i t re s  of sows in groups B and C, a ll  vaccinated at least 
a month before farrowing, declined during the f i r s t  24 hours after
farrowing and then remained fa i r ly  constant for the next 5 to 6 days
while the serum t i t re s  of group A sows (vaccinated 12dbf) increased 
dur ing the f i r s t  21 to 30 hours a f te r  farrowing before dec l in ing 
somewhat. This result was also reflected in the colostral t i t r e s  which
increased during the f i r s t  30 hours a f te r  farrowing in group A but
declined s tead i ly  in groups B and C.
The n e u t ra l iz in g  a c t i v i t y  in the colost rum/milk  taken from the
various teats  of sows in group 0 (0E91 to 94) during the f i r s t  week 
after farrowing is shown in Table 5.5, f o r  comparison the sow serum 
t i t r e s  are also given. The maximum dev ia t ion  between t i t r e s  from
d i f f e r e n t  teats occurred 3 days after farrowing and at t h i s  t ime there 
was s ig n i f i c a n t  (P>0.005) fo re  to hind v a r ia t io n  as measured by a two
way analysis o f variance. The co los t ra l  t i t r e s  at farrowing were also
corre la ted (r=0.989) with the group mean 3-day-old p ig let serum t i t r e s ,  
fo r  groups A to  D, as i l l u s t r a t e d  in Figure 5.2b and in th i s  case a 
d i r e c t  re la t io n sh ip  was suggested by the slope of the regression 
(m=0.980).
Sera co l lec ted  from group B and C p ig le ts  p r io r  to  suckl ing had no 
detectable n e u t ra l i z in g  a c t i v i t y  whereas the mean t i t r e  o f serum samples 
co l lec ted  from group A p ig le ts  1.5 to 2.5 hours after  farrowing was 1.10 
log-|Q. Furthermore, ind iv idua l  p ig le ts  in these l i t t e r s  had t i t r e s  as 
high as 1.36 and 1.72 log .g .  Peak antibody t i t r e s  were observed in 
p ig le t  groups A and B at 18 to 30 hours after farrowing and in group C 
at 72 hours after fa rrowing.
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Table 5 .5 :  N e u t r a l i z i n g  a c t i v i t y  in  serum and c o l o s t r u m / m i l k  o f  g roup D sows
( v a c c in a te d  87 t o  89 and 30 t o  32db f)  f o r  1 week a f t e r  f a r r o w in g
Sow 0E91
Colost rum/mi lk
t i t r e s
Sow 0E92
Colost rum/mi lk
t i t r e s
Sow 0E93
Colost rum/mi lk
t i t r e s
Sow 0E94
Colost rum/mi lk
t i t r e s
0 Day 
L e f t *  Right
Fore* 2 .90 2.94
Centra l 2 .99 2.94
Hind 3.14 3.19
Mean 3.02± 0 .12
t i t r e s 2. 52
Fore 2 .83 2.88
Cent ra l 2 .98 2.73
Hi nd 3.03 2.93
Mean 2.90+ 0.11
t i t r e s 2. 37
Fore 2.55 2.90
Cent ra l 2 .80 3.10
Hind 3 .00 3.05
Mean 2.90+ 0 .20
t i t r e s 2. 18
Fore 2.96 3.11
Cent ra l 3 .36 3.11
Hind 3.06 3.31
3 Day 
L e f t  Right
1.89 1.65
1.74 1.79
1.89 2.45
1 .90+0 .28
2 .48
1.72 1.68
2.13 1.72
2 .28 2.48
2.00 +0.34
2 .07
1.20 1.25
1.19 2.15
2.10 2.90
1 .80+0 .70
2 .08
1.86 1.80
2 .50 1.90
2 .86 2.36
7 Day 
L e f t  Right
1.43 1.49
1.54 1.54
1.59 1.74
1.56±0.11
2.52
1.28±0.31
2 .28
0 .9 1 ±0 . 36  
2.17
1.58 0.95
1.12 0 .99
1.68 1.37
0 .66 0 .80
0 .62 1.55
0 .69 1.13
1.45 1.45
2.26 1.45
1.90 2 .06
Mean 
Serum t i t r e s
3 .15+0 .15
2 .27
2. 21+ 0. 43
2.37
1 .76+0 .36
2 .23
*  Teat of  o r i g i n  f o r  co los t rum/ mi lk  samples 
d b f  = Days b e fo re  fa r r owing
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DISCUSSION
No FMD virus neutralizing antibodies were detectable in any piglet 
sampled at birth and prior to suckling which agrees with previous 
findings relating to the impermeability of the sow's epitheliochorial 
placenta (Brambell, 1958; Kim, Bradley and Watson, 1966(i);Porter, 1969;
Dujin, 1971 ; Bourne et 1974). Nevertheless, group A piglets
attained antibody levels as high as 1.36 log^Q within 1.5 hours and 1.72
f
log.Q within 2.5 hours of b i r t h  (Table 5.2) demonstrating the piglets  
capacity to  absorb pro tec t ive  ant ibodies from the ir  mothers colostrum.
The peak of passive antibody a c t i v i t y  was observed in the 18 to 30 hour 
samples co l lec ted from l i t t e r s  derived from s ing ly  vaccinated sows 
(groups A and B; Table 5.2 and Figure 5.1) which tends to support 
previous f ind ings  tha t  antibody absorpt ion ceases w i th in  24 to 48 hours 
of suckl ing (Lecce and Morgan, 1962; Bourne, 1971 ; Duj in ,  1971 ; Yabik i ,  
Kashiuiazaki and Nami oka, 1974). However, the maximal level of passive 
antibody in p ig le ts  from revaccinated sows occurred between 24 and 72 
hours a f te r  farrowing (Table 5.4 and Figure 5 .1 ) .  I t  is  therefore 
possible tha t  the vaccinat ion regimen of the sow may have inf luenced the 
rate at which the ant ibodies were absorbed by the p ig le ts .
No s ig n i f i c a n t  te a t- to - te a t  va r ia t io n  was detected in the colostral 
antibody t i t r e s  at the time of fa rrowing, contrary  to  publ ished data on 
the subject (Perry and Watson, 1967(k)).Therefore, any variation observed 
between the serum t i t r e s  of ind iv idu a ls  within a l i t t e r  i s  not due to 
va r ia t io n  in the colostrum t i t r e s  from d iffe rent tea ts  o f the sow. I t  
is  possible tha t  the greater degree of va r ia t io n  which occurred 3 days 
l a te r  was due to se lec t ive  suckl ing by the young p ig le ts .  I f  th is  
hypothesis is  correct then the p ig le ts  displayed a preference fo r
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suckling from the fore teats on the sow, as demonstrated by the 
sign ificantly  lower t i t re s  in samples collected from these teats 3 days 
after suckling.
There was a significant co r re la t io n  (r=0.99) between the sows
colostral t i t re s  at farrowing and 3-day-old p iglet serum t i t r e s  (Figure
5.2) and since the regression slope was very close to 1.00 (m=0.98) a
direct relationship between the two is indicated. This observation
would imply that the p iglet gut absorbs neutralizing antibodies of
d i f f e r e n t  immunoglobulin classes non-se lec t ive ly .  This is  supported by
previously published data (Bourne, 1971; Brown, 1976) and by the resu l ts
of the immunoglobulin class analysis (Table 5.1) since the class of
1
antibody predominating in  the sows colostrum at farrowing was d irectly
re la ted to the class predominating in the p ig le ts  serum 3 days l a te r .  
However, the class of immunoglobulin involved was dependent on the 
vaccination regimen employed since in group A (sows vaccinated 12 to 
13dbf) the IgM a c t i v i t y  was re la t iv e ly  greater than th a t  o f IgG while in 
groups B, C and D (sows vaccinated or revaccinated 30 to 32dbf) the 
opposite pertained and IgG a c t i v i t y  was r e l a t i v e l y  greater  than IgM. 
These f ind ings  were demonstrable in the sows colostrum and were also 
re f lec ted  in  the sera of t h e i r  piglets. The re la t io n sh ip  between IgA
I
present in the sows colostrum and tha t  in p ig le t  serum is  less c lear  and 
does not appear to be re la ted to the sows vaccinat ion regimen.
There was also a good c o r re la t io n  between sow serum and colostrum 
t i t r e s  at fa rrowing. However, the slope of the regression between the 
two (m=l.57 ) suggests tha t  some mechanism of concentrat ing the 
ant ibodies occurred during the t ra n s fe r  o f  ant ibodies from the serum to 
the colostrum. This may have been e i th e r  se lec t ive  f o r  immunoglobulin
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class or inf luenced in some way by the sows vaccinat ion regimen. The 
increased concentration of antibodies in the colostrum over and above 
that in the serum has been observed by other workers (Curtis and Bourne, 
1971; Jonsson, 1973).
The immunoglobulin class analysis also demonstrated tha t  the class 
present in the sows' serum at far rowing was re la ted  to  tha t  in the sows 
colostrum. However, the r e la t i v e  leve ls  appeared to be governed by the 
period between the f i n a l  vaccinat ion and farrowing since the leve ls  of 
IgG present in the colostrum of group A sows (vaccinated only 12 to 
13dbf) were s im i la r  to or lower than the leve ls  in the sows serum, whi le 
in groups B, C and D (vaccinated or revaccinated 30 to  32dbf) the IgG 
leve ls  in the colostrum were invariably higher.  Therefore, i t  appears 
l i k e l y  tha t  the act ive  concentrat ion of ant ibodies in to  the colostrum i s
f
inf luenced by the sows vaccinat ion regimen, in p a r t i c u la r  by the period 
between vacc inat ion and farrowing.
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CHAPTER 6
DECAY RATE OF MATERNALLY DERIVED ANTIBODIES IN PIGLETS 
INTRODUCTION
Relatively l i t t l e  attention has been directed towards the FMD 
vaccination regimen of the sow and its  e ffect on the class of antibody 
in the serum and colostrum at the t ime of farrowing. Since the antibody 
class inf luences the persistence of maternal ly derived ant ibodies in 
p ig le ts  (Porter and H i l l ,  1970; Cur t is  and Bourne, 1971) the experiments 
described here were designed to determine the e f fe c t  of various sow 
vaccinat ion regimens on the decay ra te  o f maternal antibodies passed to 
the ir  p ig le ts  and to inves t iga te  the influence of p ig le t  growth rates on 
these results. The information obtained should f a c i l i t a t e  p redic t ions 
concerning the durat ion of co los t ra l  p ro tec t ion  and any i n h ib i t o r y  
a c t i v i t y  (see chapter 7) in p ig le ts  born to FMD vaccinated sows. This 
would ass is t  in the design optimal vaccinat ion regimens fo r  breeding 
stock.
EXPERIMENTAL DESIGN
The p ig le ts  used in t h i s  chapter f o r  passive antibody decay rate 
studies were born to sows in groups A, B and C whose vaccinat ion 
regimens have been described in Chapter 4.
Blood samples were co l lec ted  from each p ig le t  at 3 days o ld , 1 week 
and then weekly f o r  10 weeks. Immediately prior to each bleeding the 
weight of the p ig le ts  was recorded and converted to  blood volume using 
the formula given in  Chapter 2.
A l l  sera were analysed f o r  neu t ra l iz in g  antibody a c t i v i t y .  In 
add i t ion ,  sera from 3 to 21 day old piglets were analysed fo r  class
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ac tiv ity  by ELISA, and S-day^old p iglet sera were also subjected to gel 
f i l t r a t io n  and the fractions were analysed for neutralizing antibody 
class a c t iv ity .  The percentage a c tiv ity  in each antibody class was
calculated by taking the antilog of the neutralization t i t r e  for one 
class, dividing i t  by the sum of the antilog values for a ll three 
classes and multiplying that figure by one hundred. The observed 
ha lf- l ives  of the maternally derived neutralizing antibodies in the 
piglet sera, before and after correction to take into account the 
expanding blood volume, were calculated according to the methods 
described in Chapter 2.
RESULTS
a) Antibody class analysis
The resu l ts  o f the n e u t ra l iz in g  antibody class analysis (Table 6.1) 
demonstrated tha t  in 3 -d a y -o ld  p ig le ts  born to group B and C sows
vaccinated or revaccinated 30 to 32dbf 60-91% of the n eu t ra l iz ing  
a c tiv ity  resided in the IgG fraction, while in p ig le ts  born to group A 
sows vaccinated 12 to  13dbf 100% of the n e u t ra l i z in g  a c t i v i t y  was in the 
IgM fraction. Results which tended to  conf irm th i s  were obtained from 
the ELISA immunoglobulin class analysis (Table 6 .2 ) .  At 3 days old the 
IgM a c tiv ity  was greatest in the piglets born to sows vaccinated 12 to 
13dbf whi le  the IgG a c t i v i t y  was greatest in the sows vaccinated or 
revaccinated 30 to 32dbf. The ELISA results also indicated that IgA was 
present at s im i la r  leve ls  in a l l  the l i t t e r s  regardless of the sow 
vaccinat ion regimen. The fa c t  tha t  the ELISA detected a c t i v i t y  in
immunoglobulin classes tha t  did not display n e u t ra l i z in g  a c t i v i t y  may
have been due to the greater sens itiv ity  of the ELISA technique over to 
neutralizing antibody assay, or the fact that the antibodies detected 
were direc ted against non-neutra l i z ing  epitopes on the FMD v i r i o n .
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Table 6.2: Immunoglobulin class a c t iv ity  in the sera of piglets born to
vaccinated sows (measured by ELISA)
Group No. 
(Vaccination)
L i t te r
No.
Age of 
piglets (days)
Class spec ific ity  
of conjugate
IgM IgA IgG
3 0.38* 0.34 0.19
NU02
6 0.17 0.15 0.16
13 0 0.02 0
A 20 0 0 0
(12 to 13dbf) 3 0.47 0.61 0.16
NU05
5 0.33 0.40 0.15
12 0.01 0.09 0
19 0 0 0
3 0.10 0.29 0.74
NUOl
6 0.05 0.13 0.60
13 0 0.03 0.48
B 20 0 0.01 0.39
(30 to 32dbf) 3 0.09 0.31 0.30
NU04
7 0.04 0.06 0.22
14 0 0.03 0.04
21 0 0.01 0.03
3 0.15 0.20 0.90
NUOO
7 0.08 0.08 0.81
14 0 0.02 0.66
C
(51 to 52 and 21 0 0.01 0.50
31 to 32dbf) 3 0.13 0.24 1.18
NU03
7 0.05 0.08 0.93
14 0 0.02 0.80
21 0 0 0.63
* O.D. values at 492nm 
dbf = Days before farrowing 121
b) Observed ha lf- l ives  of n e u tra l iz in g  antibodies
The neutralizing antibody t i t r e s  (logng) for each p ig le t,  and the 
mean t i t r e s  for each l i t t e r ,  at each sample point are shown in Tables
6.3 to 6 .8 . The observed h a lf - l iv e s  of the neutralizing antibodies in 
each p ig le t,  and each l i t t e r ,  calculated by linear regression analysis 
are provided in Table 6.9 and the decay rates are displayed graphically  
as l in e a r  regression slopes fo r  each l i t t e r  in  Figures 6.1 to  6.3. The 
re su lts  were based on 7 to  8 p ig le ts  per l i t t e r  except in  l i t t e r  NU04 
where, due the sows poor vaccination response, only 4 piglets met the 
f i r s t  cond it ion  described in Chapter 2. The observed mean h a l f - l i v e s  of 
maternally  derived antibodies were 18.4 (range 12.4 to  23.6, n=8) and
7.4 (range 4.8 to  13.2, n=4) days in  the p ig le ts  born to  sows NUOl and 
NU04 vaccinated 32 and 30dbf resp ec t ive ly ; 20.9 (range 16.9 to  25.6, 
n=8) and 20.6 (range 18.3 to  24.6, n=8) days in p ig le ts  born to  sows 
NUOO and NU03 vaccinated at 51 and 31, and 52 and 32dbf respectively; 
and 4.2 (range 3.8 to  4 .9 , n=8) and 7.8 (range 6.0 to  9.8, n=7) days in 
p ig le ts  born to  sows vaccinated 12 and 13dbf respectively. The f i t  o f 
the l in e a r  regression slopes to  ind iv id u a l p ig le t  and l i t t e r  mean data 
was highly s ig n i f ic a n t  (r>0.9 , P<0.001) in  a l l  cases.
c) Corrected ha lf- l iv es  o f n e u tra l iz in g  antibodies
The blood volume (ml) of each pig le t,  ca lcu la ted  from th e i r  body 
weights, and the l i t t e r  mean blood volumes at each sample po in t are 
provided in  Tables 6.10 to  6.15. These values were used to  co rrec t the 
antibody decay ra te  data fo r  blood volume increase (see Chapter 2) and 
the corrected decay rates are shown in  Table 6.16 and Figures 6.4a to 
6 .4 f . The h a l f - l i v e s  o f antibodies in  the serum of p ig le ts  from group A 
sows (NU02 and NU05) vaccinated 12 and 13 d b f,corrected fo r  blood volume 
increase were 6.9 and 18.5 days re spec t ive ly  (Figures 6.4H and 6.4b) 
while  the corrected h a l f - l i v e s  in  p ig le ts  from group B and C sows (NUOl,
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Figure 6 .1: Decay rate o f maternally derived neutralizing antibodies in individual piglets
from  group A  litters
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Figure 6.2: Decay rate of maternally derived neutralizing antibodies in individual piglets
from group B litters
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Figure 6.3: Decay rate of maternally derived neutralizing antibodies in individual piglets
from group C litters
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Figure 6.4: The mean observed (— ) and corrected (■■■■ ) decay rates of maternally 
derived antibodies in piglets
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Table 6.16: Comparison between the observed h a lf - l ive s  of
neutralizing antibodies and those corrected for  
blood volume increase
Group
no.
L i t te r
no.
Neutralizing antibody 
h a l f - l i f e  (days)
Observed Corrected
A
(Sows vaccinated 
12 to 13dbf)
NU02 4.19 6.89
NU05 7.82 18.45
B
(Sows vaccinated 
30 to 32dbf)
NUOl 18.44 428.62
NU04 7.74 I n f i n i t y
C
(Sows vaccinated 
51 to 52 and 
31 to 32dbf)
NUOO 20.92 I n f i n i t y
NU03 20.56 I n f i n i t y
dbf Days before farrowing
Table 6.17: The mean body weight, blood volume and blood volume doubling
over the f i r s t  70 days o f l i f e
Age o f 
piglets  
(days)
Mean body 
weight 
(Kg)
Mean blood 
volume 
(ml )
Blood volume 
doubling time 
from day 3 
(days)
3 1.75 160.04 —
5-7 2.50 223.15 7.02
12-14 3.97 343.40 8.68
19-21 5.77 486.56 10.81
26-28 7.92 653.64 12.19
33-35 10.52 851.61 13.39
41-43 13.64 1084.85 14.49
47-49 16.60 1302.76 15.58
54-56 18.67 1453.55 16.92
62-63 20.79 1606.81 18.31
69-70 22.91 1759.00 19.80 140
N004, NUOO and NU03) which were vaccinated or revaccinated 30 to  32dbf 
ranged from greater than 408 days to in f in i ty  (Figures 6.4c to 6 ,4 f ) .
The mean increase in body weight (Kg) and blood volume (ml) for a ll 
43 piglets from the six l i t t e r s  is given in Table 6.17 along with the 
blood volume doubling time frcmn 3 days of (K;e onwards calculated 
l inear regression of the rmaan log^Q values.
DISCUSSION
The vaccination schedules used in th is  experiment were based on 
p rev ious ly  published observations (Ouldridge, Francis and Black, 1982) 
and resulted in sows w ith  principally  e ith e r  IgG or IgM neutralizing  
antibodies in the ir  sera at the time of farrowing (see Chapters 4 and 
5). The re su lts  described here show th a t the l i t t e r s  from these sows
also had the corresponding predominance o f IgG or IgM in  th e i r  sera 3
days after b irth .
The group A l i t t e r s  which received principally  neutralizing IgM 
antibodies had observed h a lf- l ive s  of jk2 and 7.8 days. These
results, based on n e u tra l iz in g  a c t iv ity ,  were somewhat higher than 
published values o f 1.3 to  4.5 days which were based on the decay of 
normal serum IgM (Porte r and H i l l ,  1970; C urt is  and Bourne, 1971; 1973; 
Klobasa e t a l , 1981). However, although only n e u tra l iz in g  IgM a c t i v i t y  
could be detected in  the 3-day-old p ig le t  serum pools o f these l i t t e r s ,
i t  seems possible th a t low leve ls  o f n e u tra l iz in g  IgG were present at
farrowing which were not detectab le by the technique employed but 
nonetheless lengthened the observed ha lf- l ives  of m aternally  derived 
antibodies in the p ig le t  sera. This is  supported by the ELISA te s t  
re s u lts  which demonstrated low leve ls  of IgG a c t i v i t y  in  the sera of 
these p ig le ts .  The observed mean h a lf- l ives  in  p ig le t  l i t t e r s  from
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groups B and C which received p r in c ip a l ly  IgG antibodies were genera lly  
longer (7 .4 , 18.4, 20.6 and 2 0 ^  days). A similar range of passive IgG 
h a l f - l i f e  values (7.5 to 19.7 days) appears in the l i te ra tu re  (Porter 
and H i l l ,  1970: Curtis and Bourne, 1971; 1973; Lannais, Aynaud and 
Corthier, 1978; Frenyo et a l , 1980/81; Klobasa et a l , 1981; Paul et a l , 
1982).
In seeking an explanation fo r  the wide v a r ia t io n  in the passive 
antibody h a l f - l i v e s  observed in  th is  and other stud ies, an attempt was 
made to id e n t i f y  the true  h a lf- l ives  due to  catabolism/excretion. This 
was done by tak ing  in to  account the e f fe c t  o f d i lu t io n ,  produced by 
increased blood volume with size, on the decay ra te  o f the neutralizing  
antibodies. Although previous authors have drawn attention to the 
e f fe c t  th a t the rapid growth ra te o f young pigs might have on the ir  
observed serum antibody h a l f - l i f e  values (Porter and H i l l ,  1970; Curtis 
and Bourne, 1971; 1973) and used th is  to  expla in  l i t t e r  to  l i t t e r  
va r ia t io n  (Curtis and Bourne, 1971; 1973) few have attempted to  q uan t ify  
th is  effect or co rrec t the antibody decay ra te  fo r  blood volume 
increase. The corrected h a l f - l i v e s  of passive IgM antibodies in the 
l i t t e r s  due to  catabolism were ca lcu la ted to be between 6.9 and 18.4 
days. However, w ith  regard to  the IgG antibodies the results suggested 
th a t there was l i t t l e  or no IgG catabo lism /excre tion  during the f i r s t  10 
weeks of the pigs l i f e  and th a t a l l ,  or almost a l l ,  the f a l l  o f f  in  the
I
p ig le ts  n e u t ra l iz in g  IgG t i t r e s  was due to  the increase in  the vascular 
compartment volume.
In a recent study (Paul et a l , 1982) on Porcine Parvovirus antibody 
n e u tra l iz a t io n  the h a l f - l i f e  was corrected fo r  body weight increase in 
16 to  24 week old p ig le ts  and a mean corrected h a l f - l i f e  value o f 29 
days was obtained. I t  seems poss ib le , therefore, th a t  the low ca tabo lic
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ra te  observed fo r  the IgG antibodies in th is  study was due to the age of 
the piglets used.
That the control mechanism i^)r IgG catabolism/excretion rate is 
mediated by the total serum IgG concentration has been reported in other 
species (Fahey and Robinson, 1963; Se ll ,  1964; Waldmann and Strober, 
1969). I f  a similar mechanism exists in young piglets then the results 
observed here may be explicable since the p ig le ts  used in th is  study 
were less than 10 weeks old and young pigs do not a t ta in  adult IgG 
leve ls  u n t i l  they are 12 to 16 weeks old (Curtis and Bourne, 1971; 
Frenyo et a l , 1980/81). I t  follows therefore that no catabolism/ 
excretion of IgG would be expected at an early age but th a t  catabolism/ 
excre tion  might be expected to  occur to an increasing extent as the 
vascular volume expansion slowed down and as adu lt immunoglobulin leve ls  
were a tta ined. Furthermore, IgM and IgA catabolism has been shown to  be 
independent o f serum concentration (Waldmann and Strober, 1969) which 
would expla in  why catabolism was observed in group A p ig le ts .
The re s u lts  obtained here also showed th a t the doubling time o f the 
vascular volume depended la rg e ly  on the age and period over which the 
observations were made. For example, when measured in  3 to  7-day-o ld  
p ig le ts  the doubling time fo r  blood volume was approximately 7 days but 
when measured in  the same p ig le ts  over 3 to  70 days the blood volume 
doubling time was almost 20 days. Thus, although a l inear regression 
provides a good f i t  to  the data (r>0.95 in  a l l  6 l i t t e r s ) ,  the observed 
h a l f - l i f e  is  not s t r ic t ly  l in e a r  and is  in fluenced by the rapid blood 
volume doubling time in  the f i r s t  few weeks o f the piglets l i f e .  The 
in f luence o f these f in d in g s  on the h a l f - l i f e  o f the maternally derived 
IgG antibodies is  apparent in  the case o f l i t t e r  NU04 where the 
re la t ive ly  short h a l f - l i f e  o f 7.4 days can be ascribed to the fa c t  th a t
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the t i t r e s  o f the maternal antibodies were low and could only be 
measured for 13 days a fter farrowing. After that tin^ the inore gradual 
decrease which could be expected for IgG antibodies remaining in the 
sera could not be measured as i t  f e l l  below the threshold of sensitiv ity  
of the neutralization t i t r a t io n  method employed. During the f i r s t  13 
days the doubling time of the blood volume was correspondingly short 
(8.7 days). Therefore the observed h a l f - l i f e  value ihar neutralizing  
antibodies may be a ffec ted  by the p ig le ts  age and the period over which 
observations are made. This is  supported by the work of Paul et al 
(1982) who noted tha t the h a l f - l i f e  o f parvovirus antibodies varied w ith  
the age o f the p ig le ts .
I t  is  possible to  account fo r  some of the differences in previously 
published IgG h a l f - l i f e  values by relating them to  the observation 
period used in  each instance. For example, an IgG h a l f - l i f e  o f 12 to  14 
days (Curtis and Bourne, 1971) was ca lcu la ted  over the f i r s t  4 weeks o f 
l i f e  during which time the blood volume doubled, on average calculated 
from the population o f 54 p ig le ts  used in th is  study, every 12.2 days 
while  an IgG h a l f - l i f e  of 17 days (Lannais, Aynaud and C orth ie r ,  1978) 
was calculated over the f i r s t  10 weeks l i f e  during which time the 
mean blood volume doubled every 19.8 days.
For p ra c t ica l purposes a l in e a r  regression drawn through the 
observed neutralizing antibody t i t r e s  of a l l  the p ig le ts  in  a l i t t e r  is  
useful to  predict the time at which the t i t r e s  w i l l  drop below 
protective leve ls  (Black et a l , 1984) and also when any vaccination 
in h ib i t in g  a c t i v i t y  (see Chapter 7) subsides below acceptable l im i t s .
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CHAPTER 7
THE RESPONSE OF YOUNG PIGS TO VACCINATION IN THE PRESENCE AND ABSENCE
OF MATERNALLY DERIVED NEUTRALIZING ANTIBODIES
INTRODUCTION
Chapters 5 and 6 described the transfer cf neutralizing antibodies 
from the sow to her l i t t e r  and siams of the factors effecting the 
persistence these antibodies in the young. The results indicated 
that maternally derived antibodies subside well before the piglets were 
6 months old, the marketing age required by the bacon industry. 
Consequently in areas where FMD is endemic the young pigs need to twa 
a c t iv e ly  immunized at as early an age as possib le.
Some published work claims th a t oi1-emulsion vaccines are capable of 
inducing immunity to FMD in one-month-old p ig le ts  ir re s p e c t iv e  of 
whether they are derived from vaccinated or unvaccinated sows (Giraud et 
a l , 1969) and that FMD oil vaccines produce a 'meaningful response' in
p ig le ts  regardless of the immune status of th e i r  mothers (Morgan and
McKercher, 1980). However, other workers have shown,to the contrary, 
th a t passively acquired maternal antibodies in te r fe re  w ith  the active
immune responses o f p igs. Examples include studies using aqueous FMD
vaccines (van Bekkum, Frenkel and Nathans, 1963; Nathans, 1965; Sidorov, 
1974), a r t i f ic ia l  antigens (Hoerle in , 1957; Muscoplat, Setcavage and 
Kim, 1977), b ac te r ia l antigens (Watson, Bennell and Chaniago, 1979; 
Pedersen and Jensen, 1980; Senft and Heckelmann, 1980; Hoerlein, 1957) 
and also vira l antigens other than FMDV (Coggins, 1964; Renshaw, 1975; 
Mensik et a l , 1976; Corthier, 1976; Mierzejewska et a l , 1977; Launais, 
Aynaud and Corthier, 1978). S im ila r ly ,  in h ib i t io n  by maternal 
antibodies has been reported in calves using aqueous FMD vaccines 
(Graves, 1963; van Bekkum, 1966; Srubar, 1966; Wisniewsky and Jankowska,
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1972; Mayr and Thein, 1972; Nicholls et a l , 1984) and oil-emulsion FMD
vaccines (Brum et a l , 1977).
In addition, the results of recent work (Black et a l , 1982), 
ind ica te  that some depression o f the o i l  emulsion vaccination response 
in pigs by m aternally  derived FMD antibodies might be expected. This 
chapter of the thes is  is  designed to  es tab lish  the e a r l ie s t  age at which 
young pigs are capable of responding to I11D vaccination, the nature of
the response, whether early vaccination has any adverse e ffe c ts  on the
p ig le ts '  weight gain and what e f fe c t  the m aternally  derived antibodies 
have on the immune response, in  terms o f the neutralizing antibodies and 
antibody classes invo lved.
EXPERIMENTAL DESIGN
Eight pregnant Large White sows, never previously vaccinated against 
or exposed to FMD v iru s ,  were div ided in to  2 groups o f 4. One group 
(group D from Chapter 4) was vaccinated w ith  0-jBFS vaccine batch 0-121 
at 87-89 and again 30-32dbf. The other group was l e f t  unvaccinated. At 
farrowing the p ig le ts  were d iv ided in to  4 groups o f 6 to  8 p ig le ts  from 
the vaccinated sows and 4 groups from the unvaccinated sows. Most 
groups contained representatives of the p ig le ts  from e i th e r  the four 
vaccinated or fou r  unvaccinated sows. One group of p ig le ts  from the 
vaccinated and one group from unvaccinated sows were subsequently 
vaccinated against FMD when they were 1, 2, 4 or 8 weeks old and a l l  
were challenged w ith  l iv e  FMD v irus  when they were approximately 7 
months o ld . A plan o f the p ig le t  d is t r ib u t io n  and vacc ination schedule 
is  shown in  Table 7.1.
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Blood samples were collected from the piglets at 3 dc^ fs old, at the 
time of vaccination and then at 3 days, 7 days and weekly until they 
were challenged.
All the piglets were weighed at b irth , at 3 days old and then weekly 
for 10 weeks. Weights vw:re again recorded for 3 to 4 weeks before 
challenge.
RESULTS
a) Effect of FMD o i l  emulsion vaccination on p ig le t  growth ra te
The weights of ind iv idu a l p ig le ts  at each sample po in t are shown in 
Tables 7.2 to  7.9, and the mean increase in body weight fo r  p ig le ts  from 
e i th e r  vaccinated or unvaccinated sows are presented g ra p h ica l ly  in
Figures 7.1(a) and 7.1(b) respectively. Pooled data fo r  p ig le ts  from 
both vaccinated and unvaccinated sows is  given in Figure 7.2.
Examination of these f ig u res  shows th a t the only group th a t appeared to  
e x h ib i t  any dev ia tion  from the general trend was the p ig le ts  from 
unvaccinated sows vaccinated at 1 week old . In order to determine 
whether t h is  group was sign ificantly  d i f fe re n t  a two-way analysis of 
variance was ca rr ie d  out between p ig le t  vacc ination age and ind iv idu a l
day weights. Where the ages were matched up to 69 days the weights of
p ig le ts  from vaccinated and unvaccinated sows were grouped together 
(Table 7 .1 0 (a )) .  However, since the weights of p ig le ts  from 
unvaccinated sows at 179-209 days old and from vaccinated sows at
195-226 days o ld  were not matched they were analysed separately (Tables 
7.10(b) and ( c ) ) .  These calculations showed tha t no s ig n i f ic a n t  
differences were demonstrable in  the weights o f p ig le ts  vaccinated at 1, 
2, 4 or 8 weeks old e i th e r  fo r  the f i r s t  10 weeks of l i f e  or just prior
to challenge at 6 to  7 months o ld .
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Figure 7.1 : Effect of vaccination on the growth rate of piglets
(a) Piglets from vaccinated sows
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Table 7.10: Results of a two way analysis  of variance to study the e f f e c t
that the vaccination age has on the growth rate of p ig l e t s
a) Grouped data of l i t t e r s  from vaccinated and unvaccinated sows
Variable
(day) ' F ' value
Degrees o f 
freedom
S ign if icance
(P)
0 0.53 3, 46 N.S.
3 0.25 3, 46 N.S.
7 0.54 3, 46 N.S.
14 ^ 0.41 3, 46 N.S.
21 0.10 3, 46 N.S.
2 8 ^ 0.07 3, 46 N.S.
35 0.14 3, 46 N.S.
42 0.39 3, 46 N.S.
49 0.73 3, 46 N.S.
5 6 ^ 0.85 3, 46 N.S.
63 2.27 3, 46 N.S.
69 1.98 3, 46 N.S.
Data o f l i t t e r s  from vaccinated sows
Vari able 
(day) ' F ' value
Degrees of 
freedom
S ign if icance
(P)
179 0.39 3, 22 N.S.
196 0.34 3, 22 N.S.
209 0.29 3, 22 N.S.
Data o f l i t t e r s  from vaccinated sows
Vari able 
(day) ' F ' value
Degrees of 
freedom
S ign if icance
(P)
195 0.73 3, 23 N.S.
206 0.64 3, 23 N.S.
223 0.74 3, 23 N.S.
226 1.01 3, 23 N.S.
N.S.
day a p ig le t  group was vaccinated
Not s ig n i f ic a n t
155
b) Neutralizing antibody response
( i )  Piglets from unvaccinated sows - The neutralizing serum antibody 
t i t re s  (log^QSNrg) for individual piglets derived from unvaccinated sows 
and vaccinated at 1, 2, 4 or 8 weeks old are given in Tables 7.11 to
7.14. The mean t i t re s  are plotted graphically in Figure 7.3.
Piglets vaccinated at 1 or 2 weeks old showed a rapid production of 
neutralizing antibody which reached peak levels of >2.4 log.gSNgQ 3 to  4 
weeks a f te r  vaccination. The leve ls  then gradually declined over the 
next 6 months to f in a l  pre-challenge t i t r e s  o f between 1.9 and 2.0
logngSNgQ. However, while the piglets vaccinated when 4 to 8 weeks old 
showed in i t ia l  peak t i t r e s  which were lower than in the groups 
vaccinated when 1 or 2 weeks old, (1.9 to 2.0 logigSNrg), the ir  
n e u tra l iz in g  antibody leve ls  then remained stable, or gradually 
increased, over the next 5 to  6 months. The f in a l  t i t r e s  in  7 month old 
piglets were between 2.0 and 2.4 log^QSNrg.
( i i )  P ig le ts  from vaccinated sows - The neutralizing antibody t i t r e s  
(logigSN^Q) for individual piglets derived frian vaccinated s(Mvs and
vaccinated themselves at 1, 2, 4 or 8 weeks old are given in Tables 7.15 
to 7.18. The mean t i t re s  are p lo t te d  graphically in  Figure 7.4 and a 
comparison between these responses and those of l i t t e r s  derived from
unvaccinated sows appears in Figures 7.5(a) to  7 .5 (d ) .
P ig le ts  vaccinated at 1, 2 or 4 weeks old d id not appear to  show any 
response to  vacc ination and the maternally derived passive antibodies 
continued to decline (see Figures 7.5(a) to 7 .5 (c ))  with h a lf- l iv es  of 
23.4, 19.7 and 23.0 days from 3 to 69 days old, and 44.3, 4 2 and 48.7 
days from 3 to  226 days old respectively.
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I able 7.11: Neutra l iz ing  antibody t i t r e s  of p ig le ts  vaccinated at 1 week old (born to unvaccinated sows)
P i g l e t
n o .
Age o f  p i g l e cs (Days)
3 ► 7 10 14 21 28 35 42 49 56 63 69 76
96/01 <0 .47* <0.47 <0.53 1 . 1 7 1.17 2.38 2.43 2 .48 2.18 2 . 0 8 2 .08 2 .23 2 .18
96 /02 <0.47 <0.47 <0.47 1.48 1.93 1.93 2 .18 2.44 2.28 2 .28 2.13 1.98 2.33
97/01 <0.47 <0.65 <0.65 1.45 1.61 1.91 2.21 2.11 2.04 1.96 1.91 1.95 2.16
97 /12 <0.47 <0.65 <0.65 1.66 1.61 2.41 2.46 2.41 2.36 2.26 2 .36 2.66 2.51
98/01 <0.47 <0.47 <0.47 1.67 1.93 2.83 2.73 2.73 2.78 2 .48 2.58 2.41 2.24
98 /02 <0.47 <0.47 <0.53 1.57 1.98 3.68 3.53 3.43 3.38 3.13 3.14 3.03 2.88
X <0.47 <0.53 <0.55 1.50 1 . 7 1 2.52 2.59 2 .60 2.50 2.37 2.37 2.38 2 .38
P i g l e t
no.
Age of  p i g l e cs (Days)
83 90 97 104 111 118 125 129 153 166 179 196 209
96/01 2 .28 2.13 2.23 1.97 2.13 2.03 2.03 1.88 1.92 1.93 1.98 1.93 1.93
96 /02 2 .0 8 2.28 1.93 2.08 2.13 2.18 2 .38 2.28 2 .03 2.28 2.13 2.41 2.33
97/01 2.01 2.26 2.01 2.06 2.06 1.86 1.90 1.86 1.76 1.75 1.56 1.66 1.55
97/12 2.21 2.36 2.61 2.56 2.56 2.23 2.81 2.41 2 .60 2.61 2.56 2.51 2.46
98/01 2 .23 2.18 1.98 1.93 2.03 2.03 2.18 1 98 1.92 1.64 1.53 1.67 1.47
98/02 2 .77 2.63 2.58 2.67 2.53 2.28 2.53 2.43 2 .18 2 .08 2.18 2 .03 1.87
X 2 .26 2.31 2.22 2.21 2 .24 2.10 2.31 2.14 2.07 2.05 1.99 2.04 1.94
Vacc inat ion ' log^gSNcQ (mean o f  3 t e s t s )
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Table 7.12: N eutra l iz ing  antibody t i t r e s  of p ig le ts  vaccinated at 2 weeks old (born to unvaccinated sows)
1 P i g l e t  
no.
Age of  p i g l e t s  (Days)
3 ► 14 17 21 28 35 42 49 56 63 69 76 83
96 /03 < 0 . 4 7* 0 .47 0.53 1.62 2.03 2.03 2.03 2.23 2 .08 1.88 1.78 2 .08 1.83
96 /04 <0.47 <0.47 <0.53 1.32 1.77 2.28 2.33 2.28 2.43 2.28 2.08 2.23 2.03
97 /03 <0.65 0.65 0.65 1.25 1.35 1.95 2.06 1.85 1.52 2.31 2.51 2.61 2.56
97 /04 <0.65 <0.65 <0.65 1.50 1.71 1.91 2.06 2.01 2.01 1 .91 1.86 1.91 1.90
98 /03 <0.47 <0.47 <0.47 1.42 2.23 3.31 3.18 3.18 2 .98 3.00 2.93 2 .78 2.48
: 93 /04 <0.47 <0.47 ' 0 . 4 7 2.03 2.93 2.98 3.19 2.78 2 .98 2.80 2.77 2.73 2.73
■ X <0 . 53 <0.53 <0.55 1.52 2.00 2.38 2.47 2.39 2.33 2.36 2.32 2 .39 2.26
P i g l e t
no.
Age of  p i g l e t s (Days)
90 97 104 111 118 125 139 153 166 179 196 209
96/03 2 . 0 3 1.78 2.03 1.92 2.18 2.13 2.28 2.08 2.23 1.98 2.22 1.87
96/04 2 . 0 8 2.02 1.93 2.08 1.93 2.03 1.83 1.98 1.98 1.83 1.87 1.72
97/03 2 . 7 9 2.86 2.96 2.91 2.76 2.86 2.91 2.81 2 .96 2.76 2.96 2.86
97/04 2.21 2.31 2.36 2.26 2.26 1.90 2.21 1.86 2.11 1.66 1.71 1.66
98/03 2 . 7 8 2 .53 2.58 2.43 2.48 2.43 2.53 2.48 2.23 2.33 2 .18 2 .13
98/04 2 . 8 3 2 .5 8 2.67 2.63 2.58 2.53 2.53 2.53 2.33 2 .28 2.03 2.23
X 2 . 4 5 2 .35 2.42 2.37 2.37 2.31 2.38 2.29 2.31 2.14 2.16 2.08
Vacc inat ion *log^QSNgQ (mean o f  3 t e s t s )
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Table 7.13: N eutra l iz ing  antibody t i t r e s  of p ig le ts  vaccinated at 4 weeks old (born to unvaccinated sows)
P i g l e t
no.
Age o f  p i g l e t s (Days)
3 28 31 35 42 49 56 63 69 76 83 90
95/07 <0.47* <0.47 0 . 5 9 1.88 1.53 1.77 1.93 1.88 1.87 1.88 2.08 2.08
96/05 <0.47 <0.53 <0.63 1.88 2.43 2.18 1.98 2.07 2.03 1.97 2.23 2.22
96/06 <0.47 <0.47 <0.53 1.88 1.88 1.93 1.57 1.52 1.63 1.53 1.53 1.47
96/07 <0.47 <0.47 0 .57 1.37 1.78 1.88 1.83 1.87 1.72 1.82 1.67 1 .73
97/05 <0.65 <0.65 0.71 1.75 2.31 1.90 1.71 1.65 1.71 1.65 1.81 1.81
97/06 <0.65 <0.65 <0.65 1.91 1.90 1.85 1.81 1.71 1.91 1.65 1.76 1.71
97/11 <0.65 <0.65 <0.65 1.70 1.91 1.61 1.76 1.65 1.75 1.55 1.66 1.76
98/05 <0.47 <0.47 <0.53 2.23 2.38 2.47 2.53 2.36 2.14 2.51 2.28 2 .18
X <0.54 <0.55 <0.61 1.83 2.02 1.95 1.89 1.84 1.85 1.82 1.88 1.87
P i g l e t
no.
Age of  p i g l e t s  (Days)
97 104 111 118 125 139 153 166 179 196 209
95/07 2.38 2 .13 2.13 2 .18 2 .48 2.68 2.43 2.58 2.38 2.33 2.23
96 /05 2.43 2 .13 2 .38 2 .38 2 .73 2.43 2.78 2.78 2.73 2.58 2.88
96 /06 1.47 1.62 1.67 1.72 1.78 1.73 1.52 1.62 1.73 1.77 1.67
96 /07 1.63 1 .77 1.97 1.98 1.83 1.93 1.82 1.73 1.63 1.57 1.67
97 /05 1.75 1.91 1.91 2.01 1.86 1.96 1.91 1.70 1.45 1.51 1.71
97 /06 1.75 1.81 1.81 1.81 1.80 1.80 1.86 1.55 1.80 1.55 1.61
97/11 1.71 1.61 1.81 1.65 1.81 1 .71 1.90 1.45 1.65 1.50 1.61
98 /05 2.03 2 .23 2.43 2 .43 2 .48 2.68 2.68 2 .48 2.43 2 .58 2.88
X 1.89 1.90 2.01 2.02 2.10 2.12 2.11 1.86 1.98 1.92 2.03
Vacc inat ion *log^QSNgQ (mean of  3 t es t s ]
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Table 7.14: N eutra l iz ing  antibody t i t r e s  of p ig le ts  vaccinated at 8 weeks old (born to unvaccinated sows)
P i g l e t
no.
Age of  p i g l e t s (Days)
3 56 59 63 69 76 83 90 97 104 111
95/09 0 . 4 7 * <0.53 0.63 1.62 1.22 1.47 1.72 1.99 1.63 1.93 1.73
96/08 <0.47 <0.53 <0.62 1.93 1.83 1.92 2.03 1.77 1.67 1.73 1.77
96/09 <0.47 <0.47 - 0 . 6 2 1.47 1.73 2 .43 2 .38 2.03 1.73 2.03 2.33
96/10 <0.47 <0.53 <0.62 1.63 1.71 2.23 2.08 1.88 1.73 1.88 1.98
97/07 <0.47 <0.71 0.77 1.51 1.61 1.75 1.81 1.86 1.95 1.80 2.01
97/08 <0.47 < 0 . 6 5 <0.65 1.46 1.29 1.76 1.50 1.61 1.51 1.55 1.75
97/10 <0.47 <0.65 <0.65 1.50 1.25 1.56 1.85 1.81 1.65 1.75 1.81
X <0.55 <0.58 <0.65 1.59 1.52 1.88 1.91 1.85 1.70 1.81 1.91
P i g l e t
no.
Age of  p i g l e t s (Days)
118 125 139 153 166 179 196 209
95/09 2.13 2 .48 2.73 2.77 2 .78 2.83 2.86 2.96
96/08 1.67 1.67 1.67 1.72 1.68 1.63 1.73 1.77
96/09 2.18 2.53 2.33 2.78 2 .78 2 .78 2 .58 2 .58
96/10 2 .43 2.43 2.63 2.63 2 .58 2 .58 2 .63 2.38
97/07 1.91 2 .06 2.16 2.46 2.41 2.41 2.36 2.26
97/08 1.91 1.96 2.26 2.36 2.21 2.36 2.56 2.36
97/10 1.86 1.71 1.86 1.96 2.21 2.31 2.31 2.46
X 2.01 2.12 2.23 2.38 2.41 2.41 2.43 2.40
V a c c in a t io n *log,QSNcQ (mean of  3 t e s t s )
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Table 7.15: Neutra l iz ing  antibody t i t r e s  of p ig le ts  vaccinated at 1 week old (born to vaccinated sows)
P i g l e t  
no.
Age of  p i g l e t s (Days)
3 ► 7 10 14 2 1 28 35 42 49 56 63
92/01 2. 68* 2 .18 2 .28 2 .28 2.07 1.88 1.88 1.93 1.73 1.62 1.83
92 /09 2.58 2.38 2.48 2.43 2.23 2.28 2.07 1.93 2.03 1.78 1.72
93/01 2.65 2.45 2.35 2.40 2.10 2.05 2.00 2.25 1.85 1.75 1.69
93/02 2.60 2 .60 2.45 2.30 2.45 2.15 2.10 1.95 1.85 1.80 1.85
94/01 2.96 2.66 2.61 2.61 2.46 2.41 2.56 2.16 2.05 1.95 2.16
94 /09 2.66 2.56 2.61 2.61 2.31 2.21 2.21 2.01 1.90 1.90 1.86
X 2.69 2.47 2.46 2.44 2.27 2.16 2.13 2.04 1.90 1.80 1.85
P i g l e t
no.
Age of  p i g l e t s (Days)
69 76 83 90 97 104 111 118 125 139 153
92/01 1.47 1.62 1.83 1.37 1.32 1.52 1.22 1.32 1.27 1.32 1.42
92 /09 1.98 1.83 1.58 1.58 1.47 1.36 1 .47 1.27 1.32 1.32 1.32
93/01 1.80 1.55 1.55 0.99 1.44 1.65 1.40 1.40 1.24 1.14 1.09
93 /02 1 .75 1.60 1.70 1.49 1.45 1.34 1.44 1.34 1.25 1.14 1.24
94/01 1.95 2.01 1.70 1.7S 1.50 1.65 1.70 1.60 1.55 1.45 1.54
94 /09 1.86 1.80 1.76 1.60 1.76 1.65 1.65 1.60 1.55 1.29 1.40
X 1.80 1.74 1.69 1.50 1.51 1.47 1 .48 1.42 1.36 1.28 1.34
P i g l e t
no.
Age o f  p i g l e t s (Days)
167 181 195 206 223 226
92/01 1.32 1.07 1.07 1.02 0.88 0.94
92/09 1.13 1.17 1.07 1.12 1.13 1.02
93/01 0 .89 1.30 1.24 1.08 1.19 1.19
93 /02 1.18 1 .04 0 . 80 1.04 0 .84 0.99
94/01 1.35 1.21 1.30 1.35 1.15 1.09
94 /09 1.20 1.19 1.09 1.01 0.97 0.86
X 1.18 1.16 1.10 1.10 1.03 1.02
V acc inat ion rlog,QSN^Q (mean o f  3 t e s t s )
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Table 7.16: N eutra l iz ing  antibody t i t r e s  of p ig le ts  vaccinated at 2 weeks old (born to vaccinated sows)
P i g l e t Age of  p i g l e t s (Days)
no. 3 ► 14 17 21 28 35 42 49 56 63 69
91/03 2 . 9 5 * 2.64 2.35 2.19 2.14 2 .24 2.04 1.84 1.95 1.65 1.65
91/04 2 .40 2.25 2.20 2.19 1.94 1.69 1.78 1.59 1.39 1.59 1.34
92/03 2 . 7 8 2 .38 2.38 2.28 2.23 2.13 1.88 1.83 1.78 1.57 1.83
92/04 2 .78 2 .38 2.43 2.33 2.28 1.98 2.03 1.83 1.88 1.88 1.83
93/03 2 .60 2.45 2.40 2.35 2.20 2.05 1.80 2.00 1.90 1.75 1.85
93 /04 2 .60 2 .30 2.05 2.25 2.00 2.10 1.80 1.90 1.75 1.69 1.65
94/03 2.71 2.56 2.61 2.46 2.21 2.20 2.26 2.00 1.90 1.81 1.70
94/04 3 .00 2.56 2.76 2.66 2.56 2.31 2.16 1.96 1.90 1.75 1.80
X 2 .73 2.44 2.40 2.34 2.20 2.09 1.97 1.87 1.81 1.72 1 .71
P i g l e t
no.
Age of  p i g l e t s (Days)
76 83 90 97 104 111 118 125 139 153 167
91 /03 1.54 1.74 1.59 1.49 1.39 1.28 1.18 1.18 1.23 1.03 1.01
91 /04 1 .33 1.23 1.04 0 .9 8 1.03 0.94 1.04 1.18 1.25 1.33 1.18
92/03 1.83 1.68 1.52 1.47 1.52 1.46 1.53 1.32 1.42 1.47 1.13
92 /04 1 .72 1.63 1.42 1.47 1.37 1.36 1.53 1.52 1.32 1.47 1.37
93 /03 1.50 1.65 1.55 1.30 1.47 1.34 1.29 1.30 1.20 1.19 1.09
93 /04 1.44 1.44 1.50 1.40 1.34 1.29 1.25 1.30 1.14 1.08 0 .98
94 /03 1.80 1.55 1.70 1.50 1.50 1.35 1.40 1.44 1.35 1.20 1.09
94 /04 1.80 1.86 1.55 1.60 1.55 1.45 1.61 1.40 1.40 1.39 1.25
X 1.62 1.60 1.48 1.40 1.39 1.31 1.35 1.30 1.29 1.27 1.14
P i g l e t
no.
Age o f  p i g l e t s (Days)
181 195 206 223 226
91 /03 0 . 9 9 0 .90 0 . 7 8 0 .94 1.03
91 / 04 1 .18 1.29 1.04 0 .94 0 .98
92 /03 1.08 1.02 1.07 0 .90 0 .94
92 / 04 1.32 1.07 1.22 1.32 1.16
93 /03 0 .75 0 .94 0 .99 0 .74 0.75
93 /04 0 . 9 4 0 .79 0.89 0 .80 0 .79
94 /03 1.15 1.10 1.05 0 .82 <0.82
94 /04 1.25 1.25 1.16 1.01 0.96
X 1.08 1.04 1.03 0 .93 0 .93
Vacc inat ion "log^.SN^Q (mean of  3 t e s t s )
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Table 7.17: N eutra l iz ing  antibody t i t r e s  of p ig le ts  vaccinated at 4 weeks old (born to vaccinated sows)
P i g l e t
no.
Age of  p i g l e t s (Days)
3 28 31 35 42 49 56 63 69 76 83 90 97
91/05 2 . 29* 1.94 1.79 1.75 1.64 1.43 1.33 1.59 1.33 1.39 1.54 1.34 1.2
91/06 2.69 2 .30 2.29 2.24 1.99 2.09 1.85 1.84 1.84 1 .74 1 .64 1.43 1.3
92 /05 2.68 1.83 2.08 1.83 1.98 1.75 1.88 1.88 1.77 1.62 1.63 1.58 1.4
92/06 2.63 2.13 2.03 1.97 2.03 1.83 1.88 1.78 1.68 1.68 1.52 1.47 1.6
93 /05 2.70 2.20 2.20 2.15 1.95 1.80 1.75 1.70 1.80 1.75 1.49 1.34 1.5
93 /06 2 .50 2 .30 2.10 2.10 1.75 1.85 1.80 1.90 1.80 1.80 1.65 1.45 1.5
94 /06 2.66 2.36 2.21 2.21 2.00 1.95 1.81 1.85 1.80 1.60 1.70 1.55 1.5
X 2.59 2.15 2.10 2.04 1.91 1.81 1.76 1.79 1.72 1.65 1.60 1.45 1.4:
P i g l e t
no.
Age of  p i g l e t s (Days)
104 111 118 125 139 153 167 181 195 206 223 226
91/05 1.29 1.18 1.28 1.23 1.29 1.13 1.18 1.28 1.18 1.00 1.04 1.14
91/06 1.33 1.24 1.13 1.08 0.90 0.30 0.86 0.86 1.04 1.13 0 . 9 4 0 .94
92/05 1.27 1.27 1.37 1.37 1.27 1.47 1.32 1.26 1.18 1.27 1.12 1.03
92 /06 1.37 1.32 1.53 1.32 1.37 1.36 1.26 1.22 1.12 1.07 0 . 98 0 .99
93/05 1.55 1.40 1.34 1.24 1.24 1.14 1.20 1.09 1.08 1.19 0.85 0 . 8 4
93 /06 1.50 1 .40 1.24 1.34 1.25 1.14 1.09 0 .94 0.79 0 .94 0 . 8 9 0 .84
94/06 1.50 1.54 1.14 1.25 1.44 1.20 1.05 1.02 0.97 0.88 <0.82 0.88
X 1.40 1.34 1.29 1.26 1.25 1.18 1.14 1.10 1.05 1.07 0 .95 0 .95
V a c c in a t io n
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Table 7.18: N eutra l iz ing  antibody t i t r e s  of p ig le ts  vaccinated at 8 weeks old (born to vaccinated sows)
P i g l e t
no.
Age of  p i g l e t s (Days)
3 56 59 63 69 76 83 90 97 104 111
91/07 2 . 7 9 * 1.79 1.84 1.40 1.69 1.68 1.33 1.49 1.39 1.38 1.18
91/08 1.84 1.00 1.03 1.13 1.69 2.40 2.14 2.25 2.15 2.25 1.95
92/07 2.48 1.88 1.83 1.72 2.13 2.33 2.23 1.83 1.78 1.62 1.43
92/08 2.53 1.83 1.98 1.88 1.97 2.03 1.98 1.98 1.87 1.46 1.47
93/07 2.55 1.65 1.95 1.85 1.65 1.75 1.59 1.50 1.60 1.50 1.50
94/07 2.61 2.11 2.01 2.11 1.76 1.65 1.65 1.76 1.61 1.61 1.61
X 2.47 1.71 1.77 1.68 1.82 1.97 1.82 1.80 1.73 1.64 1.52
P i g l e t
no.
Age of  p i g l e t s  (Days)
118 125 139 153 167 181 195 206 223 226
91/07 1.04 1.18 1.08 0 . 9 8 0 .90 0 .98 1.49 1.18 1.00 0 .90
91 /08 1.84 1.75 1.95 1.79 1.79 1.79 1.84 1.79 1.79 1.74
92 /07 1.57 1.52 1.58 1.78 1.73 1.62 1.73 1.62 1.78 1.77
92 /08 1.47 1.62 1.73 1.72 1.47 1.37 1.37 1.35 1.47 1.42
93/07 1.40 1.30 1.30 1.25 1.24 1.25 0 .79 1.34 1.30 1.30
94/07 1.40 1 .70 1.61 1.29 1.15 1.24 1.05 1.00 0.82 0 .82
X 1.45 1.51 1.54 1.47 1.38 1.38 1.38 1.38 1.36 1.33
► = Vaccinat ion * log 10^^50 (mean o f  3 t e s t s )
165
5
8I
CO
.E
Ü
u
CO
>
I
CD
a
Sco
Q.
mi -
c
o
CO
.E■q
U
CO
>
2
3
0»
H
z  CO CO CO
LU o  ^  ^  ^
O  ^  LU H i UJ H I
<  t— W  LU UJ UJ
c o <
LU 5  
CL >
CM r — r -
(0S|\|S 01bo|)
a y i i i  A o o a i i N v  O N i z n v y i n a w
166
oSI
Oî
'El
%
C
oo.
m
c
g
wea
C
y
CD>
(ü
CI
II
l
Ou
iq
2
&
ü_
8
Ic
I>c3
T3
C
(D
I
CD
C
I>
2
O
</>
g
$
CN
4_»
CD
I
CD
C
Ô
U
CD
>
jD
0
m
1
+-•
CD
T3
B
CD
Ooo o
o
R
T3
OIDt /3
00
§
-D
T3
O  C/3
h-
S
2
0 
(/) jd
1
8
§
CD
CD
C
■ |
>
g
U
o
O Oo o
LU
O
LL
O
LU
0
<
00 CM 00 CM
(03 ,^5  o l b o i) g a i n  A O o a i i N V  0 N i z n v a i n 3 N
167
Vaccination o f p ig le ts  at 8 weeks old (by which time the passive 
antibodies had declined to a imean t i t r e  of 1 wH TogimSNcg) appeared to 
evoke some active  immunity. However, th is  re s u l t  was dependent on the 
level of passive antibody present in the individual p ig let at the time 
o f vacc ina tion . For instance, p ig le t  91/08 which had the lowest t i t r e  
(1.00 log^gSNgg) at vaccination produced the best vaccination response 
with a t i t r e  of 2.40 log^nSNcQ at 21dpv while p ig let 94/07 which had the 
highest t i t r e  (2.11 vaccination produced the worst
vaccination response w ith  a t i t r e  of 1.65 log^gSNgg at 21dpv. The 
h a l f - l i f e  o f neutralizing antibodies in  these p ig le ts  was 25.7 days from 
3 to  69 days old and 78.3 days from 3 to  226 days old.
The e f fe c t  o f passive antibody level at the time o f vaccination on 
the p ig le ts  responses at 21dpv (increase or decrease in  the serum 
antibody t i t r e )  has been p lo t te d  in  Figure 7.6. A regression l in e  drawn 
through the po in ts  has a slope o f -0.82 and a c o r re la t io n  c o e f f ic ie n t  of 
-0.78 (which is  significant at a 1% le ve l)  confirming th a t the 
inhibiting a c t iv ity  o f materna lly  derived antibodies was d i r e c t ly  
p roportional to  the t i t r e s  in  the p ig le ts  at time o f vacc ina tion .
c) Immunoglobulin class a c tiv ity
( i )  P ig le ts  from unvaccinated sows - The mean 00 values from repeat 
ELISA te s ts  employing c la s s -s p e c i f ic  an ti- IgG , anti-IgM  and a n t i- IgA  
conjugates were estab lished fo r  the p ig le ts  vaccinated between 1 and 8 
weeks o ld . These are presented as immunoglobulin response curves in 
Figure 7.7, the data fo r  which is  given in  appendix 3 (Table A3.4). By 
comparing the response profiles of each immunoglobulin class i t  appears 
th a t while  IgG a c t i v i t y  was similar between a l l  groups (peak 00 1.2 to  
1.4) the IgM and IgA a c t i v i t y  was lower in  p ig le ts  vaccinated at 1 or 2 
weeks old than in  those vaccinated when 4 or 8 weeks o ld .
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Figure 7.6: The effect of maternally derived antibodies on piglets 
21 day post vaccinal titres
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( i i )  P ig le ts  from vaccinated sows - The mean OD values from repeat 
immunoglobulin class specific ELISA tests, on piglets vaccinated ^  
between 1 and 8 weeks old, are presented as immunoglobulin response 
curves in Figure 7.8, the data fo r  which is  given in  appendix 3 (Table 
A3.5). All the a c tiv ity  present at the time of vaccination in the 1 to 
8 week old piglets, that is as a result of maternally derived antibody, 
was due to IgG antibodies. This was expected as the sows had been 
vaccinated twice with the la s t  vaccination being given more than a month 
before fa rrow ing.
In the p ig le ts  vaccinated when 1 and 2 weeks old there was a s l ig h t  
IgM response, no IgG or IgA response and the leve ls  o f m aternally  
derived IgG continued to  steadily subside. Vaccination at 4 weeks old 
produced a more clearcut IgM response. However, the IgA and IgG 
responses were s t i l l  poor. Vaccination o f the 8-week- old p ig le ts  did 
provoke IgG, IgM and IgA responses, although the leve ls  were in v a r ia b ly  
lower than those observed in p ig le ts  born to  unvaccinated sows.
d) Protection from FMD in fe c t io n
The results of te s ts  ca rr ied  out to  challenge the immunity o f 6-7 
month-old p ig le ts  from unvaccinated and vaccinated sows are given in 
Tables 7.19 and 7.20 re sp ec t ive ly  and are summarised in Table 7.21.
Piglets from unvaccinated sows vaccinated at 1 to  8 weeks o ld were 
between 33.3 and 87.5% protected against FMD virus infection at 6 to  7 
months old while  p ig le ts  from FMD vaccinated sows vaccinated at 1 to  8 
weeks old were a l l  unprotected at 6 to  7 months o ld .
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Table 7.19: Results of challenge tests  on p ig le ts  from unvaccinated sows
P i g l e t s v a c c in a te d  a t  1 week old P i g l e t s  vaccinated a t  2 weeks old
P i g l e t
no.
Foot les ions
Resul t P i g l e tno.
Foot l es ions
R e s u l t
LF RF LH RH LF RF LH RH
96/01 + + + NP 96/03 + + + + NP
96/02 - - + - P 96/04 + - - - P
97/01 + + -t + NP 97/03 - - - - P
97/12 - - - - P 97/04 + + + + NP
98/01 + + + + NP 98/03 + - - - P
98/02 + - + + NP 98/04 + + + + NP
P i g l e t s  v a c c in a te d  a t  4 weeks o ld P i g l e t s  v a c c in a te d  a t  8 weeks o ld
P i g l e t Foot les ions Resul t P i g l e t
Foot l es ions
Resul tno. LF RF LH RH no. LF RF LH RH
95/07 - - - - P 95/09 - - - - P
96/05 - - - - P 96 /08 + + + + NP
96/06 + + - - P 96 /09 - - - - P
96 /07 + - - - P 96/10 - - - - P
97/05 + - - - P 97/07 - - - - P
97/06 - - + - P 97 /08 - - - - P
97/11 + + + + NP 97/10 - - - - P
98 /05 + - - - P
P
NP
Protected  
Not Protec ted  
FMD les ions  
No FMD les ions
N.B. A l l  4 control  p ig s  were +ve, on a l l  4 f e e t ,  and t h e r e f o r e  n o t  prot ect ed .
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Table 7.20: Results of challenge tes ts  on p ig le ts  from FMD vaccinated sows
P i g l e t s  vaccinated at  1 week old
P i g l e t
no.
Foot les ions
Resul t P i g l e tno.
Foot l es ions
Resul t
LF RF LH RH LF RF LH RH
92/01 + + + + NP 91/03 + + + + NP
92/09 + + + + NP 91/04 + + + + NP
93/01 + + + + NP 92/03 + + + + NP
93/02 + + + + NP 92/04 + + + NP
94/01 + + + + NP 93/03 + + + NP
94/09 + + + + NP 93/04 + + + + NP
94/03 + + + + NP
94/04 + + + + NP
P i g l e t s  vaccinated a t  2 weeks old
P i g l e t s  vaccinated at  4 weeks o ld P i g l e t s  vaccinated a t  8 weeks old
P i g l e t
no.
Foo t  l e s io n s
- ......................
Resul t P i g l e tno.
Foo t  l es ions
Resul t
LF RF LH RH LF RF LH RH
91/05 f + + + NP 91/07 + + + + NP
91/06 + + + NP 91/08 + + + + NP ;
92 /05 + + + + NP 92/07 + + + + NP j
92 /06 + f + + NP 92/08 + + + + NP ;
93/05 f + + + NP 93/07 + + + + NP
93/06 + + + + NP 93 /08 + + + + NP
94/06 f f + + NP
P = Protec ted
NP = Not Protected
+ = FMD l es ions
- = No FMD le s io n s
N.B. A l l  4 cont ro l  pigs were +ve,  on a l l  4 f e e t ,  and t h e r e f o r e  not pr ot ec t ed .
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Table 7.21: Summary o f challenge te s t  re su lts  on 6-7 month old pigs
P ig le ts '  age Source o f p ig le ts
at vaccination Unvaccinated
Sows
Vacci nated 
Sows
1 week old 2 /6 *(33.3%)**
0/6
(0%)
2 weeks old 3/6(50%)
0/8
(0%)
4 weeks old 7/8(87.5%)
0/7
(0%)
8 weeks old 7/8(87.5%)
0/6
(0%)
* No. o f p ig le ts  protected out o f the to ta l  no. challenged.
* *  Percentage o f p ig le ts  protected.
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DISCUSSION
Before considering the prophy lac tic  po ten t ia l o f FMD o i l-e m u ls io n  
vaccine in young pigs i t  was important to establish whether the 
vaccination ha  ^ arr/ harmful effect on the animals. From a practical 
point of vi(^v the most important aspect vwas thought to be the growth 
rate as this is of greatest economic importance to the farmer and also 
generally reflects  the health of the animals. One group of workers 
(Chappuis et a l , 1976) has reported th a t FMD o i l  vaccination at 14 days 
old retarded the growth ra te  of p ig le ts  while another group from the 
same in s t i t u te  la te r  showed (Mougeot e t a l , 1980) th a t vaccination o f 28 
day o ld p ig le ts  d id  not retard growth or reduce the market value o f the 
carcasses, since the o i l  vaccine was assim ilated within 3 weeks. The 
present study however showed th a t p ig le ts  could be vaccinated as early  
as 7 days old with no harmful e f fe c ts  and no s ig n i f ic a n t  reduction in 
growth ra te . Chappuis et al (1976) did not perform s t a t i s t i c a l  analyses 
on th e i r  re s u lts ,  but i f  the d if fe rences demonstrated were significant 
then th is  could have been due to  the fa c t  th a t a d i f fe re n t  o i l  
fo rm u la tion  was used to  th a t described in th is  study.
The re su lts  o f n e u tra l iz in g  antibody assays showed tha t p ig le ts ,  
born to  unvaccinated sows, were capable o f responding to  FMD vaccination 
when only 1 week o ld . Although studies with FMD o i l  vaccines have not 
prev ious ly  been ca rr ied  out in p ig le ts ,  born to  unvaccinated sows, 
younger than 1 month old (Giraud et a l , 1969; Morgan and McKercher, 
1978), such an early a b i l i ty  to respond to an tigen ic  s t im u la t ion  has 
been observed previously in  pigs injected with  other v i r a l  (Niles and 
R e itz , 1920; Precausta, Kato and Brun, 1983) and non-v ira l antigens 
(Young, Hinz and Underdahl, 1955; Murdoch and Jungk, 1957).
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However, examination o f the nature and development o f the anti-FMD 
ac tiv ity  in piglets from unvaccinated sows indicates that there are 
differences between the responses (yF piglets vaccinated when 1 or 2 
weeks old and those vaccinated at 4 or 8 weeks old.
The response o f the 4 or 8-week-old p ig le ts  was s im ila r  to  th a t  of 
adult sows (see Chapter 4 ). The neutralizing antibodies reached in i t ia l  
peak t i t re s  2 to  4 weeks a f te r  vacc ina tion , subsided sligh tly  and then 
recovered and persisted u n t i l  the p ig le ts  were challenged at 6 to 7 
months o ld , at which time they were 87.5% protected. Furthermore, the 
antibody class response in both groups was s im i la r ,  with IgM and IgA 
antibodies reaching peak a c tiv ity  at 7 to  14dpv and p e rs is t in g  fo r  
approximately 28 days while the IgG antibody a c t i v i t y  did not reach a 
peak u n t i l  21 to  28dpv and then pers is ted at similar or increasing 
levels.
The i n i t i a l  peak t i t r e s  observed in  p ig le ts  vaccinated at 1 or 2 
weeks old were higher than those observed in the p ig le ts  vaccinated at 
an o lder age (4 and 8 weeks o ld ) .  These t i t re s  however declined 
s te a d i ly  over the course o f the experiment so th a t animals were only 
33.3 to  50% protected from challenge at 6 to  7 months o ld . This re s u lt  
may simply have been due to  the fa c t  th a t in  these animals there was a 
greater time in te rva l  (2 to  3 weeks extra ) between vaccination and 
challenge; however the antibody class analysis did ind ica te  ce r ta in  
d e f ic ie n c ie s  in  th e ir  immune response. For instance, the IgM response 
of 1-week-old p ig le ts  was reduced and pers is ted fo r  less than 21dpv in 
the 2-week-old group. Furthermore, the IgA response was poor in  both 1 
and 2-week-old p ig le ts .  I t  is  unlikely th a t  these re su lts  were due to  
normal variation between the groups since the p ig le ts  w ith in  each group
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were l i t te rm a te s .  These re su lts  suggest, therefore, th a t although the 1 
and 2-week-o ld  p ig le ts  were capable o f mounting a s ig n i f ic a n t  immune 
response against FMD, following o i l  emulsion vacc ination, th e i r  
responses were not fu l ly  mature.
The results obtained in the p ig le ts  from FMD vaccinated sows were 
markedly d iffe rent to those frcm unvaccinated stMvs in that the vac-
c ina t ions  ca rr ied  out at 1, 2 and 4 weeks old appeared to  have l i t t l e  or 
no e f fe c t  on the leve ls  o f neutralizing antibody and the decay rates of 
the f i r s t  69 days (t |=19 .7  to  23.4 days) were s im i la r  to  those of 
maternally derived antibodies in unvaccinated pigs {t|=21 days; see 
chapter 6). I t  is  also interesting to note th a t  the antibody h a l f - l i f e  
from 3 to  226 days, in  these animals, was between 44.3 and 48.7 days, 
which confirms the observation in Chapter 6 th a t the decay ra te  is  
re la ted  to  the time over which measurements are taken. Furthermore 
vaccination at 8 weeks old o f p ig le ts  from vaccinated mothers produced 
only a small increase in the n e u tra l iz in g  a c t i v i t y .  From these results  
i t  is c lea r  th a t the passive anti-FMD antibodies in the p ig le ts ,  
obtained by suckling from the ir  immunized mothers, suppressed the
I
p ig le ts  ac tive  response to  the o i l  vacc ina tion , a po in t th a t is  well 
i l l u s t r a te d  in Figures 7.5a to  7.5d. This suppressive e f fe c t  was 
confirmed by the re s u lts  o f challenge te s ts  ca rr ied  out when the p ig le ts  
were 6 to  7 months old . In contrast to  the re su lts  obtained w ith  
p ig le ts  from unvaccinated sows (33.3 to  87.5% p ro te c t io n ) ,  none o f the 
p ig le ts  from vaccinated sows were immune to  experimental in fe c t io n  with 
FMD v irus  in  sp ite  o f the fa c t  tha t they themselves had been vaccinated.
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Although a s im ila r  suppressive e f fe c t  has also been observed in 
young pigs w ith  many other antigens, inc lud ing  an oil -formulated  
Aujeskys disease vaccine (Wittmann, 1981), i t  is interesting to note 
th a t previous work on the use o f FMD o i l  emulsion vaccines in young pigs 
has fa i le d  to  detect any suppression by maternally derived antibodies 
(Giraud et a l , 1969; Morgan and McKercher, 1978). These re su lts  have 
even led one group of workers to conclude that colostra lly  acquired 
antibodies are not involved in suppression or in h ib i t io n  o f the young 
pigs response to FMD o i l  emulsion vaccines (Morgan and McKercher, 1980). 
However, in  th e i r  studies no comparisons were made w ith  matched groups 
o f p ig le ts  from unvaccinated sows. Furthermore, the in h ib i to r y  a c tiv ity  
observed is  dependent on the concentration o f passive antibody present 
at the time of vaccination (see Figure 7.6) and also on the potency of 
the vaccine employed. The use o f a highly potent vaccine and/or waning 
maternally derived antibody t i t r e s  may produce a s i tu a t io n  where 
inhib ition is  not e a s i ly  demonstrable. Indeed from th is  study i t  would 
appear th a t  some increase in antibody t i t r e s  21 days after vaccination 
should be expected when passive antibody leve ls  f a l l  below 1.9
l o g ^ Q S N g Q .
The antibody class analysis provides some in s ig h t  in to  the 
mechanisms involved in  maternal antibody suppression. In p ig le ts  w ith  
r e la t iv e ly  high leve ls  o f maternally derived IgG at the time of 
vaccination (1 and 2 weeks o ld) suppression occurred in a l l  the antibody 
classes studied while  in  the p ig le ts  th a t possessed lower leve ls  of 
passive IgG at time o f vaccination (4 and 8 weeks old at vacc ination) 
the ac tive  IgM response appears to  have escaped from the suppressive 
e f f e c t .
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Two possib le mechanisms o f passive antibody suppression have been 
proposed (Uhr and Mol 1er, 1968; Solomon, 1971). F irs t ly ,  the active
production antibody be suppressed a rapid elimination
antigen frcmi the c irculation, due to the presence of high levels of 
maternally derived antibodies, which would reduce the chances of 
immunocompetent c e l ls  coming in to  contact w ith  antigen. This would 
re s u lt  in  the type of to ta l  suppression observed in  the p ig le ts
vaccinated at 1 or 2 weeks old. Secondly, the passive antibody nmy be
suppressing antibody formation a feedback action on those cells  
responsible fo r  producing s p e c if ic  immunoglobulins. This feedback may 
act e i th e r  by preventing secretion o f antibody or by in h ib i t in g  further  
p ro l i fe ra t io n  o f stimulated c e l ls .  Such a mechanism may account fo r  the 
observation th a t IgM a c t iv ity  appeared to  escape from suppression by the 
lower leve ls  o f m aternally  derived IgG present in  p ig le ts  vaccinated at 
4 or 8 weeks o ld . I t  seems possib le th a t both mechanisms are acting to  
a greater or lesser extent in  the p ig le ts  and th a t th is  is  dependent on 
the t i t r e  o f passive antibody present in the p ig le ts  at the time of 
vaccination.
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CHAPTER 8
THE EFFECT OF INJECTED NEUTRALIZING ANTIBODIES ON THE 
RESPONSE OF YOUNG PIGS TO VACCINATION
INTRODUCTION
Chapter 7 has shown that maternally derived antibodies can have a 
suppressive effect on the response young pigs to o il-em ulsion
vaccination and tha t the degree of suppression is  dependent on the 
n e u tra l iz in g  antibody t i t r e  present at the time o f vacc ination.
The purpose of the work described in  th is  chapter was to  es tab lish  
whether suppression is  a property of co lo s t ra l  antibody only or i f  
injected anti-FMD IgG is  also capable o f inh ib iting  the response o f pigs 
to  vacc ina tion . The importance o f the time of administration was also 
studied since some authors recommend vacc ination immediately p r io r  to 
colostrum in take (Lee et a l , 1980).
EXPERIMENTAL DESIGN
Twelvej fo u r -m o n th -o ld  Large White pigs weighing 82.89±7.84Kgs, 
equiva lent to  a blood volume o f approximately 4501ml, were d iv ided in to  
four groups o f three and each group was vaccinated w ith  o i l  emulsion 
batch 0-115 and/or in je c ted  in t ra p e r i to n e a l ly  w ith  anti-FMD IgG antibody 
(250ml o f 3.26 log^gSN^g per p ig le t  prepared as described in Chapter 2) 
in the fo l lo w in g  manner:
Group 1: Vaccinated only.
Group 2: In jec ted  w ith  anti serum only.
Group 3: In jec ted  w ith  an ti serum two days before vacc ina tion .
Group 4: Injected w ith  anti serum two days after  vacc ina tion .
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The volume of passive antibody injected was calculated to give the 
piglets neutralizing antibody t i t re s  of approximately 2 log^g^Mn the ir  
serum.
Blood samples were collected at the time of vaccination or passive 
antibody in jection, one and/or di f^s la te r  and then weekly ixir the 
next four months.
RESULTS
The re su lts  o f neutralization te s ts  on in d iv id u a l pigs in  each group 
are shown in  Table 8.1. In groups 3 and 4, which received passive 
antibody either 2 days before or 2 days after vacc ina tion , certain  
animals th a t did not show a s ig n i f ic a n t  increase in  n e u tra l iz in g
a c t i v i t y  in  t h e i r  sera within 24-48 hours o f the passive t ra n s fe r ,  (NW55 
in  group 3, and NW57 and 59 in group 4 ), were excluded before
c a lcu la t in g  the group mean t i t r e s ,  shown in Table 8.1 and Figure 8.1. 
This Figure shows th a t  the n e u tra l iz in g  antibody t i t r e s  o f groups 3 and 
4 are similar to  those o f group 2, the passive antibody control group, 
throughout the experiment. This is  supported by the ca lcu la ted 
h a l f - l i v e s  of the n e u tra l iz in g  antibodies in groups 2, 3 and 4 o f 35.6, 
39.6 and 34.3 days re sp e c t ive ly .  I t  is  possib le th a t the t i t r e  in  group 
4 may have increased during the f i r s t  20 to  30 days post vaccination 
before d ec lin in g  to  the leve ls  observed in groups 2 and 3. However,
th is  re s u l t  remains inconclus ive  as the observation is  based on only a 
s ing le  animal's response. In group 1, the vaccination contro l group, 
the n e u tra l iz in g  a c t iv ity  gradually increased fo r  the f i r s t  30 to  40dpv 
and then remained f a i r l y  s tab le  at 1.7 to  1.8 log^gSNgg fo r  the duration 
o f the experiment (up to  120dpv). A l l  fou r groups had s im ila r  mean
t i t r e s  at 30 to  35 days; however at no po in t after th is  d id the t i t r e s  
o f groups 2, 3 or 4 reach the leve ls  observed in  group 1.
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Table 8.1: The e f fe c t  of anti-FMD IgG In jected intraperitoneally on the ne u tra l iz in g  antibody
response of 4 month old p ig le ts  to vaccination
Group T rea tm en t
Group 1 Group 2
DPV Vaccinat ion o n ly Passive a n t ib o d y  o n ly
NW* NW* NW* Mean NW* NW* NW* Mean
48 49 50 (n=3) 51 52 53 (n=3)
-2
0 < 0 . 5 2 * * <0.52 <0.52 <0.52 <0.52 <0.52 <0.52 <0.52
1 <0.56 0.52 <0.46 <0.51 1.95 1.91 1.65 1.84
2
3
<0.52 0 .5 8 <0.52 <0.54 2.01 1.85 1.65 1.84
4
8 1.09 1.15 1.40 1.21 1.81 1.86 1.66 1.77
14 0 .89 1.45 1.70 1.35 1.85 1.75 1.44 1.68
23 1.24 1 .71 1 .80 1.58 1.90 1.65 1.50 1.68
30 1.30 1.45 1.96 1.57 1.80 1.50 1.44 1 .58
36 1.35 1.40 1.91 1.55 1.55 1.41 1.25 1.40
44 1.50 1.50 2.01 1.67 1.55 1.40 1.30 1.41
51 1.60 1.75 1.95 1.77 1.55 1.34 1.10 1.33
58 1.80 1.75 1.81 1.79 1.55 1.19 0 .89 1.21
65 1.96 1.61 1.80 1.79 1.34 1.15 1.05 1.18
72 1.85 1.60 1.80 1.75 1.24 1.19 1.04 1.16
79 1.85 1.75 1.30 1.80 1.65 1.05 0 .84 1.18
86 2.06 1.55 1 .55 1.75 1.45 0 .99 0 .90 1.11
TOO 2.01 1.55 1.70 1.75 1.25 0 .9 4 0.86 1.01
107 2.00 1.61 1.85 1.82 1.09 0.86 0 .74 0 . 9 0
114 2.16 1.61 1.90 1.89 0 .99 0 .80 0.66 0 . 82
120 2.01 1.65 1.85 1.84 1.25 0 .70 0.66 0.87
*  P igs  i n c lu d e d  i n  c a l c u l a t i o n  o f  g roup mean
* *  log^gSNgg mean r e s u l t  o f  3 t e s t s  
-  No sample 
DRV Days po s t  v a c c i n a t i o n
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Tab le  8.1 C o n td . :  The e f f e c t  o f  an t i-FMD IgG i n j e c t e d  1n t r a p e r i t o n e a l l y  on th e  n e u t r a l i z i n g  a n t ib o d y
response o f  4 month o ld  p i g l e t s  t o  v a c c in a t i o n
Group Treatment
DPV
Group 3
A n t ib o d y  i n j e c t e d  2 days b e fo re  
va cc i na t i on
Group 4
A n t ib o d y  i n j e c t e d  2 days a f t e r  
va cc inat ion
NW*
54
NW
55
NW*
56
Mean
(n=2)
NW
57
NW*
58
NW
59
Mean
(n = l )
-2 < 0 . 5 2 * * <0.46 <0.52 <0.50 - - - -
0 1.86 <0.46 1.65 1.76 <0.52 <0.40 <0.52 <0.40
1 2.06 <0.52 1.55 1.81 - - - -
2 2.05 <0.56 1.65 1.85 <0.56 <0.52 <0.52 <0.52
3 - - - - 0 .79 2.06 <0.55 2 .06
4 - - - - 0 .90 2.11 0.66 2.11
8 1.90 1.54 1.50 1.70 1.65 2.00 1.60 2.00
14 1.86 1.76 1.80 1.83 1.39 2.11 1.09 2.11
23 1.81 2.06 1.90 1.86 1.40 2.30 1.14 2 .30
30 1.65 1.91 1.61 1.63 1 .45 1.76 1.19 1.76
36 1.50 1.81 1.45 1.48 1.25 1.61 1.20 1.61
44 1.35 1.71 1.35 1.35 1.45 1.50 1.20 1.50
51 1.35 1.96 1.30 1.33 1.35 1.45 1.40 1.45
58 1.15 1.81 1.30 1.22 1.45 1.25 1.73 1.25
65 1.09 1.90 1.09 1.09 1.40 1.24 2.01 1.24
72 1.09 2.26 1.05 1.07 1.45 1.20 2.01 1.20
79 1.04 1.95 0 .99 1.01 1.40 1.19 2.16 1.19
86 1.00 1.85 1.09 1.05 1.25 1.15 2.26 1.15
100 0 .99 2.15 0.94 0.97 1.61 1.05 2.26 1.05
107 0 .94 - 1.50 1.22 1.61 1.25 2.35 1.25
114 0 .99 2.21 1.35 1.17 1.95 1.30 2.31 1.30
120 0 .84 2.16 1.03 0 . 9 4 1.81 1.30 2 .40 1.30
*  P igs  in c lu d e d  i n  c a l c u l a t i o n  o f  g roup mean
* *  log.gSNcQ mean r e s u l t  o f  3 t e s t s  
- No sample 
DPV Days p o s t  v a c c i n a t i o n
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DISCUSSION
The results have confirmed and extended the conclusions reached in 
Chapter 7 by showing that antibodies injected 2 days before vaccination
have a suppressive effect which is  s im i la r  to  th a t obtained with natural 
maternally derived antibodies. Thus passive antibodies, whether derived 
from the colostrum or injected intraperitoneally , can suppress the pigs 
response to FMD oil-emulsion vacc ina tion . Furthermore a re s u lt  was 
obtained suggesting tha t antibody may also suppress the vaccination 
response o f p ig le ts  when administered 2 days a f te r  vacc ina tion . In th is  
case the small increase in  the n e u tra l iz in g  a c tiv ity  over the f i r s t  
30dpv may have been due to  an IgM response while the response >30 days 
a f te r  vacc ina tion , which is  known to  be mainly due to IgG (Ouldridge, 
Francis and Black, 1981) was suppressed. I f  t h is  were true  then passive 
antibody administered at different times a f te r  vaccination could be used 
to  study the IgM to  IgG switching mechanism in  th is  species. However, 
since th is  observation was based on a s ing le  animal only, fu r th e r  data 
would be required before any firm conclusion could be drawn. The poor 
uptake by some o f the animals o f passive antibody may have been due to  
aggregation o f the antibody molecules as a re s u l t  o f polyethylene g lyco l 
precipitation. Ammonium sulphate p re c ip i ta t io n  may be a pre ferab le  
method fo r  fu tu re  studies although extensive d ia ly s is  would be required 
before animal inocu la t ion  in order to  e lim ina te  to x ic ity .  Once again 
the in jec te d  antibody h a l f - l i f e  in  the pigs sera (T#=34.3 to  39.6 days 
measured over 120 days) confirms the observations made in  Chapter 6 
re la t in g  the serum antibody decay ra te  to  the time over which 
measurements are taken.
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CHAPTER 9
GENERAL DISCUSSION
In conclusion, the results have shown th a t pregnant sows respond 
well to FMD vaccination and th a t i n i t i a l  double vacc ina tion , with the 
doses given one month apart, w ill  provide adequate immunity fo r  at leas t 
a year. Subsequent annual revaccination should then be s u f f ic ie n t  to 
maintain neutralizing antibodies above the protective le v e l .  In high 
risk areas a s ix  month interval or revaccination at time o f service 
would be advisable. Such a regimen would ensure th a t sows pass high 
t i t r e s  o f passive antibody to  t h e i r  l i t t e r s .
The passage o f antibodies from the sow to  her p ig le ts  is  a rap id  and 
e ff ic ie n t  process. The sow's colostral n e u tra l iz in g  antibody t i t r e  at 
the time o f farrowing may be taken as a good indicator of the mean serum 
antibody t i t r e  tha t would be present in  her three - day- old l i t t e r ,  
regardless o f antibody class invo lved. However, the interval between
vaccination and farrowing can a f fe c t  the concentration o f neutralizing  
antibodies in  the colostrum since an in te rv a l  o f 12-13 days resu lted  in  
co lo s t ra l  t i t r e s  tha t were lower than the sow's serum t i t r e s  at
farrowing while an interval of 30-32 days genera lly  resu lted  in
c o lo s t ra l  t i t r e s  tha t were higher than serum t i t r e s .  Therefore,
s u f f ic ie n t  time should be allowed fo r  the tra n s fe r /con cen tra t ion  of 
antibodies from serum, in to  the colostrum, to  take place and sows should 
not be vaccinated, or revaccinated, w ith in  30 days o f fa rrow ing.
From the time p ig le ts  are three days old the class o f antibody which 
they derive  from the sow has a considerable in f luence on the persistence
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of the antibodies in the ir  sera because each antibody class has a 
different decay rate. The results obtained here demonstrated th&t 
neutralizing IgM antibodies have a more rapid decay rate than IgG 
antibodies, and i t  appears that during the f i r s t  70 dc^ rs of a piglets  
l i f e  the decay of n e u tra l iz in g  IgG antibody is  mainly the re s u lt  of 
dilution due to  the expanding blood volume. Since the class of 
maternally  derived antibodies passed onto p ig le ts  depends on tha t 
present in  the sow at farrowing, i t  is  des irab le  to  vaccinate sows in 
such a way tha t IgG predominates in the ir  sera at tha t time. This 
provides further support fo r  the recommendation th a t sows should not be 
vaccinated or revaccinated within 30 days o f farrowing. Regular 
revacc ination o f sows at time o f service would be id e a l.
In breeding stock which have been previously vaccinated on one or 
several occasions revacc ina tion  produces a r is e  in  both IgG and IgM in 
the immediate post vaccination period. However, in  primovaccinates IgM 
is  primarily responsible fo r  n e u tra l iz in g  a c t i v i t y  in  the ea r ly  post 
vaccination period and i t  is  often only in the th i r d  or fourth week 
after vacc ination th a t IgG class antibodies co n tr ibu te  s ig n i f i c a n t ly  to 
the neutralization t i t r e s .  Hence, the design o f the vaccination regimen 
is  esp ec ia l ly  important when susceptib le  sows are being vaccinated fo r  
the f i r s t  time, fo r  example in a country th a t is  in troduc ing  a pig 
vacc ination campaign. A su ita b le  regimen would be a double vaccination 
w ith  the f i r s t  dose being given at time o f service and the second dose 
at leas t one month before fa rrow ing . Furthermore while  no adverse 
e f fe c t  o f FMD vacc ination on pregnant sows has ever been demonstrated i t  
seems wise to  avoid vacc ination during the f i r s t  month o f pregnancy when 
the foetus is  most prone to  damage.
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Young pigs devoid o f maternally derived antibodies are capable of 
responding to FMD vaccination at one week o ld , w ith no de le te r ious 
effects on the ir  growth rate. In these circumstances, however, the ir  
immunity to experimental infection at six months old is not complete. 
Consequently, i t  would be preferable to delay vaccination of susceptible 
piglets until they are at least one month old or a lternative ly , in high 
risk areas, animals vaccinated at one vwsek old should receive a booster 
dose one to two months old to ensure adequate protection.
In p ig le ts  born to  immunized sows the maternally derived antibodies 
have a suppressive e f fe c t  on the early vaccination responses. In th is  
study the suppression was complete in  one, two and four-week-old p ig le ts  
and partia l in  8 week old p ig le ts .  However, i t  was c lear th a t such 
suppression was a ffected  by the t i t re s  of maternally derived antibody 
present in  the p ig le ts  at time o f vacc ination and also by the potency of 
the vaccine used. The vaccine in  th is  study fo r  example, which
contained 13.4pg of 146S v i r a l  antigen per dose, did not induce a 
p o s it iv e  n e u tra l iz in g  antibody response in p ig le ts  when the maternal 
antibody t i t r e  was greater than 1.9 log^gSNgg at time o f vacc ina tion . 
Thus, provided the potency of the vaccine is known, i t  should be 
possib le fo r  f i e l d  personnel to  estimate the time at which maternally 
derived antibodies subside to  a level th a t would not in terfere  with 
vacc ination and design a su ita b le  vaccination regimen on th is  basis. 
This could be ca rr ied  out simply by monitoring the antibody leve ls  in
the sow popula tion , since these c o rre la te  well w ith  maternally derived
antibody t i t r e s  in the ir  l i t t e r s ,  and by fo l lo w in g  the growth ra te  of 
the p ig le t  l i t t e r s ,  since th is  can be regarded as an indicator of the
n e u t ra l iz in g  IgG h a l f - l i f e  in the serum u n t i l  the p ig le ts  are at least 
70 days o ld . In the present study, fo r  example vaccination of the
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l i t t e r s  born to vaccinated sows, would have been ineffective  i f  carried 
out before the piglets were two months old. Thus, i t  would be advisable 
to delay vaccination of p iglets, born to sows possessing a high t i t r e  of 
IgG antibodies, until they are two to three months old.
Regarding the possib ility  of future kmrk in this f ie ld ,  i t  may tx! 
possible to overcome the suppressive effect of passive antibody by 
giving piglets repeat vaccinations. Such cm approach has been proposed 
by Nathans (1965) on the basis that a f i r s t  vaccination, with aqueous 
vaccine, primed the animals fo r  an enhanced response to  the second 
vaccination even though the response to  the f i r s t  vaccination was 
undetectable. I t  may also be possib le to  produce an e sp ec ia lly  potent 
vaccine fo r  use in  very young stock which would overcome the suppressive 
e f fe c t  of maternal antibodies. However, both these approaches would 
require fu r th e r  inve s t ig a t io n s  in to  the re la t io n s h ip  between the passive 
antibody t i t r e ,  the vaccine potency and the tim ing  o f the vacc ina tion . 
Results of such a study could produce information th a t would enable 
vaccine manufacturers to  recommend the most su ita b le  vaccination regimen 
fo r  vaccine batches o f known potency.
F ina lly , the results obtained here emphasise the importance of 
designing vaccination programs on a ra t io n a l basis since vaccines 
in c o r re c t ly  administered may re s u lt  in  p ig le ts  w ith  d e f ic ie n t  t i t r e s  of 
maternal antibody, p ig le ts  which suffer a break in  immunity between 
subsidence o f passive p ro tec tion  and ac tive  immunization, or p ig le ts  
which respond poorly to  vaccination as a result of the suppressive 
effects o f maternally derived antibodies. I t  is hoped th a t th is  thes is  
w ill  form the basis o f a b e tte r  understanding o f how and when to  
administer FMD vaccines to  pig stock in  order to  optimise th e ir  e f fe c ts ,
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and o f the immunological mechanisms involved in the humoral response o f 
young pigs. Furthermore, fundamental in formation obtained here should 
be applicab le  not only to  current vaccines but also to the new 
generation of synthetic or expressed peptide vaccines th a t may be 
produced in the fu tu re .
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APPENDIX 1
MEDIA
a) Virus Maintenance Medium (VMM)
Constituent Volume (ml)
Eagles B.S.S. (xlO conc.) 80
Tryptose Phosphate Broth (2% w/v) 100
Sodium Bicarbonate (4.4% w/v) 100
Glucose (20% w/v) 18
A n t ib io t ic s  -
P e n ic i l l in  (200,000 i .u . /m l ) 1.0
Neomycin (200,000 i .u . /m l ) 1.0
Polymyxin (200,000 i .u . /m l ) 1.0
D is t i l l e d  water Up to  1,000
N.B. Medium also contained 0.001% Phenol Red as a pH in d ic a to r  
(b) M icro tes t medium
Constituent Volume (ml)
Eagles B.S.S. (xlO conc.) 80
Tryptose Phosphate Broth (2% w/v) 100
Glucose (20% w/v) 18
Sodium Bicarbonate (4.4% w/v) 20
S te r i le  Bovine Serum 20
A n t ib io t ic s  -
P e n ic i l l i n  (200,000 i . u . /m l ) 1.0
Neomycin (200,000 i . u . /m l ) 1.0
Polymyxin (200,000 i . u . /m l ) 1.0
D is t i l l e d  water Up to  1,000
N.B. Medium also contained 0.001% Phenol Red as a pH in d ic a to r 192
APPENDIX 2
METHODS OF ANALYSIS
a) Analysis of microneutralization te s t  re su lts  - a worked example
The re su lts  from the example test pla tes shown in  Figures A2.1(a) to  
A2.1(d) and A2.2(a) to  A2.2(d) would be calculated as fo l lo w s :
1) Virus t i t r e
4.79 TCID
75
X 0.5
11 Virus dose
4.79 - (4.6-2) = 2.19 log 10
111 Correction fa c to r
Expected dose
 L l2a io i___
3
2
1
Observed dose 
( l o g ip )____
3.19
2.19
1.19
Control serum t i t r e  
 Ü o i ia )______
2.11
2.85
3.61
Slope = 7.332 Correlation = -0.9999
2.19 log-|Q value from slope = 2.86 
2.00 log-jg value from slope = 3.00 
Correction factor = +0.14
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Figure A2.1 : Examples of Microneutralization Control Plates
(a) Medium, Cell and Negative Serum Controls
NP5 ke k#ee eo »ee ee *ee ©Gee 0#ee eeee ee wee
riK&i VM
Normal
Pig
Serum
Control
Cell
Control
Medium
Control
(b) P o s it ive  Serum Control
V irus Dose 
(TCIDso)
1,000
100
10
—  — —0-eY SX5 ^
2 . 1 1
2.85
3.61
Serum T i t r e  
(Logio SNso)
(c) Plate 1
Virus T i t r a t io n  Plates
(d) P late 2
0  6P 5  iftSh?- 
##0 j##e
e e e
_  3 # # #  
e u e #  eee  ee eeee  weeee
i  t  I'l I
OSFS eee  eeee  3 eee  o ee eeee  e ee eeee  eeee  e ee >eee eee  e eee
35 In ta c t  
Cell Sheets
40 In ta c t  
Cell Sheets 194
Figure A2.2 : Examples of Microneutralization Test Plates 
6 Samples per Plate
(a) (b)
! •
e e
m ueeee
%
ee
e e
w ëeeee
Of er  I 9 2
y a k # "eeeee e ie
e e b e  
e e l i .
eeeeoe
% %eeee
e e
eeee
e e
ee
e e
, o u  93 I
e eee
ee
e e
ooQ»
3-O
a>
c
r+
1.34 1.51 1.51 1.34 1.95 1.65 
TITRES (logic)
1.65 1.65 1.65 1.34 1.65 1.34
TITRES (logic)
4 Samples per Plate
(c) (d)
IkB, '3fcl»l34SJ 
# # * # # «
• • « • l é
t
r ( T '
e e  
u e
#
ce <11.
I ??ia
# # » * # # # #
# * # * # * # #  
# # »  # ! # # # #  
e e i e e t * * # #  
# # # # # # # #  
# # e # K ) * e #
j i  *  •
o c i
oo
OJ
3-a
n>
o
c
r+
1.65 3.31 1.95 1.65 
TITRES (logic)
2.56 3.16 3.01 3.01 
TITRES (logic)
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iv) Test sample results
Observed t i t r e  Corrected t i t r e  
Fig. Tag No. Sample no. (log^g)____  (log^g)____
2a 0E92 2807 1.34 1.48
2808 1.51 1.65
2809 1.51 1.65
2810 1.34 1.48
2811 1.95 2.09
2812 1.65 1.79
2b 0E93 2951 1.65 1.79
2952 1.65 1.79
2980 1.65 1.79
2981 1.34 1.48
2982 1.65 1.79
2983 1.34 1.48
2c 0E97 3689 1.65 1.79
3690 3.31 3.45
3691 1.95 2.09
3692 1.65 1.79
2d 0E98 2969 2.56 2.70
2970 3.16 3.30
2971 3.01 3.15
2972 3.01 3.15
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b) Methods for analysing ELISA data
( i )  The absorbance method - This method is most suitable for
testing large numbers of samples and was used in the antibody class 
analysis of sows and piglets serum, as well as of smvs colostrum/milk. 
Test samples were assayed for pig anti-FMD IgG, IgM or IgA at a single 
dilution (1 in 50) and the 00 value at 492nm for each sample was 
recorded. Mean OD values from two te s ts  were ca lcu la ted  and corrected 
by substracting negative control values which were either -
a) Pre-vaccination serum from adu lt sows d i lu te d  1:50.
b) Colostrum or m ilk  from non-vaccinated sows d i lu te d  1:50.
c) Pre-vaccination serum from p ig le ts  born to  non-vaccinated sows 
d i lu te d  1:50.
( i i )  The t i t r a t i o n  method - The anti serum under te s t  was s e r ia l ly
d i lu te d  in  0.5 log^g steps from 1.0 to  4.0 log^g. Mean values from 
dup lica te  te s ts  were ca lcu la ted  and p lo t te d  graphically as OD at 492nm 
against the log^g rec ip roca l antiserum dilu tion . A l in e  was then drawn 
using the OD value given by a negative pre-vacc ination  serum sample, 
taken from the same animal, at a 1.0 log^g d i lu t io n  and the d i lu t io n  at 
which th a t  l in e  in te rsected  the graphs o f post vacc ination samples was 
taken as the log^g antibody t i t r e .  An example is  shown in Figure A2.3 
fo r  sera co llec ted  from a sow at 0, 20, 51 and 72 days post vaccination 
(dpv).
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Figure A 2.3: The titration method for ELiSA analysis of pig sera 
on various days post vaccination (dpv)
2.0
Ec
CM
O)
72dpv
51dp
h"<
Q
d
20dpv
LU
=)
TITRATION END POINT
Odpv
UJ
3.0 3.5 4.02.0 2.51.51.0
SERUM DILUTION (log^Q)
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( i l l )  The log istic  saturation model - The log is tic  model used a 
computer programme (Hingley and Ouldridge, 1985) to f i t  a sigmoid shaped 
curve to OD values obtained in the ELISA using a fixed serum dilution  
(1.0 log^g) and variable antigen concentrations (0-8pg/ml 146S). The 
parameterisation of the model used was -
where
OD^  = Optical density corrected for no antigen (blank) for
the i t h  observation.
ODm = Plateau value of optical density.
K = Average in tr ins ic  association constant.
à = Heterogeneity index.
X. = Concentration of antigen f o r  i t h  observation.
E j = Normally d is t r ib u te d  e r ro r  (mean 0, variance 6 ^) to
i t h  observation.
Values obtained were used to study the func t iona l nature of the 
antibody population being measured. K and a values were corrected by 
sub trac ting  the value obtained w ith  -ve serum (Odpv) from values 
obtained with +ve sera (>Odpv) from the same animal.
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C alcu lation  of sedimentation coefficients fo r p u r i f ie d  pig
immunoglobulins
IgG (see Figure A 2 .4 (a ))
Centrifuge Temp. (°C) = 20
Centrifuge speed (RPM) = 40,000
R1-R2 (mm) = 228
Balance c e l l  distance (mm) = 16
Scan in te rva l  (mins) = 10
No. o f scans = 9
Rl-P (mm) = 70, 76, 82, 88, 
112, 120.
94, 100, 105,
S value = 6.412 S^qW = 6.412 X 1.0936 = 7.012
IgM (see Figure A2.4(b))
Centrifuge Temp. (°C) = 20
Centrifuge speed (RPM) = 40,000
R1-R2 (mm) = 228
Balance c e l l  distance (mm) = 16
Scan in te rv a l  (mins) = 10
No. o f scans = 7
Rl-P (mm) = 82, 100, 118.5, 
192.5
137, 155, 173.5,
S value = 18.384 S.gW = 18.384 X 1.0936 = 20.105
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Figure A2.4: Schlieren traces of porcine immunoglobulii 
sed i mentation
(a) PORCINE IgG
E(A
C
100
20
3 0  minutes
A 40 
y \5 0
0
(A
(0
(b) PORCINE IgM
100
minutes
20 30 40 60 70
Radius (r)
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APPENDIX 3
ELISA OPTICAL DENSITY VALUES
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Table A3.2: Immunoglobulin c la ss  a c t i v i t y  in sows revaccinated 20 days
post i n i t i a l  vaccination
NUOO NU03
OPPV
Conjuga te s p e c i f ic i t y
OPPV
Conjuga te s p e c i f ic i t y
IgM IgA IgG IgM IgA IgG
► 0 0* 0 0 ► 0 0 0 0
8 0.09 0.03 0.12 8 0.07 0 0.01
14 0.08 0.01 0.28 14 0.25 0.03 0.05
»-20 0.05 0.01 0.41 »-20 0.23 0.20 0.50
27 0.14 0.13 1.01 27 0.40 0.40 1.25
34 0.15 0.10 1.04 34 0.31 0.34 1.39
41 0.11 0.13 1.06 41 0.22 0.40 1.25
48 0.04 0.04 0.89 48 0.20 0.39 1.07
51 0.01 0.10 0.92 52 0.07 0.39 0.99
52 0.01 0.06 0.93 53 0.07 0.30 0.92
54 0.03 0.10 0.85 55 0.03 0.45 0.99
58 0 0.07 0.92 59 0 0.44 1.07
65 0 0.03 0.98 66 0 0.48 1.08
72 0 0.07 1.07 73 0 0.59 1.29
79 0 0.05 1.04 80 0 0.52 1.39
► = Vaccination
I I = Farrow
*Mean 00 at 492nm
OPPV = Days post primary vaccination
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Table A3.4: Immunoglobulin class involved in the vaccinat ion response of
p ig le t s  born to unvaccinated sows
Age at 
vaccination
(weeks)
Antibody
class
Days post vaccination
0 7 14 21 28 35
IgM 0 0.47* 0.45 0.38 0.29 0.25
1 IgA 0 0.09 0.10 0.11 0.09 0.10
IgG 0 0.01 0.37 0.98 1.18 1.22
IgM 0 0.74 0.61 0.19 0.14 0.16
2 IgA 0 0.21 0.18 0.08 0.10 0.13
IgG 0 0.05 0.54 1.09 1.27 1.26
IgM 0 0.90 0.79 0.34 0.21 0.19
4 IgA 0 0.50 0.33 0.13 0.11 0.15
IgG 0 0.12 0.80 1.28 1.34 1.34
IgM 0 0.68 0.58 0.37 0.06 0.04
8 IgA 0 0.39 0.28 0.11 0.03 0.03
IgG 0 0.11 0.52 1.01 1.13 1.19
^Corrected ELISA OD values at 492nm for samples d i lu te d  1:50
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Table A3.5: Immunoglobulin c la ss  involved in the vaccination response of
p ig le t s  born to FMD vaccinated sows
Age at 
vaccination 
(weeks)
Antibody
class
Days post vaccination
0 7 14 21 28 35
IgM 0.05* 0.03 0.05 0.12 0.17 0.23
1 IgA 0.04 0.01 0.02 0.05 0.08 0.05
IgG 1.15 0.93 0.85 0.70 0.69 0.57
IgM 0.03 0.03 0.12 0.12 0.05 0.04
2 IgA 0.01 0.04 0.04 0.08 0.05 0.05
IgG 0.99 0.84 0.76 0.77 0.73 0.70
IgM 0 0.02 0.29 0.22 0.14 0.18
4 IgA 0 0.03 0.09 0.08 0.09 0,11
IgG 0.77 0.65 0.62 0.65 0.72 0.68
IgM 0 0.14 0.42 0.43 0.31 0.20
8 IgA 0 0.08 0.17 0.16 0.13 0.10
IgG 0.49 0.41 0.51 0.63 0.69 0.71
^Corrected ELISA OD value at 492nm fo r  a sample d i lu te d  1:50
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The effect of vaccination regimen on the transfer of foot and 
mouth disease antibodies from the sow to her piglets
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SUMMARY
Four groups of pregnant sows were inoculated w ith type foot and mouth  
disease (F M D ) oil emulsion vaccine at various times before farrowing and samples 
of the sow's serum, colostrum and m ilk, and piglet's serum, collected during the 
first week after farrowing, were analysed for F M D  virus neutralizing activity.
No FMD neutralizing antibodies were detectable in the piglets serum at birth  
but they were present 1 5 h after suckling and peak titres were reached 1-3 days 
later. There was no significant difference between the antibody titres of colostrum 
samples collected from different teats at farrowing. However, similar samples 
collected 3 days later showed significant (T  <  0 005) fore to hind variation. The 
principal F M D  virus neutralizing antibody class present in the sow's serum at 
farrowing and in their 3-day-old piglets was governed by the inoculation schedule 
employed. W hen the  last vaccinations were given cïi 30 days before farrowing (dbf) 
the predom inant FM D virus neutralizing class was IgG. However, when the sows 
were vaccinated only ^  12 dbf the predominant class was Ig M . A significant 
correlation was observed between the sow's serum titres and colostrum titres at 
farrowing (r =  0 90), and also between sows colostrum titres at farrowing and their 
3-day-old piglets serum titres (r =  0 99).
IN TRO DU CTIO N
Pigs develop w ithin an impermeable epitheliochorial placenta and there is little  
or no placental transmission o f immunoglobulins from the mother to the pig foetus 
(Brambell, 1958). Consequently, piglets are largely devoid of immunoglobulins at 
birth (K im , Bradley & Watson, 1966; Porter, 1969; D u jin , 1971; Bourne ef aT, 
1974) and colostral antibodies are of major importance for their survival.
When designing a vaccination regimen for breeding sows it  is im portant to 
understand the factors affecting the transfer of im m unity to the young but to date 
this subject has received little  attention as far as foot and mouth disease (FM D ) 
oil emulsion vaccination is concerned. The fact tha t most or all absorption of 
colostral antibodies through the intestinal wall of the newborn piglet occurs during 
the first 24-48 h after birth (Lecce & Morgan, 1962; Bourne, 1971; D ujin , 1971; 
Yabiki, Kashiwazaki & Nam ioka, 1974) led us to consider whether the vaccination 
regimen of the sow, and hence the proportion of the various antibody classes in
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the sows serum during the critical lew days around farrowing, might influence the 
passive transfer of m aternally derived antibodies to the piglets. The predominant 
antibody class in the piglets is of special importance since IgG  (half life of 6 5 -22  5 
days), Ig M  (half life of 1 3 -7  8 days) and Ig A  (half life of 2 -3  5 days) vary  
considerably in their decay rates (P orter & Hill, 1970 ; Curtis & Bourne, 1971 ; 1973 ; 
Francis & Black, 1984). Hence inappropriate vaccination schedules administered 
to breeding sows may result in piglets which are not only deficient in their in itial 
antibody levels but also become susceptible to F M D  at an earlier stage due to the 
rapid decay rate of the passive antibodies.
The purpose of the present study was to provide detailed information about the 
influence of the sow's F M D  vaccination schedule on the class and titre  of 
neutralizing antibodies in her serum and colostrum at farrowing, and on the 
efficiency of transfer of these antibodies to her progeny.
M ATERIALS AND METHODS
Ten pregnant large white sows, never previously vaccinated against or in contact 
w ith F M D , were divided into three groups of two and one group of four animals 
and inoculated intram uscularly w ith a 2 ml dose of O^BFS 1860/67 F M D  single 
oil emulsion vaccine containing 5 23 yg 140S antigen according to the following 
schedules: group A, sows 1 and 2, vaccinated once at 12-13 days before farrowing 
(dbf); group B, sows 3 and 4, vaccinated once at 30-32 dbf; group C, sows 5 and 
6, vaccinated twice at 51-52  and 31-32 dbf and group D , sows 7, 8, 9 and 10, 
vaccinated twice at 87-89 and 30-32 dbf.
Blood was taken from sows 1 to 6 a t the tim e of farrowing and at 1, 3 and 5-7  
days later. Their piglets were bled just before suckling (Groups B and C), or 1 5 -2  5 h 
after (Group A) and again 1, 3 and 5 -7  days later. Blood samples were also collected 
from sows 7 to 10 at the tim e of farrowing and from their piglets at 3 days after 
farrowing. The blood was kept a t room temperature for 24 h and the serum was 
separated by centrifugation. The serum was then stored at —20 °C and inactivated  
at 56 °C for 30 min prior to  testing.
Colostrum /m ilk was collected from sows 1 to 6 a t the tim e of farrowing and at 
1, 3 and 5 -7  days later. Samples taken on each occasion from two fore, (one left 
and one right), two central and two hind teats were pooled. Colostrum /m ilk was 
also collected from sows 7 to 10 at the time of farrowing and a t 3 and 7 days later 
but here the teat samples were analysed separately. Each sample was centrifuged 
at 50000 for 30 min at 4 °(y and the whey separated, stored at —20 °C and 
inactivated at 56 °C for 30 min prior to testing.
The F M D  virus neutralizing activ ity  of the serum and whey was demonstrated 
using a micro neutralization test described previously by Francis & Black (1983). 
Each test was performed in triplicate and the results wore re(!orded as the mean 
log^ Q reciprocal o f the serum dilution which gave confluent cell sheets in 50 of 
the microplate wells.
o/" F M D  p2gr/e(g 125
A ?? a /ya » a  o / m t L - F M D  m r% A  a % ( t6 W y  c/a,s,s a c / / t ; / / y
Æc%/ra//z/%gr ac/ic»/y. Samples of serum from each sow at the time of farrowing, 
and pooled samples from each litte r at 3 days old, were fractionated by gel 
filtration. A 2 5 ml sample was applied to a 26 mm x 950 mm glass column (L K B  
Instruments L td ) containing Bio-Gel A .5M  gel filtration medium (Bio-Rad Labor­
atories) and was eluted with 0 1 M tris buffer (pH  7 2) containing 0 3 M-NaCl. A  
tota l of 1 8 0 x 2  7 ml fractions was collected and analysed for optical density at 
280 nm, neutralizing activ ity  and antibody class (using a combination of E L IS A , 
immunoelectrophoresis and sedimentation coefficient analysis). The reciprocals of 
the 50%  neutralization dilution endpoints for IgM , Ig A  and IgG  rich column 
fractions were added together in order to estimate the level of neutralizing activity  
attributable to each antibody class.
aggay (FLfS 'A). Serum samples collected from two 
sows (number 1 which had been vaccinated once 12 dbf and number 5 which had 
been vaccinated twice 52 and 32 dbf) at farrowing, and from their litters 3 days 
later, were selected for a n ti-F M D  virus immunoglobulin class analysis using an 
indirect E L IS A  method (Francis, Ouldridge & Black, 1983). Briedy, microplates 
;re coated overnight at room temperature with F M D  virus 146S antigen. The 
/lates were washed and test samples diluted 1 in 50 were added. A fter 1 h 
incubation at 37 °C plates were washed and anti-pig IgM , Ig A  or IgG  peroxidase 
conjugate (Departm ent o f Animal Husbandry, Bristol University) was added. 
A fter a further 1 h at 37 °C the plates were washed and an enzyme substrate was 
added. A fter 2-8  min colour development was stopped with 12-5% sulphuric acid 
and the optical density (O .D .) at 492 nm was measured in an L K B  Multiskan.
RESULTS
Fig. 1 shows the mean group F M D  virus neutralizing activ ity  of the serum and 
colostrum of sows w ithin groups A, B and C, and of their litters between 0 and 
168 h after farrowing. A t farrowing the mean serum titre  of the sows vaccinated 
once a t 12-13 dbf (group A) was 167 log ,^, while tha t of the animals vaccinated 
30-32 db f (group B) was 1 78 log ,^,. The sows vaccinated twice (group C) had mean 
titres o f 2 13 log ,^, at farrowing. The serum titres were (Tosely correlated w ith the 
colostral titres (r =  0 897) as illustrated in Fig. 2a. The interrelationship between 
the serum and colostrum titres was rejected by the slope of this regression line 
(M  =  1 568) which was in turn  induenced by colostral titres which were lower than  
the serum titres in group A but higher than them in both groups B and C.
The serum titres of sows in groups B and C all vaccinated at least a month before 
farrowing declined during the first 24 h after farrowing and then remained fairly  
constant for the next 5 -6  days while the serum titres of group A sows (vaccinated 
12 dbf) increased during the first 21-30 h after farrowing before showing signs of 
declining. This result was also reflected in the colostral titres which increased 
during the drst 30 h after farrowing in group A but declined steadily in groups B  
and C. The F M D  virus neutralizing antibody activity  in the colostrum /m ilk taken  
from the various teats of sows 7 -10  during the drst week after farrowing is shown 
in Table 1. There was no significant variation between samples collected from sows 
at the tim e of farrowing. The m axim um  deviation between titres from different
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Fig. 1. The mean FM D neutralizing antibody titres of sows serum, colostrum/milk and 
piglets serum during the first week after farrowing.
I Sow 
1 serum
Piglet 
I serum
teats occurred 3 days after farrowing and at this time there was a significant 
(F  >  0 005) fore to hind variation as measured by a two way analysis of variance. 
The colostral titres at farrowing were also correlated (r =  0 989) w ith  the group 
mean 3-day-old piglet serum titres as illustrated in Fig. 26 and in this case a direct 
relationship was suggested by the slope of the regression (M  =  0 980).
Sera collected from group B and C piglets prior to suckling had no detectable 
F M D  neutralizing activ ity  whereas the mean titre  of serum samples collected from  
group A  piglets 1 5 -2  5 h after farrowing was 1 10 log^g. Furthermore, individual 
piglets in these litters had titres as high as 1 36 and 1 72 log^Q. Peak antibody titres 
were observed in piglet groups A  and B at 18-30 hours after farrowing and in group 
C at 72 h after farrowing.
Table 2 shows tha t the class of antibodies present in the serum of the 3-day-old 
piglets was related to tha t predominating in the serum of their dams at tim e of 
farrowing and this in turn was dictated by the vaccination regimen employed. In  
sow number 1 which was vaccinated only 12 days previously the neutralizing 
activ ity  in the serum at farrowing was conhned to the Ig M  class and so too was 
the antibody transferred to the serum of the piglets when 3 days old. On the other 
hand sow number 5 which had been vaccinated twice at 52 and 32 dbf the 
neutralising activ ity  in her serum was confined to the IgG  class. Here there was 
no F M D  neutralizing Ig M  antibody in the serum of the 3-day-old piglets and the
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Fig. 2. Regression analysis of relationship between sows serum, colostrum and 3-day-old
piglet serum titres.
Table 1. m  coMecfetf yirom ata:
(eafa aoMtg /o r 7
Sample teat
Sow
tag
Days
after Left Left Left Right Right Right
Mean
titre
no. farrowing fore central hind fore central hind (Logio) S.D.
7 0 2-90 299 3 14 294 294 319 342 012
3 1-89 1 74 1 89 165 1 79 2^a 190 048
7 143 154 159 149 1 54 174 156 Odl
8 0 283 298 303 288 273 293 290 O il
3 1 72 2 13 228 168 1 72 248 200 044
7 158 1 12 168 095 099 137 128 041
9 0 2^& 280 300 290 3 10 34# 290 040
3 1 20 1 19 2dO 1 25 2 15 290 180 070
7 066 062 069 080 1 55 113 &91 046
10 0 2^# 336 306 311 3 11 341 3 15 Od5
3 186 250 286 180 1 90 236 221 043
7 1 45 226 190 1 45 1 45 206 176 046
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Table 2. q / r e g r $ m e %  o% c Wa
m aott; aW ])»g'Ze( gerwm
(a) Sow serum at farrow
Teat
ELISA (O.D.) 
Neutralizing antibody 
titre (Logio)
Test
ELISA (O.D.)
Neutralizing antibody 
titre (Logio)
Sow 1 : Group A
(vaccinated 12 dbf)
Sow 5 : Group C 
(vaccinated 52 and 32 dbf)
IgM IgA IgG IgM IgA IgG
0 17 0 14 003 001 0 10 092
2 18 <  0 75 <  0 75 <  0 90 <  0 90 262
(6) Piglet serum 3 days old
Litter 1 : Group A L itte r 5 : Group C
IgM IgA IgG IgM IgA IgG
038 034 0 19 015 020 090
1 75 <  0 50 <  0 50 <  0 54 1 96 2^1
main neutralizing activ ity  was due to IgG  antibodies. However, in this case some 
neutralizing Ig A  activ ity  was also evident in the piglets serum. The principal 
immunoglobulin class responsible for the anti-FM D  ac tiv ity  detected in the 
indirect E L IS A  was the same as th a t responsible for neutralization. However, some 
activ ity  was also detectable in the other classes possibly due to the increased 
sensitivity of the test system.
DISCUSSION
The vaccination regimen employed in this study, for the breeding sows, appeared 
to have the desired effect of providing sows w ith different levels of anti-FM D  
antibody class activ ity  a t farrowing. Vaccination ^ 1 2  dbf produced serum F M D  
neutralizing antibodies which were mainly, or exclusively, of the Ig M  class at 
farrowing while vaccination a month or more before farrowing resulted in 
predominantly IgG  class neutralizing antibodies in the serum of the farrowing sows. 
This confirms previous observations relating to the development of various 
neutralizing antibody classes in pigs after F M D  oil emulsion vaccination (McKercher 
& Giordano, 1967 ; Anderson, Masters & Mowat, 1971 ; Ouldridge, Francis & Black, 
1982). Furthermore, the 3-day-old piglets from sows vaccinated 12 dbf had only 
neutralizing Ig M  antibodies in their serum while those from sows vaccinated a 
month or more before farrowing had predominantly IgG . Some neutralizing Ig A  
was also observed in 3-day-old piglets however, since none was detectable in the 
sows serum at farrowing, its source is not clear.
The results of the IgG  and Ig M  analysis demonstrated th a t in general the class 
of F M D  virus neutralizing antibody transferred to the piglets was dependent on 
the antibody class predominating in the sows serum a t time of farrowing and 
stresses the importance of adopting a rational approach to vaccination since F M D  
virus neutralizing antibodies of different classes have m arkedly different decay 
rates in piglets. In  litters from sows vaccinated only 12-13 dbf, which receive
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predominantly an ti-F M D  Ig M , the half-life of F M D  virus neutralizing activ ity  is 
4D8 days while in litters from sows vaccinated or revaccinatcd 30-32 dbf, which 
receive predominantly an ti-F M D  IgG , the half-lilc of F M D  virus neutralizing  
activ ity  is 7-21 days (Francis & Black, 1984).
No F M D  virus neutralizing antibodies were detectable in any piglet sampled at 
birth  and prior to suckling which agrees w ith previous findings relating to the 
im perm eability of the sow's epitheliochorial placenta (Brambell, 1958; K im , 
Bradley & Watson, 1966; Porter, 1969; D u jin , 1971; Bourne a/. 1974). 
Nevertheless, group 1 piglets attained antibody levels as high as 1 36 log^„ within  
1 5  h and 1 72 log ,^, w ithin 2 5 h of birth demonstrating the piglets remarkable 
capacity to absorb protective antibodies from their mothers colostrum. The peak 
of passive antibody activ ity  was observed in the 18-30 h samples collected from  
litters derived from singly vaccinated sows which supports published findings that 
antibody absorption ceases w ithin 24-M 8h of suckling (Leece & Morgan 1962; 
Bourne, 1971; Dunin, 1971; Yabiki, Kashiwazaki & Nam ioka, 1974). However, 
the m axim al level of passive antibody in piglets from revaccinated sows occurred 
72 h after farrowing. I t  is therefore possible tha t the vaccination regimen of the 
sow, and therefore the class and titre  of F M D  virus neutralizing antibodies in the 
colostrum a t farrowing, may have induenced the rate at which the antibodies were 
absorbed by the piglets.
There was no significant teat to teat variation in colostral antibody titres at the 
time of farrowing contrary to published data on the subject (Perry & Watson, 
1967). Therefore, any variations observed between the serum titres of individuals 
within a litte r is not due to variation in the colostrum titres from different teats 
of the sow. I t  seems likely tha t the greater degree of variation which occurred 3 days 
later was due to selective suckling by the young piglets. I f  this hypothesis is correct 
then the piglets displayed a preference for suckling from the fore teats on the sow as 
demonstrated by the significantly lower titres in samples collected from these teats 
3 days after suckling.
Despite the differences in neutralizing antibody class and rate of absorption 
which have been diseussed it  was possible to establish a relationship between F M D  
virus neutralizing antibody levels in the sow and her young. There was a significant 
correlation (r =  0 99) between the sow's colostral titres at farrowing and 3-day-old 
piglet serum titres and sinee the regression slope was very close to 1 00 (w =  0 98) 
a direet relationship between the two is indicated. This observation would imply 
that the piglet gut absorbs F M D  virus neutralizing antibodies of different 
immunoglobulin classes non-selecti vely which would support published data on the 
subject (Bourne, 1971 ; Brown, 1976). There was also a good correlation (r =  0 90) 
between sows serum and colostral titres at farrowing. However, the slope of the 
regression between the two ( m =  1 57) suggest that the mechanism of concentrating 
antibodies from the serum into the colostrum is either selective for immunoglobulin 
class or influenced in some other way by the sow's vaccination regimen.
I t  is im portant for herd im m unity that young pigs are protected against F M D  
from as soon as possible after birth until they are actively immunized by 
vaccination, generally a t 1-2 months old. This study has demonstrated the role 
of m aternally derived antibodies in providing the young pigs with such protection 
and has emphasised the importance of maintaining high titres of F M D  virus
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neutralizing antibodies in breeding sows, particularly around the time of farrowing. 
Therefore, it  would be advisable to revaccinate sows during pregnaney. However, 
since it  has been shown th a t the interval between vaccination and farrowing affects 
the concentration of F M D  virus neutralizing antibodies in the colostrum, this 
should not be carried out w ithin 1 month of farrowing. Furtherm ore, a 1 month  
time interval would reduce the proportion o f F M D  neutralizing Ig M  antibodies, 
which are also provoked by revaccination (Ouldridge, Francis & Black, 1982) and 
have a rapid decay rate (Francis & Black, 1984), passed onto the young. In  a 
situation where fully susceptible breeding sows are being vaccinated against F M D , 
for example in a country introducing a pig vaccination campaign for the first time, 
regimens that produce a n ti-F M D  Ig M  at farrowing should be avoided. Therefore, 
susceptible pregnant sows should receive a double vaccination w ith  the booster 
dose being given 1 month before farrowing.
W e are grateful to Professor F . J. Bourne and D r T . J. New by of the Departm ent 
of Animal Husbandry, Bristol University for supplying the immunoglobulin 
specific conjugates used in the E L IS A .
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Effect of the sow vaccination regimen on the decay rate of 
maternally derived foot-and-mouth disease antibodies in piglets
M. J. FRANCIS, L. BLACK,
Ash Road, Pirbright, Woking, Surrey
Three pairs of sows were vaccinated against foot-and- 
mouth disease (fmd) at various intervals before 
farrowing and samples of blood were collected from 
their piglets periodically for 70 days after birth. 
When the sows were vaccinated 12 to 13 days before 
farrowing the predominating fmd neutralising 
antibody at time of parturition was IgM and the 
observed half lives of the maternally derived anti­
bodies in the piglets were short (four to eight days). 
However, when sows were last vaccinated 30 to 32 
days before farrowing, the maternally derived fmd 
neutralising antibodies in the piglets were pre­
dominantly IgG and the observed half lives were 
seven to 21 days. These observed half lives for IgG 
were shown to be closely related to the period over 
which the maternally derived antibodies could be 
demonstrated and to the rate of increase of the 
piglet’s blood volume over the same period. If  
corrections were made for increase in blood volume 
the decay rate of IgM antibodies in piglets was seven 
to 18 days while the decay rate for IgG was greater 
than 408 days. This result suggested that there was 
little or no IgG catabolism or excretion during the 
first 70 days of the piglet’s life.
SINCE piglets develop within an epitheliochorial 
placenta (Brambell 1958) they are largely devoid o f 
immunoglobulins at birth (Kim et al 1966, Porter 
1969, D ujin  1971, Bourne et al 1974) and, conse­
quently, colostral antibodies make an important 
contribution to protection from disease during their 
first weeks o f life (Renshaw 1975, Brandenbury and 
Wilson 1979, Wittmann and Jakubik 1979, Bridger 
and Brown 1981).
To date, relatively little attention has been directed 
towards the foot-and-mouth disease ( fm d ) vaccina­
tion regimen o f the sow and its effect on the class o f 
antibody in the serum and colostrum at the time o f 
farrowing. Since the antibody class is likely to 
influence the persistence o f maternally derived anti­
bodies in piglets (Porter and H ill 1970, Curtis and 
Bourne 1971) this experiment has been designed to 
determine the effect of various sow vaccination
regimens on the decay rate of the FMD neutralising 
antibodies passed to their piglets and to investigate
the influence o f piglet growth rates on these results. 
The information so obtained should facilitate 
predictions about the duration o f colostral protec- 
tion in piglets born to FMD vaccinated sows and 
enable one to design optimal vaccination regimens 
for breeding stock on this basis.
Materials and methods
Vaccination schedule
Six pregnant Large White sows were divided into 
three groups o f two and vaccinated intramuscularly 
behind the ear using a 2 ml dose o f fm d  virus strain 
0|BFS I860 oil emulsion vaccine (Batch 0-115, 
Wellcome) which contained 5-2 pg o f intact 1468 
FMD immunising antigen (Brown and Newman 1963) 
per dose. Sows 1 and 2 were vaccinated 30 to 32 days 
before farrowing, sows 3 and 4 were vaccinated 51 to 
52 days before farrowing and then revaccinated 31 to 
32 days before farrowing and sows 5 and 6 were 
vaccinated 12 to 13 days before farrowing.
Serum sampling
Blood samples were collected from each piglet at 
three days, one week and then weekly after farrowing 
for 10 weeks. This blood was kept at room tem- 
perature for 24 hours and the serum was separated by 
centrifugation. The serum was then stored at -  20°C 
and inactivated at 56°C for 30 minutes prior to 
testing.
Immediately before each blood sampling the 
weight of the piglets was recorded and converted to
blood volume using the formulae o f von Engelhardt 
(1966) as shown: Up to 25 kg body weight, BV = 9-5 
X W "° and above 25 kg bodyweight, BV =17-9
X where BV is blood volume (ml [100 g body­
weight] ” ') and W is bodyweight (kg).
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The neutralising activity of the piglet serum 
samples was demonstrated using a microneutralisa­
tion test (Francis et al 1983). Each test was done in 
triplicate and the results were recorded as the mean 
logio reciprocal of the serum dilution which gave 
confluent cell sheets in 50 per cent of the microplate 
wells.
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Pooled samples o f serum from each litter at three 
days old were fractionated by gel filtration. A 2 5 ml 
sample was applied to a 26 mm x 950 mm glass
column (LKB Instruments) containing Bio-Gel A-5 
M gel filtra tion medium (Bio-Rad Laboratories) and 
was eluted with 0-1 M  Tris buffer containing 0 3 M 
sodium chloride. A  total o f 180x2-7 ml fractions 
were collected and analysed for optical density, 
neutralising activity and antibody class (using a 
combination o f enzyme-linked immunosorbent assay, 
immunoelectrophoresis and sedimentation coefficient 
analysis). The neutralising titres observed w ithin IgM, 
IgA and IgG-rich regions o f the column were added 
together and the percentage fm d  neutralising activity 
for each class in the three-day-old litters was calcu­
lated.
Calculation o f  observed h a lf  lives
The observed half lives o f maternally derived 
antibodies fo r each litter were calculated from the 
decrease in the mean log,o neutralising antibody titres
for that litter over time using a linear regression and 
the following two conditions. First, only piglets with 
logio antibody titres greater than I - Oat three days old 
were taken into account and second, in any litter 
where the antibody levels o f individual piglets had 
fallen to their least detectable value (as indicated by 
subsequent bleedings) the mean ha lf life o f the litter 
was determined up to that point. Results were based 
on seven to eight piglets per litter except in litter 2 
where, due to the sow’s poor vaccination response, 
only four piglets met the first condition.
Calculation o f  the catabolism and, or, excretion rate
The antibody titres observed were corrected for 
increases in blood volume according to the following 
formula:
Blood volume at sample point (a)
Blood volume at start o f the experiment 
(three days after birth) (b)
X  FMD neutralising antibody titre at sample point (c) 
= Corrected titre
In practice, the log,g values for the blood volumes 
were subtracted from each other (a-b) and the result 
was added to the log,o observed antibody titre (c) to 
give the corrected log,o titre. These corrected titres 
were used to calculate the half lives o f neutralising 
antibodies due to catabolism/excretion using a linear 
regression as before.
Results
The results o f the antibody class analysis (Table 1) 
showed that in piglets born to sows vaccinated or 
revaccinated 30 to 32 days before farrowing, 60 to 91 
per cent o f the fm d  neutralising activity resided in the 
IgG fraction, whereas in those piglets born to sows 
vaccinated 12 to 13 days before farrowing 100 per 
cent o f the fm d  neutralising activity was in the IgM 
fraction.
The mean neutralisation titres (log,o) fo r each 
litter, calculated from the mean o f three titrations on 
each serum sample, are shown in Figs la  to I f  
together with the linear regression slopes. The fit o f 
the linear regression slopes to individual piglet data 
was highly significant (r>0-9, P<0-00I) fo r all 
litters. The observed ha lf lives o f maternally derived 
antibodies (mean per litter) were 18 - 4 (n = 8) and 7 - 4 
(n = 4) days in the piglets born to sows 1 and 2 which 
were vaccinated 32 and 30 days before farrowing 
respectively; 20-9 (n = 8) and 20-6 (n = 8) days in 
piglets born to sows 3 and 4 vaccinated at 51 and 31, 
and 52 and 32 days before farrowing respectively; 
and 4 - 2 (n = 8) and 7 - 8 (n = 7) days in piglets born to 
sows vaccinated 12 and 13 days before farrowing 
respectively.
TABLE 1: FMD neutralising antibody class activity in three day old piglets serum and the maternal antibody decay rates
Litter
Sow vaccination 
(days before farrowing)
Percentage of neutralising activity 
in each antibody class 
IgM IgA IgG
Observed half life 
of neutralising 
antibody (days)
Half life corrected 
fo r blood volume 
increase (days)
1 32 2 7 91 184 >408
2 30 20 20 60 7 4 Infinity
3 51 and 31 0 13 87 2 09 Infinity
4 52 and 32 6 6 88 206 Infinity
5 12 100 0 0 4 2 6 9
6 13 100 0 0 7 8 184
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FIG 1 : Observed
Age of piglets (daysl 
-I and corrected (- - decay rates of
maternally derived FMD antibodies in piglets. DBF Days before 
farrowing
The mean increase in bodyweight (kg) and blood 
volume (ml) for the 43 piglets is given in Table 2. This 
table also shows rate of increase in the mean blood 
volumes calculated from a linear regression analysis 
o f the mean log,o values.
TABLE 2: M ean bodyweight, blood volume and blood volume 
doubling over the first 70 days of life
Age of piglets 
(daysl
Mean
bodyweight
(kgl
Mean blood 
volume 
(mil
Blood volume 
doubling time 
from day 3 
(daysl
3 1 75 160 04 —
6-7 2 50 223 15 7 02
13-14 3 97 343 40 8 68
20-21 5 77 486 56 10-81
27-28 7 92 653 64 12 19
34-35 10 52 851 61 13 39
41-43 13 64 1084 85 14 49
48-49 1660 1302 76 15 58
55-56 18-67 1453 55 16 92
62-63 20 79 1606 81 18-31
69-70 22 91 1759 00 19-80
The half lives of antibodies in piglets from sows 5 
and 6 vaccinated 12 and 13 days before farrowing, 
corrected for blood volume increase, were 6 9 and 
18 4 days respectively (Figs le and If) while the 
corrected half lives in piglets from sows 1 to 4 
vaccinated or revaccinated 30 to 32 days before 
farrowing ranged from greater than 408 days to 
infinity (Figs la to Id).
Discussion
The vaccination schedules used in this experiment 
were based on previously published observations 
(Ouldridge et al 1982) and resulted in litters with 
principally either IgG or IgM fm d  neutralising anti­
bodies in their sera three days after sucking. The 
litters which received principally neutralising IgM 
antibodies had observed mean half lives o f 4-2 and 
7 8 days. These results, based on FM D  virus neutralis- 
ing activity, were somewhat higher than values 
published elsewhere o f 1-3 to 4-5 days which were 
based on the decay o f normal serum IgM (Porter and 
H ill 1970, Curtis and Bourne 1971, Curtis and 
Bourne 1973, Klobasa et al 1981). However, 
although only neutralising IgM activity could be 
detected in the three-day-old piglet serum pools of 
these litters, it seems possible that low levels o f 
neutralising IgG were present at farrowing which 
were not detectable by the technique employed, but 
nonetheless lengthened the observed ha lf lives o f 
maternally derived antibodies in the litters. The 
observed mean half lives in piglet litters 1 to 4 which 
received principally IgG antibodies were generally 
longer (7-4, 18-4, 20-6 and 20-9 days). A  similar 
range o f passive IgG ha lf live values (7-5 to 19-7 
days) appears in the literature (Porter and H ill 1970, 
Curtis and Bourne 1971, Curtis and Bourne 1973, 
Launais et al 1978, Frenyo et al 1980/81, Klobasa et 
al 1981, Paul et al 1982).
In seeking an explanation for the wide variation in 
the passive antibody half lives it was attempted to 
identify the true ha lf lives due to catabolism/ 
excretion o f the neutralising passive antibodies by 
taking into account the influence o f dilution 
produced by increased blood volume with size. 
Although previous authors have drawn attention to 
the effect that the rapid growth rate o f young pigs 
might have on their observed antibody half life 
values (Porter and H ill 1970, Curtis and Bourne 
1971, Curtis and Bourne 1973) and used this to 
explain litter to litter variation in results obtained 
(Curtis and Bourne 1971, Curtis and Bourne 1973), 
few have actually measured and corrected for body­
weight increase. The corrected half lives o f passive 
IgM antibodies in the litters due to catabolism were 
calculated to be between 6-9 and 18-4 days. With 
regard to the IgG antibodies the results suggested
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that there was little or no IgG catabolism/excretion 
during the first 10 weeks of the pigs' life and that all, 
or almost all, of the fall off in the piglet's neutralising 
IgG titres was due to their increased size and vascular
compartment volume.
In an earlier study on porcine parvovirus antibody 
the authors corrected for bodyweight increase in 
16-to 24-week-old piglets and obtained a mean 
correct half life value o f 29 days (Paul et al 1982). 
Therefore the low catabolic rate observed in this 
report may be due to the age of the piglets studied. 
Since young pigs do not attain adult levels of IgG 
until they are 12 to 16 weeks old (Curtis and Bourne 
1971, Frenyo et al 1980/81) it is possible that in 
piglets less than 10 weeks old, as used in this study, 
catabolism is controlled by the level of total serum 
IgG. The control o f IgG catabolism by the total 
serum IgG concentration has been reported in other 
species (Fahey and Robinson 1963, Sell 1964, 
Waldmann and Strober 1969). Furthermore, IgM 
and IgA catabolism has been shown to be 
independent o f serum concentration (Waldmann and 
Stober 1969) which would explain why catabolism 
was observed in litters 5 and 6.
We were also able to demonstrate that the 
doubling time of the vascular volume depended 
largely on the age and period over which the observa- 
tions were made. For example, when measured in 
three- to seven-day-old piglets the doubling time for 
the blood volume was approximately seven days but 
when measured in the same piglets over three to 70 
days the blood volume doubling time was almost 20 
days. Thus, although a linear regression provides a 
good fit to the data (r>0 95 in all six litters), the 
observed half life is not strictly linear and is 
influenced by the rapid blood volume doubling time 
in the first few weeks of the piglet's life. The 
influence o f these findings on the half life o f the 
maternally derived IgG antibodies is apparent in the 
case o f litter 2 where the relatively short ha lf life o f 
7 4 days can be ascribed to the fact that the titres of 
maternally derived antibodies were low and could 
only be measured for 13 days after farrowing. During 
this period the doubling time of the blood volume 
was correspondingly short (8-7 days). This variation 
in observed half life values due to piglet age and time 
over which observations were made has been 
reported previously for porcine parvovirus antibody 
(Paul et al 1982).
Using this hypothesis differences in previously 
published IgG half life values could be accounted for 
to a large extent by relating them to the observation 
period used in each instance. For example, an IgG 
half life o f 12 to 14 days (Curtis and Bourne 1971) 
was calculated over the first four weeks of life during 
which time the blood volume doubles, on average, 
every 12 2 days, while a half life o f 17 days (Launais
et al 1978) was calculated over the first 10 weeks of
life during which time the mean blood volume doubles 
every 19 8 days (Table 2).
For practical purposes, a linear regression drawn 
through the observed neutralising titres o f all the 
piglets in a litter is useful in that it can be used to 
predict the time at which the titres drop below protec­
tive levels (Black et al 1984) and also when the vaccina­
tion inhibitory activity subsides to below acceptable 
limits.
To provide maximum passive protection for the 
piglets against FMD it would seem advisable to give 
previously vaccinated sows a booster vaccination 
during pregnancy. Un vaccinated sows should be 
inoculated twice during this period. In order to 
ensure that antibodies predominantly o f IgG class 
and virus neutralising are passed to the piglets, an 
interval of at least 30 days is required between final 
vaccination and time o f farrowing. Finally, although 
no deleterious effect of FMD vaccination in pigs has 
ever been demonstrated it seems wise to avoid 
vaccinating during the first month of pregnancy 
when the fetus is most prone to damage.
References
BLACK, L .. FRANCIS, M . J., R W E Y E M A M U , M . M .. 
U M E H A R A , O. &  BOGE, A. (1984) Vowma/ B/o/og/ccr/
Standardisation (In  press)
BOURNE, F. J., CURTIS, J., JOHNSON, R. H. & CODLINGS, 
D. F. (1974) Research in Veterinary Science 16, 223-227 
BRAM BELL, F. W. R. (1958) 1060-1063
BRANDENBURY, A. C. & W ILSON, M . R. (1979) /m/MWMo/o&y 
24, 119-127
BRIDGER, J. C. & BROW N, J. F. ( I9 8 I) /m/fcnoM 
31, 906-910
BROWN, F. & N E W M A N , J. F. E. (1963) VourW  o/^  
(Cambridge) 61, 345-351 
CURTIS, J. &  BOURNE, F. J. (1971)
236, 319-332
CURTIS, J. & BOURNE, F. J. (1973) /mmwMo/o&K 24, 147-155
D U JIN , T. Z. (1971) Acta Veterinaria 21, 111-119 
EN G E LH A R D T, W . von (1966) Swine in Biomedical Research. Eds 
L. K. Bustad and R. O. McClellan. Battelle Memorial Institute, 
pp 307-329
FA H EY, J. L. & ROBINSON, A. G. (1963) yowrW  o /E xp en -
mental Medicine 118, 845-868 
FRANCIS, M . J., O U LD R ID G E , E. J. & BLACK, L. (1983) 
Research in Veterinary Science 35, 206-210 
FRENYO, V. L ., PETHES, G., A N T A L , T. & SZABO, I. (1980/ 
81) Veterinary Research Communications 4, 275-282 
K IM , Y. B., BRADLEY, S. G. & W ATSO N, D. W . (1966) VowrW  
o f  Im m unology  97, 52-63  
KLOBASA, F., W E R H A H N , E. & BUTLER, J. E. (1981) /(esfgrcA 
in Veterinary Science 31, 195 -206  
LA U NA IS , M ., A Y N A U D , J. M . & C O R TH IER , G. (1978) 
Veterinary M icrob io logy  3, 31-43 
O U LD R ID G E , E. J., FRANCIS, M. J. & BLACK, L. (1982) 
Research in Veterinary Science 32, 327-331 
PAUL, P. S., M E N G E LIN G , W. L. & P IR TLE, E. C. (1982) 
American Journal o f  Veterinary Research 43, 1376-1379 
PORTER, P. (1969) B/ocA/m/m zlc/o 236, 319-332
PORTER, P. & H IL L , I. R. (1970) /mmuMo/ogT 18, 365-373
76 M. J. Francis, L. Black
RENSHAW , H . W . (1975) Amencgm VourW  o/^  Fe/efmgo' W IT T M A N N , G. & JAKUBIK, J. (1979) A rc /,/vefq /|//m /o& y 60,
Research 36, 5 -13  33-42
SELL, S. (1964) Journal o f  Experimental Medicine 120, 967-986 
W A LD M A N N , T. A. & STOBER, W . (I% 9 ) fmgrejis w A //e w
13, 1-1 1 0  Received f o r  publication October 3, 1983
Reproduced with permission of copyright owner. Further reproduction prohibited without permission.
